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resumo 
 
 
Os fármacos são importantes contaminantes ambientais. Nas últimas duas
décadas, o número de estudos sobre a ocorrência destes poluentes
emergentes em matrizes ambientais aumentou significativamente. Esta
ocorrência generalizada preocupa a comunidade científica devido a evidências
que comprovam a sua capacidade de interferir nos ecossistemas, mesmo em
concentrações muito baixas. No caso particular dos fármacos psiquiátricos é
expectável que constituam um risco ecológico significativo. Para uma melhor
compreensão do impacto real destes poluentes é essencial que se proceda a
uma avaliação extensiva da sua persistência e destino em matrizes
ambientais. 
 
Os estudos apresentados nesta tese pretendem contribuir para melhorar o
conhecimento acerca da ocorrência, persistência e destino ambiental de
fármacos psiquiátricos. Para este efeito, foram seleccionados, como objecto de
estudo, dois grupos de fármacos: anti-epilépticos (carbamazepina) e fármacos
com efeitos ansiolíticos e sedativos (as benzodiazepinas diazepam, oxazepam,
lorazepam e alprazolam).  
 
A fotodegradação é o principal processo que afecta a persistência de
poluentes orgânicos em ambientes aquáticos. Consequentemente, a
persistência dos cinco fármacos seleccionados foi avaliada através de estudos
de fotodegradação directa e indirecta, tendo em consideração a influência de
parâmetros relevantes tais como pH, nível de oxigenação e matéria orgânica
dissolvida. Os estudos de fotodegradação aqui descritos foram seguidos por
cromatografia micelar electrocinética com a aplicação de um capilar com
revestimento dinâmico. Adicionalmente, os fotoprodutos resultantes de
fotodegradação directa foram identificados por espectrometria de massa. 
 
O estudo da carbamazepina no ambiente é particularmente relevante uma vez
que esta foi proposta como um potencial marcador de poluição antropogénica.
A sua ocorrência em água superficiais, de sub-solo e residuais foi investigada
através da implementação de um ensaio imunológico (ELISA), optimizado para
a aplicação a triagens ambientais e amostras com matrizes complexas. O
destino deste fármaco na interface água/solo foi também investigado usando
solos agrícolas submetidos a fertilizações de longo prazo; este estudo permitiu
tirar conclusões acerca da contaminação de águas adjacentes por solos
contaminados. 
 
O trabalho aqui descrito constitui uma abordagem multidisplinar à problemática
da ocorrência de fármacos psiquiátricos no ambiente, contribuindo de forma
relevante para esta área de estudo. 
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abstract 
 
Pharmaceuticals are considered to be important environmental contaminants.
During the last two decades, the number of studies reporting the occurrence of
these emerging contaminants in a large variety of environmental matrices has
undergone a dramatic increase. This widespread occurrence is raising
awareness amongst the scientific community due to some evidence indicating
their ability to interfere with ecosystems at extremely low concentrations.
Psychiatric pharmaceuticals, in particular, are thought to impose significant
ecological risks. A better understanding of the real impact of these pollutants
implies a comprehensive evaluation of their persistence and fate in
environmental matrices. 
 
The studies presented in this thesis aim at providing a significant contribution to
increase the existing knowledge related to the occurrence, persistence and
environmental fate of psychiatric pharmaceuticals. For this purpose, two groups
of psychiatric pharmaceuticals were selected as object of study: anti-epileptics
(carbamazepine) and pharmaceuticals with anxiolytic and sedative effects (the
benzodiazepines diazepam, oxazepam, lorazepam and alprazolam).  
 
Photodegradation is considered to be the main process affecting the
persistence of organic pollutants in aquatic environments. Consequently, the
persistence of the five selected psychiatric pharmaceuticals was evaluated by
performing direct and indirect photodegradation studies and considering the
influence of some relevant parameters such as pH, oxygenation level and
dissolved organic matter. The photodegradation studies hereby reported were
followed by a newly developed micellar electrokinetic chromatography method,
using a dynamically coated capillary. In addition, the photoproducts generated
under direct photodegradation were identified by mass spectrometry.  
 
The study of carbamazepine in the environment is particularly relevant as this
compound has been recently proposed as a possible marker of anthropogenic
pollution. The occurrence of carbamazepine in surface, ground and
wastewaters was investigated through the implementation of an immunoassay
(ELISA), optimized to perform high throughput environmental screenings in
complex matrices. Moreover, the fate of this pharmaceutical at the water/soil
interface was studied using agricultural soils submitted to different long-term
amendments, allowing for some conclusions on the possible contamination of
adjacent water resources by contaminated soils.  
 
The work here presented constitutes a multidisciplinary approach to the
environmental occurrence of psychiatric pharmaceuticals and gives a fair
contribution to this area of concern. 
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CHAPTER 1 
Introduction 
 
 
 
Nowadays, pharmaceuticals are considered to be an important group of environmental 
contaminants. These compounds are being introduced into the environment on a continuous basis, 
mainly through wastewater treatment plants, as a result of the inadequacy of the treatment 
processes applied in these facilities. The occurrence of these widely consumed compounds in a 
large variety of environmental matrices, as well as the first studies indicating their high persistence 
and toxicity to non-target organisms, justify the growing concern about these relatively recent 
environmental pollutants. However, there is still a considerable lack of knowledge about the 
environmental effects, fate and persistence of these compounds, especially regarding the group of 
psychiatric pharmaceuticals. This introductory chapter presents a brief overview about 
pharmaceuticals as environmental contaminants and delineates the main goals of the work 
presented in this thesis. 
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1.1 PHARMACEUTICALS IN THE ENVIRONMENT  
AN EMERGING CONCERN 
 
Pharmaceuticals are a large and diverse group of organic compounds used in very high 
amounts throughout the world (Jones et al., 2001; Bound and Voulvoulis, 2004; Jones et al., 2004; 
Petrovic and Barceló, 2007), developed with the aim of exerting a biological effect (Jones et al., 
2005). These compounds are used by humans and other animals (pets and live stock) to treat a large 
spectrum of diseases, fight infections and reduce disease´s symptoms. Consequently, mainly due to 
the beneficial effect produced in humans, and also to the increase of life expectancy, the use of 
pharmaceuticals is expected to grow (Daughton and Ternes, 1999). Nowadays, in the European 
Union, there are more than 3 000 active substances available in the market (Redshaw et al., 2008).  
The first known reports specifically referring to the incomplete removal of some 
pharmaceuticals by wastewater treatments and the consequent discharge into the environment by 
wastewater treatment plants (WWTP) were published in the 1960s and 1970s (Stumm-Zollinger 
and Fair, 1965; Hignite and Azarnoff, 1977). Despite these first findings indicating 
pharmaceuticals as a potential group of environmental contaminants, this issue did not attract 
significant attention until the 1990s (Purdom et al., 1994; Desbrow et al., 1998; Routledge et al., 
1998) when it was discovered that some of these compounds have the ability to interfere with 
ecosystems in concentrations as low as a few nanograms per liter (Halling-Sorensen et al., 1998). It 
was also during that decade that the first optimized analytical methods for the quantification of 
pharmaceuticals in environmental samples were developed, allowing the determination of very 
small quantities in aquatic environments (Eckel, 1993; Holm et al., 1995; Ternes, 1998; Ternes et 
al., 1998; Snyder et al., 1999). Since then, as a consequence of several published studies reporting 
the occurrence of these compounds in the environment (Ternes, 1998; Ternes et al., 2001; Kolpin et 
al., 2002; Al-Rifai et al., 2007; Conley et al., 2008), as well as the large amount of pharmaceuticals 
produced and increasing use and diversity (Bound and Voulvoulis, 2004), the existence of 
pharmaceutical drugs and pharmaceutically active metabolites in the environment has been 
considered one of the emerging concerns in environmental sciences (Halling-Sorensen et al., 1998; 
Daughton and Ternes, 1999; Heberer, 2002; Carlsson et al., 2006). Moreover, and taking into 
consideration that pharmaceuticals do not occur in the environment individually but as complex 
mixtures, several investigations showed that toxicity of pharmaceuticals to non-target organisms 
may be occurring at very low concentrations due to combined and synergistic effects (Henry and 
Black, 2007; Pomati et al., 2007; DeLorenzo and Fleming, 2008; Pomati et al., 2008; Painter et al., 
2009; Quinn et al., 2009; Schnell et al., 2009). These findings were a clear contribution to raise 
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awareness about this subject and pharmaceuticals are now unanimously considered as an important 
group of environmental contaminants. 
In January 2011, the U.S. Environmental Protection Agency published a list of 11 454 
references considered to be directly or peripherally connected to research involving 
pharmaceuticals and personal care products in the environment (EPA, 2011). Despite the growing 
number of studies on this subject, there is still much to be understood about environmental 
transformations, fate (Loffler et al., 2005; Kwon and Armbrust, 2006; Redshaw et al., 2008) and 
effects of these compounds (Calleja et al., 1994; Brooks et al., 2003a; Brooks et al., 2003b; Brain et 
al., 2004; Johnson et al., 2007; Gaworecki and Klaine, 2008; Gust et al., 2009). 
 
1.2 SOURCES  OF PHARMACEUTICALS INTO THE ENVIRONMENT  
 
Pharmaceuticals are not completely metabolized by the human body and are excreted as the 
unchanged parent compound or as metabolites or conjugates (generally glucuronides) (Heberer, 
2002) (Figure 1.1). Even if pharmaceuticals are extensively metabolized, their metabolites may 
continue to be biologically active or, in some cases, be easily transformed into the parent 
compound by hydrolysis or due to bacterial action (Halling-Sorensen et al., 1998; Richards and 
Cole, 2006). Thus, significant amounts of the parent compound in the unmetabolized form or as 
metabolites are continuously excreted into the sewage systems, reaching WWTPs. As a result of 
the inadequacy of removal treatment methods applied in these facilities, the discharge of WWTPs 
effluents is considered to be the primary pathway of pharmaceuticals into the environment (Kinney 
et al., 2006a; Gómez et al., 2007; Conkle et al., 2008; Zhang et al., 2008; Loganathan et al., 2009; 
Jelic et al., 2011). These compounds can also reach aquatic and terrestrial environments due to 
direct release of treated effluents from production industries, use of treated wastewater for 
irrigation, land application of sludge, use in veterinary treatments (Pedersen et al., 2005; Kinney et 
al., 2006a; Kinney et al., 2006b; Ruhoy and Daughton, 2008) and incorrect household disposal of 
unused packages via trash or sewage (Bound et al., 2006; Ruhoy and Daughton, 2008; Daughton 
and Ruhoy, 2009). The main sources of pharmaceuticals in the environment and the 
interconnection between different environmental compartments are illustrated in Figure 1.2. In 
2005, Bound and Voulvoulis  performed a survey, inquiring approximately 400 householders from 
the South-East of England, about the disposal and risk perception of pharmaceuticals to the 
environment. Between 67 and 100 % of the interviewees revealed that usually dispose unused 
packages into the bin together with the common organic domestic residues and 4 to 17% dispose 
the drugs into the sink/toilet (Bound and Voulvoulis, 2005). This study, along with more recent 
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literature, demonstrates that some routes of pharmaceuticals into the environment, considered as 
secondary, might require greater attention (Daughton and Ruhoy, 2009). The environmental 
relevance of some secondary sources of pharmaceuticals, as it is the case of incorrect disposal of 
unused packages, might be reduced by planning and implementing preventive and educational 
measures. 
 
 
 
Figure 1.1. Main metabolic processes of pharmaceuticals from human ingestion to excretion into wastewater 
treatment plants, considered to be the primary source of pharmaceuticals into the environment. 
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Figure 1.2. Main sources and fate of pharmaceuticals in the environment. 
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1.3 THE CASE OF PSYCHIATRIC PHARMACEUTICALS 
 
 A large diversity of pharmaceuticals has been found in the environment: analgesics, 
antibiotics, anti-epileptics, β-blockers, blood-lipid regulators, antidepressants, anxiolytics, 
sedatives, contraceptives, etc. (Jones et al., 2006). Among all the pharmaceutical groups, 
psychiatric drugs (mainly comprising anxiolytics, sedatives, hypnotics, antidepressants and 
anticonvulsants) are one of the most commonly prescribed (Schultz and Furlong, 2008). For 
instance, in North America, in 2009, 18 of the 100 most prescribed active substances were 
psychoactive pharmaceuticals (Health, 2011). In the specific case of Portugal, and also in 2009, 14 
of the most prescribed active substances belong to the pharmacotherapeutic subgroup of 
psychodrugs with special relevance for benzodiazepines, selective serotonin re-uptake inhibitors 
(SSRIs) and selective serotonin and norepinephrine re-uptake inhibitors (SSNRIs) (Infarmed, 
2009).  
 In general, pharmaceuticals are used with the intent of having some type of biological or 
physiological effect in humans or animals. Among their specific characteristics, these compounds 
have the ability to pass through cellular membranes and are relatively persistent in order not to be 
inactivated before exerting the desired therapeutic effect (Sanderson et al., 2003; Petrovic and 
Barceló, 2007). In the particular case of nervous system related pharmaceuticals, and in addition to 
the referred intrinsic properties, these compounds have great relevance on the regulation of 
behavior, having the aptitude to directly affect the central nervous system and cause neuro-
endocrine signaling disruption. The alteration of the reproduction patterns in non-target aquatic 
organisms (Brooks et al., 2003b; van der Ven et al., 2004; van der Ven et al., 2006) is one good 
example that illustrates the possible adverse effects in test organisms, thus reflecting the action 
mode of this particular group of pharmaceuticals. Several studies have demonstrated that these 
compounds can affect physiological systems at very low concentrations (van der Ven et al., 2006; 
Schultz and Furlong, 2008). Van der Ven et al. (2006) showed that mianserin, a tetracyclic 
antidepressant, has estrogenic activity and produces endocrine disruption in zebrafish. A number of 
other studies on fluoxetine, diazepam, sertraline, paroxetine, and others, clearly showed significant 
adverse effects of antidepressants and anxiolytics in living organisms of aquatic matrices (Fong, 
1998; Brooks et al., 2003a; Brooks et al., 2003b; Pascoe et al., 2003; Henry et al., 2004; Richards 
and Cole, 2006; Johnson et al., 2007; Fong and Molnar, 2008; Gaworecki and Klaine, 2008; Gust 
et al., 2009).  
 The extremely high rates of consumption of psychiatric pharmaceuticals, in conjunction 
with their mode of action, reinforce the need to assess contamination levels and better understand 
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their real ecological impact. However, and when compared to other groups of pharmaceuticals, 
there is a significant lack of knowledge about psychiatric drugs, especially concerning their 
dispersion, mobility and persistence under environmental conditions (biotic and abiotic 
degradability) and the uptake and effects on non-target organisms during chronic and life cycle 
exposure.   
 
1.4 THESIS LAYOUT 
 
This chapter aimed at presenting a brief overview concerning the occurrence of 
pharmaceuticals in the environment and some possible consequences to the ecosystems. This 
complex issue is here only superficially addressed and a more detailed discussion will be the focus 
of the following chapters.  
Amongst the vast universe of pharmaceuticals, psychiatric drugs are thought to pose 
significant risk to ecosystems and, for this reason, should be made object of special attention. 
Consequently, the work presented in this thesis was developed with the aim of giving a significant 
contribution concerning the occurrence, fate and environmental persistence of psychiatric 
pharmaceuticals. 
 The work presented in this thesis is divided into five chapters, as follows: 
CHAPTER 2 – Literature review. Here, the occurrence, persistence, fate and toxicological 
relevance of psychiatric pharmaceuticals in the environment are discussed in detail, based on the 
available literature data. This work resulted in the following publication: 
Calisto, V., Esteves, V.I., 2009. Psychiatric pharmaceuticals in the environment - a review. 
Chemosphere 77, 1257-1274. 
 
CHAPTER 3 – Study of the direct photodegradation of the anti-epileptic pharmaceutical 
carbamazepine and evaluation of pH and oxygenation levels in the photodegradation rates. This 
study also includes the development of a micellar electrokinetic chromatography methodology to 
follow the photodegradation kinetics and identification of photodegradation products by mass 
spectrometry. This work is published in: 
Calisto, V., Domingues, M.R., Erny, G.L., Esteves, V.I., 2011. Direct photodegradation of 
carbamazepine followed by micellar electrokinetic chromatography and mass spectrometry. Water 
Research 45, 1095-1104. 
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CHAPTER 4 – Study of the direct and indirect photodegradation of four benzodiazepines 
(oxazepam, diazepam, lorazepam and alprazolam), including the effects of different fractions of 
dissolved organic matter in the photodegradation rates. Similarly to the previous chapter, 
identification of direct photodegradation products of the studied benzodiazepines by mass 
spectrometry is also presented. This work is published in: 
Calisto, V., Domingues, M.R., Esteves, V.I., 2011 Photodegradation of psychiatric 
pharmaceuticals in aquatic environments - kinetics and photodegradation products. Water 
Research, in press. doi:10.1016/j.watres.2011.09.008. 
 
CHAPTER 5 – Determination of carbamazepine in ground, surface and wastewaters, 
collected in Aveiro, Portugal, by an enzyme-linked immunosorbent assay (ELISA) and validation 
by LC-MS/MS. This research work also involved the optimization of an ELISA for the 
quantification of carbamazepine in environmental samples with high salinity and high 
concentrations of dissolved organic matter. This study resulted in the following publication: 
Calisto, V., Bahlmann, A., Schneider, R.J., Esteves, V.I., 2011. Application of an ELISA to 
the quantification of carbamazepine in ground, surface and wastewaters and validation with LC-
MS/MS. Chemosphere 84, 1708-1715. 
 
CHAPTER 6 – Evaluation of the fate of carbamazepine at water/soil interfaces by studying 
the adsorption behavior of this compound onto agricultural soils. Adsorption studies were followed 
by UV spectral deconvolution and the performance of this recently developed methodology was 
compared with micellar electrokinetic chromatography.  
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CHAPTER 2 
Psychiatric pharmaceuticals in the environment: 
 
Literature Review 
 
 
 
This chapter aims to present a review of the existing literature data concerning the 
environmental impact of psychiatric drugs (anxiolytics, sedatives, hypnotics, anti-epileptics and 
antidepressants). This literature review constitutes a multidisciplinary approach to the problems 
and challenges posed by the occurrence of psychiatric pharmaceuticals in the environment. 
Through this chapter the following issues will be discussed: occurrence of psychiatric 
pharmaceuticals in different environmental matrices; metabolization of psychiatric 
pharmaceuticals in the human body; removal efficiencies of these compounds by wastewater 
treatment plant methods; environmental persistence and resistance to biotic and abiotic 
degradation processes; chronic and acute toxicity data to aquatic organisms and, finally, 
optimization of analytical methods for the determination of psychiatric drugs in environmental 
complex matrices. The topics here discussed allow for a clear identification of the main research 
needs of this field of interest. 
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2.1 CONTEXTUALIZATION 
 
The number of published studies about the occurrence and effects of pharmaceuticals in the 
environment has registered a significant increase in the last two decades, largely contributing to 
increase the knowledge about these emerging environmental contaminants. When discussing 
environmental problems and the risks caused by these compounds, psychiatric pharmaceuticals are 
particularly relevant due to the global high rates of consumption and specific mode of action 
(causing nervous central system related effects). However, psychiatric pharmaceuticals only started 
to be more closely studied in recent years. This chapter aims to present a literature review 
concerning the environmental impact of this group of pharmaceuticals, allowing the identification 
of the research needs of this area. The literature data here presented is essentially focused on 
anxiolytics, sedatives, hypnotics, the anti-epileptic carbamazepine and several classes of 
antidepressants. The structures of pharmaceuticals representative of these classes are presented in 
Figure 2.1.  
 
2.2 OCCURRENCE OF PSYCHIATRIC PHARMACEUTICALS IN THE 
ENVIRONMENT 
 
2.2.1 Anxiolytics, sedatives and hypnotics 
 
Pharmaceuticals with anxiolytic, sedative and hypnotic effects comprise, essentially, 
benzodiazepines, buspirone (an azapirone), zoplicone (a cyclopyrrolone), zolpidem (an 
imidazopyridine) and barbiturates (Chouinard et al., 1999; Kar, 2007). Among these, the group of 
benzodiazepines (with special relevance to diazepam) is the most extensively studied. 
Benzodiazepines are one of the most consumed pharmaceuticals (van der Ven et al., 2004; 
International Narcotics Control Board, 2010). The most recent data account for 2008, when a total 
of 30 billion S-DDD (“defined daily doses for statistical purposes”) of benzodiazepines were 
manufactured, the highest amount registered until now, and representing an increase of 3 billion S-
DDD relatively to 2007. Alprazolam, diazepam, lorazepam and oxazepam are the most relevant 
substances of this group, corresponding to 46, 24, 13 and 2% of the total manufactured amount, 
respectively. Europe registered as the continent with the highest total consumption of 
benzodiazepines (International Narcotics Control Board, 2010). These compounds act on the 
central nervous system and are mainly indicated to treat anxiety, amnesia and to produce sedation 
(Kar, 2007; Brunton, 2008); they are also effective anticonvulsants (Brunton, 2008).  
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Figure 2.1. Structure of several psychiatric pharmaceuticals. 
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Nowadays, 35 benzodiazepines are under international control for therapeutic use 
(International Narcotics Control Board, 2010). However, these compounds are not exclusively used 
for human therapeutics: benzodiazepines’ prescription is also common in veterinary treatments 
(Courtheyn et al., 2002; Gaskins et al., 2008). Generally, benzodiazepines have anxiolytic and 
appetite stimulant effects in domestic and wild animals (Courtheyn et al., 2002; Gaskins et al., 
2008). Benzodiazepam injections are frequently used to induce anesthesia and diazepam can be 
used as anxiolytic and sedative in the transportation of sheep, and other domestic animals, to 
prevent injuries caused by stressful transport conditions.  
In Table 2.1 is given an overview of anxiolytics, sedatives and hypnotics found in aquatic 
environments. Diazepam, a 1,4-benzodiazepine, is the most studied active substance with 
anxiolytic effects (Halling-Sorensen et al., 1998; Ternes, 1998; Ternes et al., 2001; Ternes, 2001; 
Debska et al., 2004; Baker and Kasprzyk-Hordern, 2011). It was first determined in the 
environment by Waggot (1981) who reported concentrations of < 1 μg L-1 in a sewage effluent and 
~10 ng L-1 in river and potable drinking waters (Halling-Sorensen et al., 1998). Subsequently, 
several studies indicated the presence of diazepam in WWTPs effluents and influents, rivers and 
lakes located in distinct parts of the world and even in potable waters. The concentrations found 
range from 0.49 ng L-1, in untreated drinking water in the U.S. (Benotti et al., 2009), to 1.18 μg L-1, 
in a WWTP in Belgium (van der Ven et al., 2004). In surface waters, a maximum concentration of 
0.88 μg L-1 was found, in Germany (Ternes, 2001). Diazepam was also found in fish liver, with 
concentrations up to 110 ng g-1, in the U.S. (Kwon et al., 2009). Recently, a study on 
pharmaceutical contaminants and associated potential concerns to pregnant women and children 
reported that a cumulative ingestion of 5% of a minimum clinical dose of diazepam may occur 
during pregnancy (taking as reference the ingestion of 2 liters of water per day, during 36 weeks, 
and a determined diazepam concentration in drinking water of 0.235 μg L-1) (Collier, 2007). In the 
author’s opinion, this fact may not be ignored as there are strong evidences that diazepam might 
cause several dysfunctions when used in the later stages of pregnancy (such as the withdrawal and 
the Floppy infant syndrome) (Collier, 2007). The few data available on the occurrence of the large 
majority of other benzodiazepines are referred, mainly, to the last two years, indicating the recent 
interest on these compounds (Gracia-Lor et al. 2011; Huerta-Fontela et al., 2010; López-Serna et 
al., 2010). No data was found concerning buspirone, zolpicone and zolpidem. 
 The other referred pharmaceutical group with anxiolytic, sedative and hypnotic action is 
the barbiturates’ group which is constituted by derivatives of barbituric acid (Peschka et al., 2006). 
Until the 1970s, barbiturate derivatives were the most common active substances in sleeping pills 
(Holm et al., 1995) and were also commonly used to treat anxiety symptoms (Kar, 2007). In 
Vânia Calisto | Universidade de Aveiro 
20 
 
addition, this group has an important therapeutic application as narcotics (Peschka et al., 2006). 
Nevertheless, with the exception of some specific usages, barbiturates have been replaced by 
benzodiazepines, due to the severe adverse effects to the human body (Kar, 2007; Brunton, 2008) 
and, nowadays, are mainly used as veterinary drugs (Peschka et al., 2006). Despite the small 
number of barbiturate´s prescriptions to human therapeutics, it is relevant to refer that some studies 
reported the occurrence of these compounds in the environment. An investigation performed by 
Eckel (1993) determined pentobarbital in groundwater near a landfill in Florida that used to receive 
medical wastes in 1968 and 1969, thus demonstrating that this pharmaceutical had persisted in the 
environment during 21 years (Eckel, 1993). A distinct research done by Holm et al. (1995) revealed 
a similar situation with 5,5-diallybarbituric acid. Holm analyzed groundwater close to a landfill, in 
Denmark, which received, approximately, 85 000 tones of industrial and domestic wastes between 
1962 and 1975. Once more, the barbiturate was identified in the analyzed samples, indicating an 
environmental persistence of more than 20 years (Holm et al., 1995). More recent studies reported 
concentrations of barbiturates up to 5.4 μg L-1 in surface waters, in Germany (Peschka et al., 2006). 
 
2.2.2 Anti-epileptics - Carbamazepine 
 
Carbamazepine, a dibenzazepine, is the most representative compound of the anti-epileptic 
pharmaceuticals. It has anticonvulsant properties and is used in the treatment of psychomotor 
epilepsy, grand mal (and seizures, in general) and it is also crucial for the relief of pain caused by 
trigeminal neuralgia (Kar, 2007). It is estimated that 1 014 tons of carbamazepine are consumed 
worldwide, per year (Zhang et al., 2008). 
This pharmaceutical is one of the most frequently detected in the environment, with 
numerous studies reporting its occurrence all over the world. Some relevant data about its presence 
in WWTPs effluent, influents, surface and ground waters are summarized in Table 2.2. 
Concentrations found in the environment range from 3.3 ng L-1 in surface waters, France (Togola 
and Budzinski, 2007), to 11.6 µg L-1, also in surface waters, in a European river (Loos et al., 2009). 
Note that the maximum concentration of carbamazepine reported until now (11.6 µg L-1) is 
remarkably high, especially when compared to the concentration of other psychiatric 
pharmaceuticals in surface waters. Recently, a European survey published data of the greatest 
relevance about contamination levels in Europe, concluding that carbamazepine was found with a 
frequency of 95% in 122 river water samples, and of 42% in 164 ground water samples (Loos et 
al., 2009; Loos et al., 2010). 
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Table 2.1. Occurrence of anxiolytics, sedatives and hypnotics in the environment. 
Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
DIAZEPAM 
<1 μg L-1 Sewage effluent; UK Not provided Analysis performed in  1981 (Halling-Sorensen et al., 1998) 
~10 ng L-1 River water; UK Not provided Analysis performed in 1981 (Halling-Sorensen et al., 1998; 
Jones et al., 2005a) 
~10 ng L-1 Potable water; UK Not provided Analysis performed in 1981 (Halling-Sorensen et al., 1998; 
Jones et al., 2005a) 
0.04 μg L-1 Municipal sewage treatment plant (STP) 
effluents; Germany 
GC-MS Analysis performed between 1996-1998 (Ternes, 1998, 2001) 
23.5 ng L-1 Drinking water; Italy HPLC-MS/MS - (Zuccato et al., 2000) 
< LOQ (0.20 μg L-1) Influent of a municipal Hessian STP; Germany LC–ES-MS/MS Analysis performed between 26/06/00 and 
30/06/00 
(Ternes et al., 2001) 
< LOQ (0.050 μg L-1) Effluent of a municipal Hessian STP; Germany LC–ES-MS/MS Analysis performed between 26/06/00 and 
30/06/00 
(Ternes et al., 2001) 
0.053 μg L-1 Municipal STP effluent; Germany LC–ES-MS/MS - (Ternes et al., 2001) 
0.033 μg L-1 Rivers and streams; Germany LC–ES-MS/MS - (Ternes et al., 2001) 
0.88 μg L-1 Surface waters; Germany HPLC-MS/MS Analysis performed in 2000 (Ternes, 2001) 
3-62 ng L-1 Lake Mead; USA GC-MS Analysis performed between 1997 and 1999 (Snyder et al., 2001) 
0.13 – 2.13 ng L-1 Po and Lambro rivers; Italy HPLC-MS Diazepam was found in all the 8 samples 
collected in different locations. Sampling 
performed in October, 2001. 
(Calamari et al., 2003) 
>0.01 μg L-1; 0.59 μg L-1; 
1.18 μg L-1 
STP influent; Belgium LC-ES–MS/MS - (van der Ven et al., 2004) 
>0.01 μg L-1; 0.66 μg L-1 STP influent; Belgium LC-ES–MS/MS - (van der Ven et al., 2004) 
120 ng L-1 Wastewater sewer; Germany LC-MS/MS Sampling between 2001 and 2003 (Leif et al., 2004) 
310 ng L-1 Wastewater inflow; WWTP in Germany LC-MS/MS Sampling between 2001 and 2003 (Leif et al., 2004) 
33.6 ± 7.1; 30.8 ± 9.3 and 
27.9 ± 5.1 ng L-1 
River water; Romania GC-MS - (Moldovan, 2006) 
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Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
23 – 45 ng/g, female fish; 
58 – 110 ng/g, male fish 
(wet weight) 
Fish liver; USA (California) LC-MS/MS Fish species: Pleuronichthys verticalis (Kwon et al., 2009) 
0.47 ng L-1 Untreated drinking water, USA LC-MS/MS Maximum concentration found (Benotti et al., 2009) 
6.52 (± 0.64%) ng L-1  Llobregat River basin; Spain LC-MS/MS Samples collected downstream to WWTP 
effluent discharge 
(López-Serna et al., 2010) 
49 ng L-1 6 WWTP effluents; Spain  UPLC-MS/MS - (Huerta-Fontela et al., 2010) 
1.1 ng L-1 Surface waters; UK LC-MS/MS Samples collected in 6 river locations in UK (Baker and Kasprzyk-Hordern, 
2011) 
NORDIAZEPAM 
8 ng L-1 WWTP effluent; France GC-MS - (Rabiet et al., 2006) 
8.3 ng L-1 WWTP effluent; France GC-MS - (Togola and Budzinski, 2008) 
2.4 ng L-1 Surface waters; France GC-MS - (Togola and Budzinski, 2008) 
19 – 76 ng L-1 Surface water; Spain LC-MS Samples collected in 5 rivers of Madrid (González Alonso et al., 2010) 
5.5 ng L-1 Surface waters; UK LC-MS/MS Samples collected in 6 river locations in UK (Baker and Kasprzyk-Hordern, 
2011) 
OXAZEPAM 
0.25 μg L-1 STP effluent; Germany GC-MS - (Heberer, 2002) 
6 – 129 ng L-1 Surface water; Spain LC-MS Samples collected in 5 rivers of Madrid (González Alonso et al., 2010) 
21 – 324 ng L-1 6 WWTP effluents; Spain  UPLC-MS/MS - (Huerta-Fontela et al., 2010) 
17.4 ng L-1 Surface waters; UK LC-MS/MS Samples collected in 6 river locations in UK (Baker and Kasprzyk-Hordern, 
2011) 
ALPRAZOLAM 
1 ng L-1 6 WWTP effluents; Spain UPLC-MS/MS - (Heberer, 2002) 
7 ng L-1 WWTP effluents; Spain UPLC-MS/MS Maximum concentration found (Gracia-Lor et al., 2011) 
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Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
LORAZEPAM 
31 ± 1 – 196 ± 7 ng L-1 STP effluent; France LC-MS/MS Samples collected between July 2007 – 
February 2008 
(Coetsier et al., 2009) 
22.58 (± 0.14%) and 41.27 
(± 0.23%) ng L-1 
Llobregat River basin; Spain LC-MS/MS Samples collected downstream and upstream 
to WWTP effluent discharge 
(López-Serna et al., 2010) 
4 – 532 ng L-1 6 WWTP effluents; Spain  UPLC-MS/MS - (Huerta-Fontela et al., 2010) 
40 ng L-1 Surface waters; Spain LC-MS - (Gros et al., 2010) 
81 ng L-1 WWTP effluents; Spain UPLC-MS/MS Maximum concentration found (Gracia-Lor et al., 2011) 
PENTOBARBITOL 
Qualitative analysis Groundwater near a landfill; USA  GC-MS/MS Analysis performed in 1991. The landfill 
received medical wastes in 1968 and 1969 
(Eckel, 1993; Jones et al., 2001) 
5.4 μg L-1 River Mulde; Germany GC-MS Analysis performed in April 2004 (Peschka et al., 2006) 
BUTALBITAL 
5.3 μg L-1 River Mulde; Germany GC-MS Analysis performed in April 2004 (Peschka et al., 2006) 
PHENOBARBITAL 
0.03 μg L-1 STP effluent; Germany GC-MS - (Heberer, 2002) 
0.2 – 1.3 μg L-1 Irrigation field; Germany GC-MS Analysis performed in 2004/2005 (Peschka et al., 2006) 
5,5-DIALLYLBARBITURIC ACID 
Qualitative analysis Groundwater near a landfill; Denmark HPLC-UV The landfill received ~85 000 tones of 
pharmaceutical industrial and domestic 
wastes between 1962-1975. 
(Holm et al., 1995) 
MEPROBAMATE 
Qualitative analysis Groundwater near a landfill; USA GC-MS/MS Analysis performed in 1991. The landfill 
received medical wastes in 1968 and 1969 
(Eckel, 1993; Jones et al., 2001) 
43 ng L-1 Finished drinking waters; USA Not provided - (Snyder, 2008) 
42 – 73 ng L-1 Drinking waters; USA GC-MS/MS - (Benotti et al., 2009) 
Vânia Calisto | Universidade de Aveiro 
24 
 
Table 2.2. Occurrence of the anti-epileptic carbamazepine in the environment. 
Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
CARBAMAZEPINE 
0.3 – 1.2 µg L-1 STP effluents: France, Greece, Italy and 
Sweden 
LC-MS Samples collected between February and 
March 2001 
(Andreozzi et al., 2003) 
157 – 293 ng L-1 STP effluent; South France GC-MS - (Rabiet et al., 2006) 
13.9 – 43.2 ng L-1 Wells supplying drinking water, France GC-MS - (Rabiet et al., 2006) 
30.9 ± 7.8 – 2519.3 ± 
147.6 ng L-1 
WWTP effluent, France GC-MS Samples collected between March 2002 and 
November 2002 
(Togola and Budzinski, 2007) 
3.3 ± 1.3 – 82.7 ± 13.2 ng 
L-1 
Surface water, Seine river estuary, France GC-MS Samples collected between March 2002 and 
November 2002 
(Togola and Budzinski, 2007) 
326 ± 3 - 1573 ±34 ng L-1 STP effluent; France LC-MS/MS Samples collected between July 2007 and 
February 2008 
(Coetsier et al., 2009) 
0.54 ± 0.01 – 3.0 ± 0.2 
µg L-1 
Surface waters; Germany ELISA and  
LC-MS/MS 
- (Bahlmann et al., 2009) 
2.3 ± 0.1 µg L-1 WWTP effluent; Germany ELISA and  
LC-MS/MS 
- (Bahlmann et al., 2009) 
11561 ng L-1 (Max.); 248 
ng L-1 (Average) 
122 samples of European Rivers LC-MS/MS European survey with the participation of 27 
countries, with a detection frequency of 95%. 
(Loos et al., 2009) 
178 ng L-1 Douro river, Portugal LC-MS/MS Samples collected downstream from WWTP 
effluent discharge 
(Madureira et al., 2009) 
51 ng L-1 Untreated drinking water; USA LC-MS/MS Maximum concentration found (Benotti et al., 2009) 
31.28 (± 0.29%) and 
58.43 (± 0.30%) ng L-1 
Llobregat River basin; Spain LC-MS/MS Samples collected downstream and upstream 
from WWTP effluent discharge 
(López-Serna et al., 2010) 
35 – 1160 ng L-1 Surface water; Spain LC-MS Samples collected in 5 rivers of Madrid (González Alonso et al., 2010) 
5 – 175 ng L-1 6 WWTP effluents; Spain UPLC-MS/MS - (Huerta-Fontela et al., 2010) 
     
390 ng L-1 (Max.); 12 ng 
L-1 (Average) 
164 samples of ground water, Europe LC-MS/MS European survey with the participation of 23 
countries, with a detection frequency of 42%. 
(Loos et al., 2010) 
0.145 µg L-1 Ter River; Spain GC-ECD - (Calderón-Preciado et al., 2011) 
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2.2.3 Antidepressants 
 
 Antidepressants are a largely prescribed group of pharmaceuticals (Kwon and Armbrust, 
2008; Paterson and Metcalfe, 2008; Health, 2011). One of the most common classes of 
antidepressants is known as selective serotonin reuptake inhibitors (SSRIs) and act by modulating 
the levels of the neurotransmitter serotonin (Brooks et al., 2005). They are largely prescribed to 
treat clinical depression, compulsive-obsessive disorder, panic disorder, as well as other cases in 
which selective inhibition of serotonin reuptake is desirable (Brooks et al., 2003a; Schultz and 
Furlong, 2008; Unceta et al., 2008). Presently, there are five SSRIs available in the market: 
fluoxetine, fluvoxamine, paroxetine, sertraline and citalopram (Johnson et al., 2007). There are 
other antidepressants usually prescribed when SSRIs are not effective. These include venlafaxine 
and duloxetine (selective serotonin and norepinephrine reuptake inhibitors (SSNRIs)), bupropion 
(that acts by inhibiting the uptake of dopamine and norepinephrine) (Schultz and Furlong, 2008) 
and also tricyclic and tetracyclic antidepressants such as amitriptyline and mianserin, respectively. 
Some of these, and particularly amitriptyline, are also administered to animals (Halling-Sorensen et 
al., 1998). The usage of antidepressants in animals is recommended to treat pathologies such as 
separation anxiety, obsessive-compulsive and fearful behaviors amongst other behavioral problems 
(Mills, 2003). 
 A large number of antidepressants has already been identified in water, sludge and 
biological tissues of aquatic organisms and, as for the case of anxiolytics, sedatives and hypnotics, 
concentrations found range from ng to μg L-1 or ng to μg kg-1 (Kolpin et al., 2002; Metcalfe et al., 
2003; Brooks et al., 2005; Kinney et al., 2006; Schultz and Furlong, 2008). Detailed information 
about the environmental occurrence of antidepressants is presented in Table 2.3. Fluoxetine (a 
SSRI) and its metabolite norfluoxetine (biologically active and more potent than the parent 
compound) are the most commonly investigated antidepressants throughout the world. However, 
the antidepressants found in the highest concentrations were venlafaxine, citalopram and bupropion 
(1000 ± 400 ng L-1, 90 ± 20 ng L-1, 60 ± 40 ng L-1, respectively, in samples collected downstream 
from a water reclamation plant) (Schultz and Furlong, 2008). Until now, the maximum determined 
concentration of fluoxetine was 0.099 μg L-1 in WWTP effluents in Canada (Metcalfe et al., 2003). 
Moreover, very high quantities of fluoxetine were found in biosolids produced by a WWTP, 
varying from 100 to 4700 μg kgorganic carbon–1 (Kinney et al., 2006). The determination of fluoxetine 
concentration in biosolids may be a helpful tool to understand the probable environmental fate of 
fluoxetine in water/sediment systems and also to identify the usage of sludge in agricultural fields 
as a significant pathway to the entrance of this compound into the environment (Xia et al., 2005), 
as it was previously referred in chapter 1.  
Vânia Calisto | Universidade de Aveiro 
26 
 
Table 2.3. Occurrence of antidepressants in the environment. 
Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
FLUOXETINE 
0.012 μg L-1 Surface waters; USA LC- (ESI(+))-MS Analysis performed between 1999 and 2000 (Kolpin et al., 2002) 
0.099 μg L-1 Effluents of sewage treatment plants; Canada GC-MS - (Metcalfe et al., 2003) 
0.1 ng g-1 – 10 ng g-1 Tissues (muscle, brain and liver) of fish living 
in a municipal effluent-dominated stream; USA 
GC-MS Fish species: Lepomis macrochirus, Ictalurus 
punctatus, Cyprinus carpioand, Pomoxis 
nigromaculatus 
(Brooks et al., 2005) 
100 – 4700 μg kg-1 
organic carbon 
9 biosolids produced by 8 WWTPs; USA HPLC-(ESI)-MS - (Kinney et al., 2006) 
0.14 – 1.02 μg kg-1 Fish tissues; Canada LC-(APCI)-MS/MS Fish species: Ameiurus nebulosus, Dorosoma 
cepedianum and Morone americana 
(Chu and Metcalfe, 2007) 
12 ± 3; 20 ± 10 and 12 ± 
5 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
< 0.00050 μg L-1 Finished drinking water; USA Not provided - (Snyder, 2008) 
3.0 ng L-1 Untreated drinking water; USA LC-MS/MS Maximum concentration found (Benotti et al., 2009) 
2.74 ng L-1 (± 2.24%) Drinking water; Spain LC-MS/MS - (López-Serna et al., 2010) 
15.87 ng L-1 (± 0.25%) WWTP effluent, Llobregat River basin; Spain LC-MS/MS - (López-Serna et al., 2010) 
8 – 44 ng L-1 Surface water; Spain LC-MS Samples collected in 5 rivers of Madrid (González Alonso et al., 2010) 
13.5 ng L-1 Surface water; UK LC-MS/MS Samples collected in 6 river locations in UK (Baker and Kasprzyk-Hordern, 
2011) 
NORFLUOXETINE 
0.1 ng g-1 - 10 ng g-1 Tissues (muscle, brain and liver) of fish living 
in a municipal effluent-dominated stream; USA 
GC-MS Fish species: Lepomis macrochirus, Ictalurus 
punctatus, Cyprinus carpioand Pomoxis 
nigromaculatus 
(Brooks et al., 2005) 
0.15 – 1.08 μg kg-1 Fish tissues; Canada LC-(APCI)-MS/MS Fish species: Ameiurus 
nebulosus, Dorosoma cepedianum and Morone 
americana 
(Chu and Metcalfe, 2007) 
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Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
0.83 ± 0.01; 1.0 ± 0.5 and 
0.9 ± 0.2 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
PAROXETINE 
0.48 – 0.58 μg kg-1 Fish tissues; Canada LC-(APCI)-MS/MS Fish species: Ameiurus 
nebulosus, Dorosoma cepedianum and Morone 
americana 
(Chu and Metcalfe, 2007) 
2.1 ± 0.4; 3 ± 1 and 2.2 ± 
0.2 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
SERTRALINE 
0.1 ng g-1 - 10 ng g-1 Tissues (muscle, brain and liver) of fish living 
in a municipal effluent-dominated stream; USA 
GC-MS Fish species: Lepomis macrochirus, Ictalurus 
punctatus, Cyprinus carpioand Pomoxis 
nigromaculatus 
(Brooks et al., 2005) 
36 ± 5; 49 ± 9 and 33 ± 8 
ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
NORSERTRALINE 
0.1 ng g-1 – 10 ng g-1 Tissues (muscle, brain and liver) of fish living 
in a municipal effluent-dominated stream; 
USA. 
GC-MS Fish species: Lepomis macrochirus, Ictalurus 
punctatus, Cyprinus carpioand Pomoxis 
nigromaculatus 
(Brooks et al., 2005) 
5 ± 3; 7 ± 3 and 3 ± 1 ng 
L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
CITALOPRAM 
90 ± 20; 40 ± 30 and 80 ± 
30 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
3 – 120 ng L-1 Surface water; Spain LC-MS Samples collected in 5 rivers of Madrid (González Alonso et al., 2010) 
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Concentration found in 
the environment Sample 
Method of 
analysis Additional information Reference 
DULOXETINE 
1.5 ± 0.2; 2 ± 2 and 1.2 ± 
0.9 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
BUPROPION 
50 ± 20; 60 ± 40 and 50 ± 
10 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
VENLAFAXINE 
600 ± 200; 1000 ± 400 
and 900 ± 300 ng L-1 
5 to 1762 m of distance downstream from the 
Pecan Creek Water Reclamation Plant; USA 
LC-(ESI)-MS/MS - (Schultz and Furlong, 2008) 
22 – 387 ng L-1 Surface water; Spain LC-MS Samples collected in 5 rivers of Madrid (González Alonso et al., 2010) 
875 ng L-1 Surface waters; Spain UPLC-MS/MS Maximum concentration found (Gracia-Lor et al., 2011) 
575 ng L-1 Surface waters; Spain UPLC-MS/MS Maximum concentration found (Gracia-Lor et al., 2011) 
71.6 ng L-1 Surface water; UK LC-MS/MS Samples collected in 6 river locations in UK (Baker and Kasprzyk-Hordern, 
2011) 
RISPERIDONE 
0.00034 μg L-1 Finished drinking water; USA. Not provided - (Snyder, 2008) 
AMITRIPTYLINE 
0.5 – 21 ng L-1; 0.5 – 3 
ng L-1 ;0.5 – 17 ng L-1; 
0.5 – 13 ng L-1 
Rivers in South Wales, UK HPLC-MS/MS - (Kasprzyk-Hordern et al., 2008) 
6.0 ng L-1 WWTP effluent; France GC-MS - (Togola and Budzinski, 2008) 
1.4 ng L-1 Drinking water; France GC-MS - (Togola and Budzinski, 2008) 
71.6 ng L-1 Surface water; UK LC-MS/MS Samples collected in 6 river locations in UK (Baker and Kasprzyk-Hordern, 
2011) 
LOFEPRAMINE 
<4 ng L-1 Estuaries; UK LC-(ESI)-MS/MS - (Thomas and Hilton, 2004) 
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Besides the occurrence in surface waters (Thomas and Hilton, 2004; Richards and Cole, 
2006; Kasprzyk-Hordern et al., 2008; González Alonso et al., 2010; Baker and Kasprzyk-Hordern, 
2011), amitriptyline, fluoxetine and risperidone were also recently found in treated drinking waters 
in concentrations in the order of ng L-1 (Togola and Budzinski, 2008; Benotti et al., 2009; López-
Serna et al., 2010), revealing the inefficiency of drinking water treatments to remove these 
compounds. Additionally, several antidepressants were determined in biological fish tissues, 
emphasizing the possibility of bioaccumulation by aquatic organisms. Brooks et al. (2005) found 
concentrations in the range of 0.1 to 10 ng g-1 of fluoxetine, sertraline and their metabolites 
(norfluoxetine and desmethylsertraline, respectively) in muscle, liver and brain tissues of four fish 
species in a municipal effluent-dominated stream, in Texas, USA. A similar experiment by Chu 
and Metcalfe (2007) reported concentrations from 0.14 to 1.02 μg kg-1 of fluoxetine, 0.15 to 1.08 
μg kg-1 of norfluoxetine and 0.48 to 0.58 μg kg-1 of paroxetine in other four fish species. The 
implications of these findings, concerning the toxicological relevance of the contamination levels 
of living organisms, will be discussed later, in section 2.6. 
 
2.3 METABOLIZATION OF PSYCHIATRIC PHARMACEUTICALS 
 
 As it was mentioned in chapter 1, pharmaceuticals ingested by humans are almost always 
not completely metabolized, resulting in the excretion of variable percentages of the active 
compound along with several metabolites and conjugates in urine and feces (Carlsson et al., 2006). 
Excretion by patients is considered to be the main pathway for the entrance of pharmaceuticals into 
the environment (due to the inadequacy of removal methods of WWTPs) (Sanderson et al., 2003; 
Cunningham, 2006; Jelic et al., 2011) and thus, human metabolism and excretion rates of 
psychiatric drugs should be addressed.  
 Psychiatric pharmaceuticals, and in particular benzodiazepines, are usually excreted in 
urine, being first extensively metabolized in the liver to form pharmacologically inactive 
glucuronide conjugates (Chouinard et al., 1999). Despite the pharmacological inactivity of these 
conjugates, it is thought that they are easily decomposed by bacterial action and reconverted in the 
parent active compound (Halling-Sorensen et al., 1998; Ternes, 2001; Ashton et al., 2004; Carballa 
et al., 2004). It seems to be highly probable that glucuronide conjugates are readily deconjugated in 
domestic wastewaters and WWTPs due to the generalized presence of the fecal bacteria 
Escherichia coli, responsible for the production of very large amounts of the enzyme β-glucuridase 
(Ternes, 1998; Jones et al., 2005b; Petrovic and Barceló, 2007). This deconjugation process results 
in the increase of the parent compound’s quantity in sewage conditions.  
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For a more detailed analysis of this subject, Table 2.4 presents a compilation of literature 
data about the excretion rates and most important metabolites of some psychiatric drugs that occur 
in the environment, based on data presented in Tables 2.1 - 2.3, section 2.2. Large discrepancies of 
excretion rates are found in the literature. The amounts of excreted pharmaceuticals in the 
unchanged or conjugate forms can vary considerably, from 1 to 80% of a single dose. The 
benzodiazepines alprazolam and oxazepam are examples of pharmaceuticals with excretion rates of 
75 to 80%, in unchanged or conjugate forms. Moreover, some pharmaceuticals are released as 
pharmacologically active metabolites, as it is the case of tetrazepam which, until now, is not 
reported to occur in the environment but is excreted as diazepam (from 13 to 49%). 
 
Table 2.4. Metabolites and excretion rates of psychiatric pharmaceuticals which occur in the environment. 
Excretion rates Additional information 
DIAZEPAM 
10% unchanged (Carballa et al., 2008) 
1% unchanged (Smith-Kielland et al., 2001) 
Conjugated metabolites can be 22-43% of a single intake 
dose (Smith-Kielland et al., 2001) 
<5% of the parent compound excreted  (Jjemba, 2006)  
Mean amounts of diazepam and its metabolites excreted: 
20%. Temazepam  (6.6%), desmethyldiazepam  (3.9%) 
and oxazepam  (2.8%) (Chiba et al., 1995). 
Metabolized in the liver to produce nordiazepam that is 
further converted in oxazepam e temazepam (Ariffin et al., 
2007) 
After a single dose of diazepam, urinary concentrations of 
desmethyldiazepam, temazepam e oxazepam were 29.6 ± 
22.3, 57.4 ± 47.0 and 18.4 ± 16.7 ng/mL (Chiba et al., 
1995) 
0.5 - 0.2%, 3.6 - 4.4%, 9.0 - 6.4%, and 8.7 - 6.3% of a 
single ingested dose were excreted into the urine as 
diazepam, desmethyldiazepam, temazepam and oxazepam, 
respectively (Chiba et al., 1995). 
NORDIAZEPAM 
- Metabolized to oxazepam and oxazepam glucuronides 
(Moffat, 2005). 
TETRAZEPAM 
13 – 49% as diazepam (Pavlic et al., 2007). Principal metabolites are 3-hydroxy-tetrazepam, 
norhydroxytetrazepam, diazepam and nordazepam (Pavlic 
et al., 2007). 
LORAZEPAM 
Negligible amounts unchanged (Ghasemi et al., 2006). Extensively metabolized to its glucuronide conjugate 
(Ghasemi et al., 2006). 
OXAZEPAM 
75% unchanged (Carballa et al., 2008) 
70 to 80% is excreted in the urine almost entirely as 
oxazepam glucuronide with traces of unchanged oxazepam 
- 
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Excretion rates Additional information 
and other minor metabolites. 10% is eliminated in the 
feces unchanged (Moffat, 2005). 
ALPRAZOLAM 
About 80% of a dose is excreted in urine of which 11% is 
the unchanged drug, 15% α-hydroxyalprazolam and 9% 
benzophenone metabolite. Approximately 7% of a dose in 
excreted in feces (Moffat, 2005). 
- 
CARBAMAZEPINE 
10% unchanged; 25% as the dihydroxy metabolite and 2% 
as the 10,11 – epoxide (Moffat, 2005) 
Main metabolites: 10,11-epoxycarbamazepine (as 
biologically active as the parent compound), hydroxylated 
and conjugated compounds (glucuronides) (Brunton, 2008) 
CITALOPRAM 
12-20 % unchanged (Rao, 2007) Metabolites: desmethylcitalopram, didesmethylcitalopram, 
citalopram-N-oxide and a propionic acid derivative. The 
metabolites have some pharmacological activity (Moffat, 
2005). 
FLUOXETINE 
<5% of the parent compound excreted (Jjemba, 2006) Principal metabolites include fluvoxamine and 
norfluoxetine (Chouinard et al., 1999) 
<10% unchanged parent compound in urine (Brooks et al., 
2003a; Moffat, 2005) 
20-30% remains unchanged in urine (Fong and Molnar, 
2008) 
Principal metabolite: norfluoxetine in urine (Brooks et al., 
2003a; Moffat, 2005) 
The metabolite norfluoxetine is biologically active and 
considered to be a more potent SSRIs when compared to its 
precursor (Fong and Molnar, 2008) 
SERTRALINE 
Less than 0.2% are excreted unchanged in urine (Moffat, 
2005) 
It suffers extensive metabolization in the body through: N-
demethylation,  oxidative deamination and subsequent 
reduction, hydroxylation and glucuronide conjugation 
(Moffat, 2005) 
NORSERTRALINE 
- Norsertraline is a N-demethylated metabolite of sertraline. 
It is eliminated more slowly than sertraline and has 
pharmacological activity (Brunton, 2008) 
PAROXETINE 
2% as parent compound (Moffat, 2005) in urine and <1% 
in feces (Cunningham et al., 2004). 
62% and 36% excreted in urine and feces, respectively, in 
the form of inactive metabolites (Cunningham et al., 
2004). 
 
- 
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Excretion rates Additional information 
VENLAFAXINE 
Excreted in urine: 1 to 10% as the unchanged drug, 30% 
O-desmethylvenlafaxine, 6 to 19% N,O-
didesmethylvenlafaxine and 1% N-desmethylvenlafaxine. 
2% is excreted in feces (Moffat, 2005). 
- 
AMITRIPTYLINE 
Negligible amounts unchanged (Kasprzyk-Hordern et al., 
2008). 
50% is excreted as 10–hydroxynortriptyline and its 
glucuronide conjugate and 27% as 
10 - hydroxyamitriptyline; unchanged drug constitutes less 
than 5% of the excreted material. 8% may be eliminated in 
the feces as parent compound (Moffat, 2005). 
Excreted as nortriptyline, 10-hydroxyamitriptyline (active), 
10-hydroxynortriptyline (active) (Kasprzyk-Hordern et al., 
2008). 
PHENOBARBITONE 
6 – 39% of the parent compound excreted (Jjemba, 2006). 
35% excreted unchanged (Kar, 2007). 
25% is excreted in urine as unchanged drug and up to 
about 17% as 4–hydroxyphenobarbital (half of which in 
the form of glucuronide conjugate) (Moffat, 2005). 
Enzymatic hydroxylation and carboxylation of aliphatic 
side chains following conjugation to glucuronides (Peschka 
et al., 2006). 
Major metabolites: N-glucopyranosylphenobarbital and 4–
hydroxyphenobarbital and its glucuronide conjugate 
(Moffat, 2005). 
MEPROBAMATE 
90% is excreted in urine. About 10 to 20% of the dose is 
excreted as unchanged drug and the remainder as 
metabolites (Moffat, 2005). 
Major metabolites: 2–hydroxypropylmeprobamate and 
meprobamate N-glucuronide (Moffat, 2005). 
PENTOBARBITONE 
1% remained unchanged in urine (Moffat, 2005). - 
BUTALBITAL 
About 5% is excreted in urine as the parent compound 
(Moffat, 2005). 
Major metabolite excreted in urine: 5-(2,3–
dihydroxypropyl)-5–isobutylbarbituric acid (20 to 60%) 
(Moffat, 2005). 
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2.4 RESISTANCE TO WWTPS REMOVAL METHODS AND OCCURRENCE IN 
SLUDGE 
 
Generally, literature data on pharmaceuticals in the environment suggest that the large 
majority (if not all) of urban wastewaters are contaminated with these compounds (Gros et al., 
2010; Jelic et al., 2011). An approximate prediction about the type and abundance of active 
substances which can be found in raw wastewaters can be done according to the local rates of 
consumption, which are a first indication of the pharmaceutical compounds that might be present in 
more significant amounts (Ternes, 2005). The study of the behavior of pharmaceuticals through 
WWTPs is a noteworthy tool to assess the probable concentrations of these compounds in the final 
treated effluents and sludge, allowing for the evaluation of the effects of discharging them into the 
environment (Jones et al., 2005b).  
It is now well-established that pharmaceuticals are not efficiently removed by wastewater 
treatments, being present in significant amounts in WWTPs effluents and sludge (Ternes, 1998; 
Debska et al., 2004; Xia et al., 2005; Gómez et al., 2007; Conkle et al., 2008; Zhang et al., 2008; 
Loganathan et al., 2009; Jelic et al., 2011) (see tables 2.1 – 2.3, section 2.2, for data about 
pharmaceuticals in WWTPs effluents and sludge). Actually, WWTPs were not specifically 
intended to remove bioactive xenobiotics and removal efficiencies can range from zero to almost 
complete removal, depending on specific treatments used in more or less sophisticated WWTP 
facilities (Petrovic and Barceló, 2007). Biological degradation and sorption are the most common 
mechanisms applied in WWTP; though, as it will be shown below, the removal efficiencies are not 
always satisfactory and more advanced techniques should be applied. However, even with the 
present knowledge, municipal WWTPs have been hardly focused on the removal of trace organic 
pollutants, such as pharmaceuticals. Even in the case of more sophisticated WWTPs, the large 
diversity of trace organic compounds and the difficulty of predicting individual responses to more 
advanced treatments illustrate the complexity of this issue (Ternes, 2005; Jelic et al., 2011). It must 
also be emphasized that following the disappearance of a pharmaceutical in the liquid phase is not 
sufficient to conclude that it was completely removed as it may pass into the solid phase, or exist in 
a different form of the parent compound due to chemical transformations (Petrovic and Barceló, 
2007).  
Final treated effluents are commonly discharged in surface waters; this can lead to indirect 
reuse of wastewaters in areas where these surface waters are a source of potable water (Drewes et 
al., 2001; Jones et al., 2005a; Glassmeyer et al., 2008). This indirect water reuse (planned or 
unplanned, due to water overflows or leaks in the sewage systems) might lead to the presence of 
Vânia Calisto | Universidade de Aveiro 
34 
 
pharmaceuticals in drinking water and yet, these compounds are not contemplated in the Drinking 
Water Directive 98/83/EC. Also, WWTPs effluents are increasingly being used for irrigation of 
crops and arid areas and groundwater recharge in several countries throughout the world (Drewes 
et al., 2001; Pedersen et al., 2005; Glassmeyer et al., 2008). Additionally, the use of Slow Rate 
Systems (SRS) to purify wastewater is becoming more and more common, consisting on its 
application on land, taking advantage of physical, chemical, and biological mechanisms (such as 
filtration, degradation, soil adsorption, chemical precipitation, denitrification, volatilization, and 
plant uptake) that occur concurrently in the soil-water-atmosphere environment (Paranychianakis et 
al., 2006). All these practices have the obvious advantage of reducing the demand for water 
supplies (which is a main concern due to the scarcity of potable water), but constitute viable 
pathways for the introduction of pharmaceuticals in soils, surface and ground waters (and 
ultimately in drinking waters) through runoff and infiltration (Pedersen et al., 2005).  
 Several psychiatric drugs partially or totally resist wastewater treatments. In Table 2.5 are 
gathered some data concerning the removal efficiency of the anxiolytic diazepam and of the anti-
epileptic carbamazepine. In both cases, several methods (including the most commonly used) have 
removal efficiencies bellow 10%, being evident that a large amount of diazepam and 
carbamazepine passes unaffected through WWTPs. Only more advanced methods, such as 
advanced oxidation processes and ultra and nanofiltration are able to remove diazepam and 
carbamazepine almost entirely, (50-90 or more than 90% of efficiency). These facts justify the 
frequent occurrence of these pharmaceuticals in environmental samples. In Table 2.6 it is shown a 
set of data focused on fluoxetine, meprobamate, diazepam and carbamazepine. Again, in general, 
all these compounds are particularly resistant to more advanced treatment processes (less than 30% 
of removal); globally the best results were obtained with ozonation or ozonation/peroxidation 
which were already pointed out as good efficient alternatives (yet, very energy consuming) 
(Ternes, 2005). Note that, due to the inefficiency of the large majority of the advanced treatment 
processes presented here, meprobamate (a barbiturate) was recently identified in finished drinking 
waters in the United States (Snyder, 2008; Benotti et al., 2009). 
In WWTPs it is very likely to occur a deconjugation phenomenon, as stated before (Jones 
et al., 2005b). The most relevant consequence of this deconjugation process is the increase of 
biologically active compounds in influents and, consequently, in effluents and sludges (Ternes, 
1998; Petrovic and Barceló, 2007). The hypothesis on the deconjugation of pharmaceutical 
conjugates is supported by investigations which concluded that the concentration of parent 
compounds, found in WWTPs effluents, is considerable higher than the concentration of the 
conjugated form, contradicting the excretion patterns and underlining the possibility of, at least, 
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partial cleavage of the conjugates (Ternes, 1998). Gros et al. (2010) reported that carbamazepine, 
several benzodiazepines and SSRIs suffered no elimination through the selected WWTPs, 
presenting higher concentration in effluents than in influents, corroborating this hypothesis. 
 
Table 2.5. Removal of diazepam and carbamazepine in wastewater treatment plants; adapted from the EU-
Project POSEIDON final report, 2005 (Ternes, 2005). 
Removal treatment method 
% Removal 
Diazepam Carbamazepine 
Primary treatment < 10 < 10 
COD removal (SRT* ≤ 2 days) < 10 < 10 
Nitrification (SRT 10 to 15 days) < 10 < 10 
Sludge stabilization (SRT ≥ 25 days) < 10 < 10 
Membrane bioreactor (SRT ≥ 25 days) No data < 10 
Biofilter No data < 10 
Soil, unsaturated zone No data < 10 
Groundwater, saturated zone 10 - 50 < 10 
Sludge anaerobic treatment 10 – 50 10 - 50 
Fenton process < 10 < 10 
Effluent ozonation 10 - 50 > 90 
Ozonation 10 - 50 > 90 
AOPs (Advanced oxidation processes) 50 -90 50 -90 
GAC (Granular activated carbon) > 90 > 90 
Ultrafiltration/PAC(Powdered activated carbon) > 90 > 90 
Nanofiltration > 90 > 90 
Chlorination < 10 < 10 
Chlordioxide < 10 < 10 
 *SRT: Sludge retention time 
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Table 2.6. Removal percentages of diazepam, fluoxetine, carbamazepine and meprobamate by several 
methods applied in WWTPs.  
Treatment method < 30%  30 – 70% > 70% References 
Free Chlorine (3.5 mg L-1) Diazepam 
Fluoxetine 
Meprobamate 
Carbamazepine 
  (Snyder, 
2008) 
UV at 40 mJ cm-2 Diazepam 
Fluoxetine 
Meprobamate 
Carbamazepine 
  (Snyder, 
2008) 
Ozone (2.5 mg L-1 dose)  Meprobamate Diazepam 
Fluoxetine 
Carbamazepine 
(Snyder, 
2008) 
Powder activated carbon 
(PAC) 
Meprobamate 
(0%) 
Diazepam (53%) 
Carbamazepine 
(55%) 
Fluoxetine (92-
96%) 
(Westerhoff 
et al., 2005) 
(Shon et al., 
2006) 
Flocculation with ferric 
chloride 
Diazepam (0%) 
Fluoxetine (0%) 
Meprobamate 
(0%) 
Carbamazepine 
(0%) 
  (Shon et al., 
2006) 
Flocculation with 
Aluminum 
Diazepam (5%) 
Fluoxetine (20%) 
Meprobamate 
(0%) 
Carbamazepine 
(7%) 
  (Shon et al., 
2006) 
Chlorination pH 5.5 Fluoxetine (20%) 
Meprobamate 
(16%) 
 Diazepam (71%) 
Carbamazepine 
(98%) 
(Shon et al., 
2006) 
Ozone/H2O2  Meprobamate 
(61%) 
Diazepam (85%); 
Fluoxetine (98%) 
Carbamazepine 
(98%) 
(Shon et al., 
2006) 
Ultrafiltration Diazepam (7%) 
Fluoxetine (0%) 
Meprobamate 
(0%) 
Carbamazepine 
(0%) 
  (Shon et al., 
2006) 
Nanofiltration  Meprobamate 
(32%) 
Carbamazepine 
(61%) 
Diazepam (75%) 
Fluoxetine (92%) 
 
(Shon et al., 
2006) 
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It must also be considered the presence of psychiatric pharmaceuticals in sludge which 
result, inevitably, from wastewater treatments (Chenxi et al., 2008; Lapen et al., 2008; Gielen et al., 
2009). In the United States, a WWTP produces an average of 240 kg (dry weight) of biosolids per 
million liters of treated wastewater (Kinney et al., 2006); in the European Union, it is estimated to 
be produced between 9 and 38 kg (dry weight) of biosolids per capita per year (Lapen et al., 2008). 
Knowledge about sorption of pharmaceuticals onto the solid phase is crucial to determine removal 
rates, bioavailability, transport between different environmental compartments and the rate of 
physico-chemical transformations (Caliman and Gavrilescu, 2009). Benzodiazepines and 
carbamazepine are characterized by moderate lipophilicity (Chouinard et al., 1999), low-medium 
octanol-water partitioning coefficients (e.g. 2.19 for temazepam, 2.7 for diazepam (Stein et al., 
2008) and 2.45 for carbamazepine (Hanna et al., 1998)) and relatively low water solubility; thus, 
these compounds might partition moderately into the solid phase. However, the sorption behavior 
might be mediated by different types of interactions depending also on the organic content of the 
solid phase and it is, overall, difficult to predict the relevance of sorption processes for each case 
(Loffler et al., 2005; Stein et al., 2008; Yamamoto et al., 2009; Yu et al., 2009). A recent study by 
Jelic et al. (2011) indicated that sorption onto sludge was responsible for the removal of 
approximately 20% of the initial concentration of diazepam in the influent of 3 WWTPs. This 
indicates that, in this case, while sorption onto sludge contributes to the removal of this compound 
from the liquid effluent, it is not the main mechanism of elimination from aquatic compartments, 
being consistent with a low-medium sorption capacity. Relatively to antidepressants, Kinney et al. 
(2006) found fluoxetine in 9 samples of biosolids collected in 8 different WWTPs with 
considerably high concentrations in the range of 100 to 4700 μg kg-1 (in the same study 
carbamazepine was also found in biosolids with concentrations between 15 and 1220 μg kg-1). 
These relatively high sorptions to biosolids enable the removal of the pharmaceuticals from 
wastewaters. However, the biosolids produced in WWTPs are used in agricultural soils, large-scale 
landscaping, domestic landscaping and soil-surface revegetation (Jones et al., 2005b; Kinney et al., 
2006; Lapen et al., 2008) and constitute a vehicle of these compounds into the environment. More 
detailed data about the sorption and persistence of psychiatric drugs in soils/sediments will be 
given along the next sub-chapter. 
  
2.5 (A)BIOTIC DEGRADABILITY AND PERSISTENCE IN THE ENVIRONMENT 
 
 The degradability (through abiotic or biotic processes) and persistence of pharmaceuticals 
in water/sediment compartments are of great importance to the assessment of chronic exposure of 
organisms living in these environments. However, despite the strong evidences of considerable 
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high persistence and resistance to (bio)degradation of compounds from this pharmaceutical group, 
few data is available on this issue. The available literature is essentially focused on carbamazepine, 
the most studied psychiatric pharmaceutical (Andreozzi et al., 2003; Doll and Frimmel, 2003; Lam 
and Mabury, 2005; Chiron et al., 2006; Matamoros et al., 2009). Few studies are related to some 
antidepressants and anticonvulsants (Kwon and Armbrust, 2005; Kwon and Armbrust, 2006; 
Peschka et al., 2006) and research concerning benzodiazepines is, up to date, very scarce, 
especially photodegradation and biodegradation studies. 
  
2.5.1 Anxiolytics, sedatives and hypnotics 
 
  Generalized occurrence of diazepam in rivers, lakes and WWTP influents and effluents, 
suggests limited degradation of these compounds under environmental conditions (Redshaw et al., 
2008). A study on the biodegradability of diazepam and related pharmaceuticals (oxazepam and 
temazepam), performed in liquid and solid matrices containing bacterial cultures typical of sewage 
sludge-amended soils, reported that diazepam is the most persistent of the considered 
pharmaceuticals. No losses caused by biotic or abiotic factors were observed during a 60 days 
experiment. Oxazepam underwent a loss of 40% due to biodegradation but the study also revealed 
the hypothesis of being transformed in another biologically active and persistent metabolite 
(Redshaw et al., 2008). Loffler et al. (2005) also considered diazepam as a highly persistent 
pharmaceutical, with a dissipation time (DT90) >> 365 days and oxazepam as moderately persistent 
in water/sediment systems. According to this study, diazepam suffers rapid and extensive sorption 
onto sediments; it is highly stable in soils and during wastewater treatments (Loffler et al., 2005) 
and remains stable in ground waters (Ternes, 2005). Photodegradation of diazepam is also 
considered to constitute a feasible mechanism for the decrease of its concentration in surface waters 
(Boreen et al., 2003; Kummerer, 2008). However, there are no studies corroborating the relevance 
of this hypothesis under environmental conditions. Overall, literature data suggest that diazepam is 
potentially being accumulated in the environment. Note that differences in behavior between 
several benzodiazepines, which are detailed in some of the referred investigations, are associated 
with small differences in functional substituent groups. This fact underlines the importance of 
analyzing a wider range of extensively prescribed benzodiazepines to minimize the lack of 
information on the fate and persistence of this type of pharmaceuticals. Nevertheless, up to date, 
there are no references to studies concerning other environmentally occurring benzodiazepines, 
such as alprazolam and lorazepam.  
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Another relevant study related with the persistence of anxiolytics, sedatives and hypnotics 
is presented by Peschka et al. (2006). The biotic and abiotic degradability of several barbiturates 
(butalbital, secobarbital, hexobarbital, aprobarbital, phenobarbital, and pentobarbital) were assessed 
and barbiturates were subjected to biodegradability under aerobic conditions and hydrolysis. None 
of the barbiturates showed any evidence of degradation, stressing their high stability in the 
environment (Peschka et al., 2006). This behavior was also suggested by two distinct investigations 
that reported the identification of barbituratures in landfills which did not receive industrial or 
domestic wastes for more than 20 years (Eckel, 1993; Holm et al., 1995; Jones et al., 2001).  
 
2.5.2 Anti-epileptics - Carbamazepine 
 
When compared to benzodiazepines, much more is known concerning the environmental 
persistence and fate of the anti-epileptic carbamazepine. In the last few years, this drug has been a 
preferential target of the scientific community, mainly due to its generalized occurrence.  
Several studies reported that carbamazepine is considerably more resistant to 
photodegradation than several other pharmaceuticals, which is crucial for the determination of its 
environmental half-life time in aquatic systems exposed to sunlight irradiation (Pal et al., 2010). 
Andreozzi et al. (2003) demonstrated that carbamazepine exposed to sunlight (in different seasons 
and at different latitudes) can persist in aquatic environments for more than 100 days. Under 
simulated irradiation conditions, several studies indicated that carbamazepine has half-life times in 
the order of 100 h (Andreozzi et al., 2002; Lam and Mabury, 2005; Yamamoto et al., 2009). Doll 
and Frimmel (2003) also showed that it is more resistant to photodegradation than the other tested 
compounds (clofibric acid and iomeprol), but environmental half-life times are not evidently 
presented. While it is clear that the literature suggests limited degradation of carbamazepine under 
solar irradiation, it is also difficult to predict real environmental half-life times and to compare 
different studies performed at different simulated irradiation conditions. Most importantly, the 
relevance of water composition in the persistence of contaminants should not be forgotten, due to 
the contribution of indirect photodegradation processes that might be triggered by, for instance, 
naturally occurring dissolved organic matter, nitrates and chloride. The influence of water 
components in the elimination of carbamazepine from the environment is not trivial and several 
investigations described that they can exert contrary effects; for example, Lam and Mabury (2005) 
and Matamoros et al. (2009) reported that dissolved organic matter was responsible for an 
enhancement of carbamazepine photodegradation rates while Chiron et al. (2006) reported that 
dissolved organic matter caused a decrease in the photodegradation. Moreover, some of the 
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photodegradation products already identified in literature are known to produce more adverse 
effects than carbamazepine itself. This is the case of acridine, one of the most frequently identified 
photoproducts, that is considered a mutagenic and carcinogenic compound (Chiron et al., 2006; 
Kosjek et al., 2009). Some literature studies also concluded that biodegradation processes hardly 
contribute to the decrease of carbamazepine concentrations (Stamatelatou et al., 2003; Joss et al., 
2006; Zhang et al., 2008; Yamamoto et al., 2009; Pal et al., 2010). Concerning its fate in the 
water/soil(sediment) interface, and similarly to benzodiazepines, carbamazepine also presents low 
to medium sorption capacities and results may differ significantly according to the soil/sediment 
composition (Scheytt et al., 2005; Chefetz et al., 2008). Overall, it is considered that a significant 
amount of carbamazepine will remain in the aqueous phase (Zhang et al., 2008). As a consequence, 
and also due to its high resistance to bio and photodegradation, carbamazepine has been repeatedly 
proposed as an adequate marker of anthropogenic pollution (Clara et al., 2004; Glassmeyer et al., 
2008; Yu et al., 2009). Thus, the assessment of carbamazepine contamination levels might 
constitute a valuable tool for the identification of relevant focal points of anthropogenic pollution. 
 
2.5.3 Antidepressants 
 
 Published information on the (bio)degradability of SSRIs stated that these pharmaceuticals 
are potentially persistent, remaining in aquatic environments for relatively long periods of time and 
raising several concerns about environmental accumulation (Kwon and Armbrust, 2006; Paterson 
and Metcalfe, 2008; Redshaw et al., 2008; Kosjek and Heath, 2010). Several experiments have 
already demonstrated that fluoxetine and norfluoxetine are resistant to biodegradation processes 
occurring in liquid and soil cultures of bacteria of sewage sludge-amended soils (Kwon and 
Armbrust, 2006; Redshaw et al., 2008). No fluoxetine losses were observed during a 270 days 
assay (Redshaw et al., 2008). Kwon and Armbrust (2006) also concluded that fluoxetine is 
hydrolytically and photolytically stable in aquatic environments (with half-lives greater than 100 
days). However, a distinct study reported that, under simulated conditions, fluoxetine has half-life 
times of 55 h and 5.5 – 22 h in deionized water and synthetic field water, respectively (Lam et al., 
2005). The photo resistance of citalopram was also studied, indicating environmental half-life times 
of 14 to 65 days, depending on aqueous matrix composition (Kwon and Armbrust, 2005). Again, as 
stressed out in the previous sub-chapter, half-life times are dependent on different experimental 
conditions (natural or simulated sunlight – and, in this case, adopted lamp and irradiance levels); 
most of the times it is unclear how did the authors convert half-life times under simulated 
conditions to sunlight days. Therefore, it is difficult to predict real environmental half-life times 
and to properly compare different studies, and a uniform normalization of the results is lacking. 
Literature Review | Chapter 2 
41 
 
According to some literature, the major concern about fluoxetine environmental fate should 
not be focused on its persistence in water but in the sediments/soils distribution. Fluoxetine rapidly 
dissipates from water compartments as a result of high adsorption to sediments and soils, where it 
appears to be greatly persistent (Kwon and Armbrust, 2006; Redshaw et al., 2008). In general, 
SSRIs have sorption capacities greater than 91% (Kwon and Armbrust, 2008) and yet, these values 
could not be explained by high octanol-water partition coefficient (Kow) (actually, benzodiazepines 
have higher Kow and lower sorption capacities). The Kow is related with the compounds 
hydrophobicity (Sabljic et al., 1995). For neutral and hydrophobic pharmaceuticals it is known that 
the organic carbon content of biomass, soils or sediments may be related with sorption mechanisms 
and therefore plausibly well correlated with Kow (Kwon and Armbrust, 2008). In the particular case 
of SSRIs, log Kow values vary from 1.12 (fluvoxamine) to 1.39 (citalopram); additionally, these 
pharmaceuticals also have relatively high water solubilities (from 3.022 to 15.460 mg L-1). Hence, 
hydrophobic interactions could not justify the sorption mechanism of these pharmaceuticals and, 
consequently, Kow is not an adequate parameter to properly predict their fates in environmental 
conditions (Kwon and Armbrust, 2008). A study performed by Wells (2006) presented Dow, the pH 
dependent octanol-water distribution ratio (a combination of Kow and pKa) as a more appropriate 
physicochemical parameter to understand the distribution of pharmaceuticals in water/sediment 
systems. This parameter takes into account the hydrophilic character of a pharmaceutical at a 
specific pH, allowing to understand the mobility of a compound at environmentally relevant pH 
conditions. Also, multiple mechanisms may be useful to describe the unexpectedly high SSRIs 
sorption onto soils/sediments based, for instance, on cation exchange, cation bridging at clay 
surfaces, surface complexation or hydrogen bonding (Kwon and Armbrust, 2008).  
 As far as other antidepressants are concerned, very limited data is available, resulting in a 
substantial lack of knowledge about these emerging environmental pollutants. However, the 
information gathered indicates that persistence and accumulation are very likely to occur. One 
example is the case of the tricyclic antidepressant amitriptyline which was shown to be non 
biodegradable under sewage treatment conditions (Halling-Sorensen et al., 1998), highlighting the 
importance of performing more studies on the (bio)degradation of these pharmaceuticals in 
environmentally relevant conditions and to find newer solutions to promote their elimination. 
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2.6 TOXICITY OF PSYCHIATRIC DRUGS FOR NON-TARGET ORGANISMS  
 
 Psychiatric pharmaceuticals occur in the environment in the range of ng L-1 to μg L-1. 
Although these concentrations are below the predicted levels to cause harm to humans, as well as 
to cause acute toxicity to non-target organisms, it is pertinent to take into account that these 
compounds do not occur isolated but as complex mixtures, such that additive and synergistic 
effects might occur (Bound et al., 2006; Pomati et al., 2008; Quinn et al., 2009; Schnell et al., 2009; 
Styrishave et al., 2011). In this context, and due to having an intrinsic biological activity that can 
affect nervous and endocrine systems, psychiatric pharmaceuticals are one of the most significant 
groups in what concerns the evaluation of ecotoxicological effects in terrestrial and aquatic non-
target organisms (van der Ven et al., 2006). Furthermore, the increasing number of studies about 
chronic toxicity on non-target aquatic organisms point out that no extrapolations between acute and 
chronic toxicity should be done, underlining the need to develop a distinct approach to better 
clarify this issue (Cunningham, 2006; Kummerer, 2008). In fact, seeing that aquatic organisms are 
extensively exposed to pharmaceuticals, it would be more important to understand life cycle 
toxicity rather than perform acute toxicity tests (Halling-Sorensen et al., 1998; Petrovic and 
Barceló, 2007). 
 
2.6.1 Anxiolytics, sedatives and hypnotics 
 
 The toxicity data for diazepam are gathered in Table 2.7. Actually, to the best of our 
knowledge, diazepam is the only benzodiazepine with anxiolytic, sedative or hypnotic properties 
whose toxic effects were studied and evaluated. Interestingly, only one study was found concerning 
effects due to other anxiolytics (buspirone and chlordiazepoxide) (Bencan et al., 2009). Acute 
toxicity tests on several aquatic organisms revealed that the concentrations needed to the 
observation of acute adverse effects caused by diazepam (in the mg L-1 scale) are well above the 
environmental concentrations of diazepam – the maximum concentration detected in surface waters 
was 0.88 μg L-1 (Ternes, 2001). Nonetheless, a study performed by Pascoe et al. (2003), comparing 
acute and chronic toxicity to an aquatic invertebrate sedentary organism (Hydra vulgaris), 
described visible adverse effects (deficient regeneration of polyps) at concentrations of 10.0 μg L-1. 
More recently, Oggier et al. (2010) showed that diazepam affects gene expression in zebrafish, 
after 14 days of exposure, at levels as low as 235 ng L-1. This concentration is lower than the 
concentration found in some surface waters and effluents of WWTPs. This is a clear first indication 
that diazepam is able to exert effects on non-target organisms at environmentally relevant 
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concentrations, after a chronic exposure. With these findings, and as the continuous discharge of 
these compounds in the environment results in exposures during the entire life cycle of the 
organisms (Halling-Sorensen et al., 1998; Pascoe et al., 2003), it is of great relevance to refer the 
inexistence of more chronic toxicity studies for other organisms or for other pharmaceuticals with 
the same mode of action.  
 
2.6.2 Anti-epileptics - Carbamazepine 
 
In the last few years there has been a significant increase in the number of studies dealing 
with the ecotoxicity of carbamazepine. Some relevant data are gathered in Table 2.8. 
  Similarly to benzodiazepines, the majority of literature data reports that acute toxic effects 
caused by exposure to carbamazepine are not likely to occur at concentration levels found in the 
environment (Ferrari et al., 2003; Jos et al., 2003; van den Brandhof and Montforts, 2010; Li et al., 
2011). Nevertheless, there is one literature study describing acute toxic effects (48 h of exposure) 
related to changes in the oxidative metabolism of cnidarians at concentrations that might cause 
some concern (7 - 47 μg L-1) (Quinn et al., 2004); note that the maximum concentration of 
carbamazepine found until now, in surface waters, was approximately 11.6 μg L-1 (Loos et al., 
2009). Another relevant investigation also found that carbamazepine might be able to induce 
changes in the reproduction of C. dubia at concentrations that are reasonably close to the 
environmental concentrations (no observable effects concentration, NOEC, 25 μg L-1; lowest 
observable effects concentration, LOEC, 100 μg L-1), during a 7 day exposure (Ferrari et al., 2003). 
In addition, Quinn et al. (2009) showed that complex mixtures of pharmaceuticals can exert the 
same toxic effect in concentrations that are 2 to 3 orders of magnitude lower than the relevant 
pharmaceutical alone. The pharmaceutical mixture studied comprised carbamazepine and 
concentrations causing sub-lethal effects in a freshwater cnidarian were found to be in the range 
between ng L-1 and μg L-1. These studies evidence that concentrations of carbamazepine found in 
the environment might not be as innocuous as it has been concluded in some investigations 
(focused in individual acute toxicity data). 
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Table 2.7. Toxicity data of diazepam for non-target organisms.  
Test species Acute toxicity Test  Acute toxicity data 
Chronic toxicity 
data Additional information Reference 
DIAZEPAM 
Daphnia magna (Invertebrate) EC50, 24h 14.1 mg L-1 - - (Calleja et al., 1994) 
EC50 13.9 mg L-1; 4.3 
mg L-1 
- - (Halling-Sorensen et al., 1998) 
LC50 13.9 mg L-1 - - (Lilius et al., 1995) 
LC50 4.3 mg L-1 - - (Halling-Sorensen et al., 1998) 
Hydra vulgaris (Invertebrate, 
cnidarian) 
- <1 mg L-1 10.0 μg L-1 Evaluation of the capacity for 
regenerate polyps  
(Pascoe et al., 2003) 
Artemia parthenogenetica 
(crustacean) 
LC50 12.2 mg L-1  
 
- The most toxic compound between 
clofibric acid, SDS and clofibrate 
(Nunes et al., 2005) 
Tetraselmis chuii (unicellular 
marine algae) 
IC50 16.5 mg L-1  
 
- The most toxic compound between 
clofibric acid, SDS and clofibrate 
(Nunes et al., 2005) 
PLHC-1 and RTG-2 cell lines 
(Fish) 
EC50 0.363 - 0.604 mM 
(103 - 172 mg L-1) 
- - (Caminada et al., 2006) 
Gambusia holbrooki (euryhaline 
fish) 
LC50 12.7 mg L-1  
 
- The second most toxic compound 
between clofibric acid, SDS and 
clofibrate 
(Nunes et al., 2005) 
Danio rerio (zebrafish) - - - Signs of significant anxiolytic effects 
after a 3 min exposure to 0 – 20 mg L-1. 
The same was observed for the 
anxiolytic buspirone. 
(Bencan et al., 2009) 
- - 235 ng L-1 Diazepam affected after 14 days of 
exposure both at 235 ng L-1 and 291 μg 
L-1 concentration levels; significant 
changes in locomotor activity in 
embryos at 291 μg L-1 
(Oggier et al., 2010) 
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Table 2.8. Toxicity data of the anti-epileptic pharmaceutical carbamazepine for non-target organisms.  
Test species Acute toxicity Test Acute toxicity data 
Chronic toxicity 
data Additional information Reference 
CARBAMAZEPINE 
Hydra attenuata (cnidarian) Monitorization of 
oxidative metabolism, 
48 h  
0.03 – 0.2 μM 
(7 – 47 μg L-1) 
- Signs of lethal toxicity at 0.6 and 6 mM 
levels (142 and 1418 mg L-1), after 48 
h. 
(Quinn et al., 2009) 
Daphnia magna (Invertebrate) EC50, 48h >13 800 μg L-1 - - (Ferrari et al., 2003) 
EC50, 24 and 48h 475 and 414 μM 
(112 and 98 mg L-1) 
- Indicator for EC50 test: immobilization, 
after 24 and 48 h, respectively. 
(Jos et al., 2003) 
Ceriodaphnia dubia 
(Invertebrates) 
EC50, 48h 77 700 μg L-1 NOEC 25 μg L-1; 
LOEC 100 μg L-1  
7 days chronic exposure (Ferrari et al., 2003) 
Pseudokirchneriella subcapitata 
(Algae - green) 
- - - Bioaccumulation factor of 2.2 after 24h 
exposure to 150 mg L-1 
(Vernouillet et al., 2010) 
Vibrio fischeri (bacteria) EC50, 5, 15 and 60 min 370, 332 and 272 
μM (87, 78 and 64 
mg L-1) 
- Indicator for EC50 test: 
bioluminescence. Results after 5, 15 
and 60 min, respectively 
(Jos et al., 2003) 
Brachionus calyciflorus (rotoxkit) - - NOEC 377 μg L-1; 
LOEC 754 μg L-1 
48h test used to calculate NOEC and 
LOEC 
(Ferrari et al., 2003) 
      
Oncorhynchus mykiss (rainbow 
trout) 
LC50, 96h 19.9 mg L-1 - - (Li et al., 2011) 
Danio rerio (fish) EC50, 72h 86.5 mg L-1  NOEC – 30.6 mg L-1 (van den Brandhof and 
Montforts, 2010) 
Cyprinus carpio (common carp) - - - Evidences of oxidative stress in fish 
spermatozoa after 2h; range of tested 
concentrations: 0.2 – 20 mg L-1 
(Li et al., 2010) 
Oryzias latipes (fish) - - 9 days of chronic 
exposure 
Changes in feeding behavior and 
swimming speed after exposure to 6.15 
mg L-1  
(Nassef et al., 2010) 
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2.6.3 Antidepressants 
 
A large number of researches are focused on the potential environmental adverse effects of 
steroids and other estrogens, since it was discovered their interference in endocrine responses of 
aquatic organisms (Brooks et al., 2003a). On the contrary, little attention has been paid to non-
steroidal pharmaceuticals that present the same ability, which is directly related to the action mode 
of antidepressants: not only can they affect the neuronal system but also disrupt neuro-endocrine 
signaling causing perturbations on the reproductive behavior (Foran et al., 2004; van der Ven et al., 
2006; Henry and Black, 2008; Péry et al., 2008; Gust et al., 2009; Sánchez-Argüello et al., 2009). 
Detailed information on the toxicity of antidepressants to aquatic organisms can be found in Table 
2.9. Amongst antidepressant pharmaceuticals, the SSRI fluoxetine has been the most extensively 
studied compound. Yet, the effects of this compound (and other antidepressants, in general) on 
aquatic organisms are not completely understood (Cunningham, 2006). A first interesting 
conclusion on the ecotoxicity of fluoxetine arises from the comparison between its acute toxicity 
data (Table 2.9) and acute toxicity data for diazepam or carbamazepine (Tables 2.7 and 2.8, 
respectively). While the majority of studies concerning diazepam or carbamazepine pointed out 
acute toxicity levels higher than 10 mg L-1, fluoxetine acute toxic concentrations are, usually, well 
below 1 mg L-1 and several studies even reported acute toxic effects at concentrations as low as 20 
– 40 μg L-1 (Brooks et al., 2003a; Brooks et al., 2003b; Johnson et al., 2007).  
Fluoxetine, paroxetine and sertraline are possible examples of antidepressants that are 
suspected to be hormonally active (Kolpin et al., 2002). In primary producers, invertebrates and 
fish, the mechanistic responses to SSRIs are not completely clarified. However, several fish species 
were identified for the possession of serotonin receptors, making it possible to predict that SSRIs 
can modulate serotonin levels in these animals (Brooks et al., 2005). An investigation of chronic 
and acute toxicity of SSRIs to Ceriodaphnia dubia, by Henry et al. (2004), confirmed that the 
reproduction patterns of these invertebrates are affected by the exposure to these antidepressants. 
SSRIs were shown to have the ability of reducing the number of neonates and broods per female 
with a LOEC of 0.045 mg L-1. This study also established that increasing concentrations of 
citalopram, fluvoxamine, fluoxetine, sertraline and paroxetine caused an increase in the mortality 
of C. dubia: LC50 values ranged from 0.12 mg L-1 for sertraline to 3.90 mg L-1 for citalopram. The 
locomotion capabilities of C. dubia were also negatively affected at SSRIs concentrations below 
the determined LC50 values (Henry et al., 2004).  
 Several other studies have already established a direct connection between exposure to 
SSRIs and gonadal maturation, induction of parturition, metamorphosis and spawning in aquatic 
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organisms (Henry et al., 2004; Fong and Molnar, 2008; Gust et al., 2009; Bringolf et al., 2010). 
Concentrations as low as 32 ng L-1 were shown to induce spawning in male zebra mussels 
(Dreissena polymorpha) (Fong, 1998). There are also experimental evidences that norfluoxetine 
induces spawning in zebra mussels and dark false mussels at concentrations of 1 μM, 
approximately 0.3 mg L-1 (Fong, 1998; Fong and Molnar, 2008). A similar study with fluoxetine 
showed that it also induces spawning in zebra mussels and dark false mussels but at concentrations 
between 10 to 20 times lower than norfluoxetine. Moreover, fluoxetine causes parturition in 
fingernail clams (Sphaerium striatinum) at concentrations of 10 μM (3 mg L-1) (Fong, 1998; Fong 
et al., 1998; Fong and Molnar, 2008). Consequently, this class of pharmaceuticals may constitute a 
real concern as, in this particular case, the induction of spawning and parturition in the wrong time 
of the year may increase the percentage of early stage mortality due to the scarcity of food for 
juvenile development, resulting in serious negative consequences for these species (Fong and 
Molnar, 2008).  
Of particular relevance are two recent researches that performed chronic toxicity tests and 
concluded that fluoxetine can cause changes in the behavioral response of E. marinus (crustacea) 
when present at concentrations of 10 ng L-1 (Guler and Ford, 2010). Also, fluoxetine can affect 
growth during metamorphosis stages of X. laevis (Tadpoles) at 10 μg L-1 (Conners et al., 2009). 
These concentrations are extremely low and commonly found in aquatic environments, especially 
those close to WWTP effluents discharge points. The validity of these studies implies the 
assumption that non-target aquatic organisms are actually being directly affected by the presence of 
fluoxetine. 
 Relatively to the possibility of bioaccumulation, the uptake and depuration of fluoxetine 
was investigated in freshwater fish species. Paterson and Metcalfe (2008) exposed the Japanese 
Medaka (Oryzias latipes) to a fluoxetine concentration of 0.64 μg L-1 during seven days followed 
by a 21 days period of depuration. The concentrations of fluoxetine and its active metabolite 
norfluoxetine increased during the uptake period and decreased during the depuration phase. 
Uptake of fluoxetine and norfluoxetine was observed in the first five hours of exposure, with a 
maximum concentration determined on the third day. The depuration phase permitted to determine 
the fluoxetine half-life in the fish tissues (9.4 ± 1.1 days), clearly indicating that fluoxetine and 
norfluoxetine can persist in biological tissues and present a large potential for bioaccumulation in 
fish. 
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Table 2.9. Toxicity data of antidepressants for non-target organisms.  
Test species Acute toxicity test  Acute toxicity data Chronic toxicity data Additional information Reference 
FLUOXETINE 
Daphnia magna (Invertebrate) EC50 820 μg L-1 - - (Brooks et al., 2003a) 
LC50 820 μg L-1 - - (Brooks et al., 2003b) 
- - 429; 430 and 444 μg L-1 (LOEC 
survival test with R-fluoxetine, rac-
fluoxetine and S-fluoxetine, 
respectively ) 
21 day chronic exposure (Stanley et al., 2007) 
- - 8.9 and 31 μg L-1 (NOEC and LOEC 
affecting the length of newborns, 
respectively) 
 (Péry et al., 2008) 
Ceriodaphnia dubia (Invertebrate) EC50 234 μg L-1 - - (Brooks et al., 2003a) 
LC50 234 μg L-1 - - (Brooks et al., 2003b) 
- - 0.056 mg L-1 - (Brooks et al., 2003a) 
LC50, 48h 0.51 ± 0.07 mg L-1 
(n=3) 
0.089 mg L-1 (NOEC affecting the 
mean number of neonates produced) 
Range of acute test 
concentration: 0.19-2.92 mg L-1 
(Henry et al., 2004) 
Xenopus laevis (Tadpoles) EC50 6.4 mg L-1; 6.6 mg L-1 - - (Richards and Cole, 
2006) 
- - 10 μg L-1 LOEC, reduced growth at 
metamorphosis 
70 day chronic exposure through 
metamorphosis 
(Conners et al., 2009) 
- - - A delay in the development of 
tadpoles was observed, during a 
several week assay at  
0.029 – 0.29 μg L-1. 
(Foster et al., 2010) 
Hyalella azteca EC50 >43 μg kg-1 - - (Brooks et al., 2003a) 
Chironomus tentans LC50 15.2 mg kg-1 - - (Brooks et al., 2003b) 
EC50 15.2 μg kg-1 - - (Brooks et al., 2003a) 
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Test species Acute toxicity test  Acute toxicity data Chronic toxicity data Additional information Reference 
Echinogammarus marinus 
(Crustacea) 
- - Changes in behavioral response and 
increased predation risk were 
observed at 10 ng L-1 with a peak at 
100 ng L-1 
21 day chronic exposure. 
Range of tested concentrations: 
10 ng L-1 – 10 μg L-1 
(Guler and Ford, 2010) 
Potamopyrgus antipodarum 
(Mollusc gastropod) 
- - 13 and 69 μg L-1 (NOEC and LOEC 
affecting reproduction, respectively) 
 (Péry et al., 2008) 
- - 33.3 and 100 μg L-1 (NOEC and 
LOEC affecting the cumulate number 
of neonates, respectively) 
42 day chronic exposure (Gust et al., 2009) 
Pseudokirchneriella subcapitata EC50 24 μg L-1 - - (Brooks et al., 2003a) 
IC10;IC50, 96h 31.34 ± 1.93; 
 44.99 ± 1.76 μg L-1 
- - (Johnson et al., 2007) 
Scendesmus acutus (Algae) IC10;IC50, 96h 55.60 ± 4.73;  
91.23 ± 2.74 μg L-1 
- - (Johnson et al., 2007) 
S. quadricauda (Algae) IC10;IC50, 96h 97.76 ± 13.54; 
 212.98 ± 16.13 μg L-1 
- - (Johnson et al., 2007) 
Chlorella vulgaris (Algae) IC10;IC50, 96h 2901.57 ± 1218.97; 
4339.25 ±446.09 μg L-1 
- - (Johnson et al., 2007) 
Unspecified (Algae - green) - - 0.001 mg L-1 - (Crane et al., 2006) 
Oryzias latipes (Japanese medaka) LC50, 96h 5.5, 1.3 and  
0.20 mg L-1 at pH 7,8 
and 9, respectively 
- - (Nakamura et al., 
2008) 
PLHC-1 and RTG-2 cell lines 
(Fish) 
EC50 0.0110 - 0.0242 mM 
(3.4 – 7.5 mg L-1) 
- - (Caminada et al., 2006) 
Pimephales promelas (fish) EC50 705 μg L-1 - - (Brooks et al., 2003a) 
LC50 705 μg L-1 - - (Brooks et al., 2003b) 
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Test species Acute toxicity test  Acute toxicity data Chronic toxicity data Additional information Reference 
LC50, 48h 212; 198 and 216 μgL-1 
for R-fluoxetine, rac-
fluoxetine and S-
fluoxetine, respectively 
170; 174 and 101 μg L-1 (LOEC 
survival test with R-fluoxetine, rac-
fluoxetine and S-fluoxetine, 
respectively ) 
7 day chronic exposure (Stanley et al., 2007) 
Elliptio complanata, Lampsilis 
cardium, Lampsilis fasciola 
- 300 – 3 000 μg L-1, 
changes in reproductive 
behavior after  
48 h – 96 h 
- - (Bringolf et al., 2010) 
   PAROXETINE   
Ceriodaphnia dubia  LC50, 48h 0.58 ± 0.13 mg L-1 
(n=3) 
- Range of acute test 
concentration: 0.22 - 6.96 mg L-1 
(Henry et al., 2004) 
Xenopus laevis EC50 4.6 mg L-1  - (Richards and Cole, 
2006) 
   CITALOPRAM   
Ceriodaphnia dubia LC50, 48h 3.90 ± 0.27 mg L-1 
(n=3) 
4 mg L-1 (LOEC affecting the mean 
number of neonates produced) 
Range of acute test 
concentration: 0.59 - 7.84 mg L-1 
(Henry et al., 2004) 
Ceriodaphnia dubia - - 0.8 mg L-1 - (Crane et al., 2006) 
   FLUVOXAMINE   
Ceriodaphnia dubia  LC50, 48h 0.84 ± 0.41 mg L-1 
(n=3) 
0.366 mg L-1 (NOEC affecting the 
mean number of neonates produced) 
Range of acute test 
concentration: 0.10 - 2.21 mg L-1 
(Henry et al., 2004) 
Pseudokirchneriella subcapitata IC10;IC50, 96h 3987.38 ± 322.88; 
4002.88 ± 42.52 μg L-1 
- - (Johnson et al., 2007) 
Unspecified (Algae – green) - - 31 mg L-1 - (Crane et al., 2006) 
Scendesmus acutus (Algae) IC10;IC50, 96h 2503.65 ± 328.78; 
3620.24 ± 34.96 μg L-1 
- - (Johnson et al., 2007) 
S. quadricauda (Algae) IC10;IC50, 96h 1662.91 ± 157.16; 
3563.34 ± 118.94 μgL-1 
- - (Johnson et al., 2007) 
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Test species Acute toxicity test  Acute toxicity data Chronic toxicity data Additional information Reference 
Chlorella vulgaris (Algae) IC10;IC50, 96h 6162.86 ± 814.30; 
10208.47 ± 379.24 μg 
L-1 
- - (Johnson et al., 2007) 
   SERTRALINE   
Ceriodaphnia dubia LC50, 48h 0.12 ± 0.05 mg L-1 
(n=3) 
0.045 mg L-1 (LOEC affecting the 
mean number of neonates produced) 
Range of acute test 
concentration: 0.04 - 1.84 mg L-1 
(Henry et al., 2004) 
Pseudokirchneriella subcapitata IC10;IC50, 96h 4.57 ± 0.66;  
12.10 ± 1.00 μg L-1 
- - (Johnson et al., 2007) 
Scendesmus acutus (Algae) IC10;IC50, 96h 54.59 ± 6.52;  
98.92 ± 6.74 μg L-1 
- - (Johnson et al., 2007) 
S. quadricauda  IC10;IC50, 96h 48.19 ± 3.27;  
317.02 ± 21.46 μg L-1 
- - (Johnson et al., 2007) 
Chlorella vulgaris  IC10;IC50, 96h 152.73 ± 5.09;  
763.66 ± 25.42 μg L-1 
- - (Johnson et al., 2007) 
Xenopus laevis (Tadpoles) EC50 4.6 mg L-1 - - (Richards and Cole, 
2006) 
- - 0.1 μg L-1 LOEC, reduced growth at 
metamorphosis 
70 day chronic exposure through 
metamorphosis 
(Conners et al., 2009) 
   RISPERIDONE   
Unspecified (Algae - 
cyanobacteria) 
- - <100 mg L-1 - (Crane et al., 2006) 
Unspecified (Algae - green) - - <10.0 mg L-1 - (Crane et al., 2006) 
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2.7 ANALYTICAL METHODS FOR THE DETERMINATION OF PSYCHIATRIC 
PHARMACEUTICALS IN ENVIRONMENTAL MATRICES 
 
 One of the main challenges in monitoring the occurrence of psychiatric pharmaceuticals in 
waste, surface and ground waters (as for all pharmaceuticals, in general), is the lack of simple, 
sensitive and low cost analytical methods to quantify pharmacologically active substances (and 
their metabolites) in the concentration range of ng L-1 to μg L-1 (Ternes, 2001; Debska et al., 2004; 
Buchberger, 2007). However, in the last decade, major advances have been achieved with the 
development of new analytical methods that allow the quantification of trace amounts of 
pharmaceuticals (Debska et al., 2004; Kostopoulou and Nikolaou, 2008; Buchberger, 2011). The 
first efforts in the field of pharmaceutical trace analysis often resulted in single-analyte 
methodologies but, nowadays, the development of multi-analyte methodologies, capable of 
quantifying up to several dozens of pharmaceuticals is becoming more and more common (Gracia-
Lor et al., 2011; Togola and Budzinski, 2008; Huerta-Fontela et al., 2010; López-Serna et al., 2010; 
Baker and Kasprzyk-Hordern, 2011). The development of robust analytical methodologies is of 
crucial importance taking into account that all steps involved in a proper environmental risk 
assessment would depend, inevitably, on the existence of reliable analytical data. One of the most 
important difficulties in analyzing pharmaceuticals in environmental matrices (such as wastewaters 
and sludge) relies on the complexity of the samples, being this another reason for the requirement 
of analytical techniques with very high resolution and extremely low quantification limits (Jones et 
al., 2005b; Kosjek and Heath, 2010; Buchberger, 2011). Hence, the fundamental step of this type of 
analysis is often considered to be sample preparation (Sliwka-Kaszynska et al., 2003; Ramirez et 
al., 2007). 
 In the particular case of psychiatric pharmaceuticals, some data concerning the 
performance of analytical methods optimized for their determination are presented in Table 2.10. 
Note that, despite the novelty of this issue, literature data about analytical methods for psychiatric 
pharmaceuticals rose exponentially in the last few years. Consequently, this section does not intend 
to present a comprehensive compilation and analysis of published papers but to give a general idea 
of state-of-the-art and progresses made.  
The most frequently used techniques include GC and LC with mass spectrometry detection 
(Gros et al., 2006; Buchberger, 2007; Kot-Wasik et al., 2007; Terzic et al., 2008; Buchberger, 
2011). Even so, LC related methods have been much more explored as GC methods are limited to 
be applied to classes of compounds which are easily volatized or, alternatively, which can be 
derivatized to volatile compounds without the emergence of undesirable side products. 
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 LC-MS/MS is the most used technique due to its versatility, specificity and selectivity. One 
of the major disadvantages of LC-MS/MS methods is their susceptibility to matrix interferences, in 
special when they are associated with the electrospray ionization mode (ESI), which is undoubtedly 
the most used ionization technique in pharmaceutical trace analysis. These matrix interferences are 
related to the suppression of the analyte signals (most commonly) due to the co-elution of matrix 
components and leading to erroneous results (Kot-Wasik et al., 2007; Buchberger, 2011). 
Therefore, the use of this technique requires an extensive preliminary study of the matrix effects 
(Gros et al., 2006). To overcome this difficulty, Vasskog et al. (2006) developed a HPLC-(ESI)-
MS method with a two-step sample cleaning procedure including SPE (solid-phase extraction) and 
LLE (liquid-liquid extraction), resulting in a very sensitive and selective method with limits of 
quantification in the order of pg L-1. Another way of minimizing these effects was investigated by 
Chu and Metcalfe (2007) that optimized the HPLC-MS technique for the determination of 
antidepressants, using the atmospheric pressure chemical ionization (APCI) that is less affected by 
the mentioned matrix effects. Specifically, HPLC-(ESI)-MS was already developed for the 
quantification of diazepam in environmental water samples (Ternes, 2001; Debska et al., 2004; 
Ramirez et al., 2007), consisting on a sample pretreatment (filtration with glass filters, 1 μm pore 
diameter, at pH 7.0) and a SPE enrichment (column RP C18 using MeOH for the elution, 
evaporation to dryness in gentle stream nitrogen and redissolution in phosphate buffer) prior to 
HPLC-(ESI)-MS analysis. Recently, Schultz and Furlong (2008) developed a quantitative method 
for the determination of 8 antidepressants and 2 derivatives in environmental aqueous samples, 
comprising a pretreatment using SPE followed by LC-(ESI)-MS/MS. The analyzed samples were 
collected from several municipal wastewater effluents and from a waste-dominated stream. As 
stated before, attention is drawn into the development of multi-analyte methods and psychiatric 
pharmaceuticals have started to be commonly included in the selected group of analytes. 
 It is also possible to name some examples of GC/MS methods which were optimized for 
the determination of psychiatric pharmaceuticals in environmental samples (Brooks et al., 2005; 
Wille et al., 2005; Chu and Metcalfe, 2007; Kosjek and Heath, 2010). A large number of active 
substances included in this pharmacological group are considered as “neutral pharmaceuticals” – 
designation used for compounds which do not have acidic functional groups (Ternes, 2001). As a 
consequence, these pharmaceuticals can be enriched at neutral pH using SPE and sorbents can be 
subsequently analyzed by GC-MS without the need of derivatization (Ternes, 2001). Togola and 
Budzinski (2008) developed a GC-MS based method for the simultaneous determination of the 
anxiolytics and antidepressants amitryptiline, imipramine, doxepine, nordiazepam and diazepam 
without derivatization. This technique has also already been optimized for the determination of 
diazepam, consisting on an initial sample pretreatment (filtration with glass filters, 1 μm, at pH 7.5) 
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followed by an enrichment step using SPE (column RP C18 using MeOH for the elution). The 
sample was then analyzed by GC-MS using MSTFA for the derivatization (Ternes, 2001; Debska 
et al., 2004). 
 As can be concluded from the data presented in Table 2.10, SPE is the most commonly 
adopted pre-concentration procedure. Due to the moderate hydrofobicity of the majority of 
psychiatric pharmaceuticals, SPE reverse-phase materials are usually adequate. On the other hand, 
with the rising trend of developing multi-analyte methodologies, the majority of the studies here 
presented used new polymeric sorbents that allows satisfactory results when in the presence of a 
wide variety of hydrophobic/hydrophilic compounds (Madureira et al., 2009; González Alonso et 
al., 2010; López-Serna et al., 2010; Baker and Kasprzyk-Hordern, 2011; Buchberger, 2011).  
Few examples of immunoanalysis applications and their comparison with reference 
analytical techniques were reported (Valentini et al., 2002; Debska et al., 2004; Huo et al., 2007; 
Shelver et al., 2008; Bahlmann et al., 2009). From these literature studies, only one presented the 
development of an immunochemical method for the determination of psychiatric pharmaceuticals 
in the environment (determination of carbamazepine in surface waters) (Bahlmann et al., 2009). 
Consequently, the potentialities of environmental immunoanalytical methods have not been 
properly explored, in particular, in the determination of psychiatric drugs. Immunochemical 
methods usually require only little sample preparation procedures and are characterized by high 
sensitivity. They are capable of analyzing large amounts of samples in just a few hours, being 
adequate for high-throughput analysis. Also, these methods usually involve fewer costs than the 
common chromatographic methods. For these reasons, immunochemical analysis may be an 
excellent tool to quick and inexpensive environmental screenings (Buchberger, 2007; Buchberger, 
2011). Although immunoassay techniques are not suitable for the determination of several 
structurally different analytes, they will be certainly useful techniques in the determination of 
markers of environmental pollution, allowing to take conclusions on the contamination levels of 
selected areas. Diazepam, fluoxetine and carbamazepine were pointed out to be considered 
references relatively to other pharmaceuticals with similar mode of action and they might constitute 
good indicators of the presence of psychiatric drugs in environmental samples (Cunningham, 2006; 
Buchberger, 2007; Yu et al., 2009).  
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Table 2.10. Performance of several analytical methods optimized for the determination of psychiatric pharmaceuticals in environmental samples.  
Method Sample Sample preparation Recovery ± standard deviation LOQ References 
DIAZEPAM 
LC-MS/MS Sludge USE followed by SPE 37 ± 6% (activated sludge, absolute recovery); 59 ± 
11% (activated sludge, relative recovery); 25 ± 3% 
(digested sludge, absolute recovery); 48 ± 10% 
(digested sludge, relative recovery) 
20 ng g-1 (Ternes et al., 1998) 
LC-MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 106 ± 9% - 115 ± 9% 2.6 – 10 ng L-1 (Gros et al., 2009) 
LC-MS/MS Surface waters close 
to effluent discharge 
SPE 64.5 ± 9.8% - 75.1 ± 4.3% 2.60 ng L-1 (Madureira et al., 2009) 
UPLC – MS/MS WWTP influents and 
effluents 
SPE 88 ± 3% 1.5 ng L-1 (Huerta-Fontela et al., 
2010) 
UPLC – MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 89 ± 2% - 105 ± 13% (SPE absolute recovery);  
99 ± 3% - 103 ± 10% (SPE relative recovery) 
0.5 – 6.0 ng L-1 (Baker and Kasprzyk-
Hordern, 2011) 
GC-MS Surface water and 
drinking water (n=5) 
SPE 102 ± 14% 20 ng L-1 (Ternes et al., 1998) 
GC-MS STP effluent (n=5) SPE 102 ± 14% 100 ng L-1 (Ternes et al., 1998) 
GC-MS Tap water SPE 73% 22 ng L-1 (Sacher et al., 2001) 
GC-MS Surface water SPE 99% 22 ng L-1 (Sacher et al., 2001) 
LORAZEPAM 
LC-MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 111 ± 11% - 138 ± 25% 6 – 24  ng L-1 (Gros et al., 2009) 
UHPLC-MS/MS Surface waters and 
WWTP effluents 
SPE 86 ± 2% - 96 ± 2% (surface water);  
85 ± 2% - 87 ± 2% (WWTP effluents) 
4.3 ng L-1 and 30 
ng L-1  
(Gracia-Lor et al., 2010) 
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Method Sample Sample preparation Recovery ± standard deviation LOQ References 
UPLC – MS/MS WWTP influents and 
effluents 
SPE 101 ± 4% 1.5 ng L-1 (Huerta-Fontela et al., 
2010) 
ALPRAZOLAM 
UHPLC-MS/MS Surface waters and 
WWTP effluents 
SPE 78 ± 4% - 83 ± 4% (surface water);  
75 ± 4% - 78 ± 3% (WWTP effluents) 
2.9 ng L-1 and 11 
ng L-1  
(Gracia-Lor et al., 2010) 
UPLC – MS/MS WWTP influents and 
effluents 
SPE 110 ± 5% 1.5 ng L-1 (Huerta-Fontela et al., 
2010) 
OXAZEPAM 
UPLC – MS/MS WWTP influents and 
effluents 
SPE 75 ± 4% 0.02 ng L-1 (Huerta-Fontela et al., 
2010) 
UPLC – MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 51 ± 3% - 62 ± 2% (SPE absolute recovery);  
96 ± 4% - 205 ± 5% (SPE relative recovery) 
0.5 – 5.9 ng L-1 (Baker and Kasprzyk-
Hordern, 2011) 
BARBITURATES  
(BUTALBITAL, SECOBARBITAL, PENTOBARBITAL, HEXOBARBITAL, APROBARBITAL, PHENOBARBITAL) 
GC-MS Rhine river water SPE 64 ± 1% - 105 ± 1% 1 - 5 ng L-1 (Peschka et al., 2006) 
CARBAMAZEPINE 
LC-MS/MS Surface water SPE 93 ± 1% (high spiking level); 67 ± 6% (low spiking 
level) 
10 ng L-1 (Gros et al., 2006) 
LC-MS/MS WWTP effluents SPE 97 ± 5% (high spiking level); 93 ± 12% (low spiking 
level) 
40 ng L-1 (Gros et al., 2006) 
LC-MS/MS Surface water SPE 98 ± 3% (high spiking level); 105 ± 10% (low spiking 
level) 
61 ng L-1 (Gros et al., 2006) 
LC-MS/MS Surface waters SPE 82.2 ± 8.1% (spike level: 50 ng L-1)  
73.5 ± 11.5% (spike level: 500 ng L-1)  
48 pg L-1 (Zhang and Zhou, 2007) 
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Method Sample Sample preparation Recovery ± standard deviation LOQ References 
LC-MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 72 ± 16% - 99 ± 3% 0.8 – 8 ng L-1 (Gros et al., 2009) 
LC-MS/MS Surface waters close 
to effluent discharge 
SPE 83.2 ± 3.1% - 92.2 ± 4.9% 0.11 ng L-1 (Madureira et al., 2009) 
UPLC - MS/MS Surface waters SPE 99.3 ± 2.2% 2.85 ng L-1 (Conley et al., 2008) 
UPLC - MS/MS WWTP influents and 
effluents 
SPE 71 ± 3% 1.5 ng L-1 (Huerta-Fontela et al., 
2010) 
ELISA Surface water None -  
(validated by LC-MS/MS) 
0.05 – 50 µg L-1 
(quantitation 
range) 
(Bahlmann et al., 2009) 
FLUOXETINE 
LC-APCI-MS/MS Fish tissues (n=8) PLE followed by SPE 96.2 ± 2.9% 0.07 ng g-1 (Chu and Metcalfe, 2007) 
LC-(ESI)-MS/MS Surface waters SPE 105 ± 6% (high spiking level); 74 ± 12% (low spiking 
level) 
76 ng L-1 (Gros et al., 2006) 
LC-(ESI)-MS/MS WWTP effluent SPE 60 ± 2% (high spiking level); 74 ± 2% (low spiking 
level) 
70 ng L-1 (Gros et al., 2006) 
LC-(ESI)-MS/MS WWTP influent SPE 108 ± 4% (high spiking level); 67 ± 12% (low spiking 
level) 
100 ng L-1 (Gros et al., 2006) 
HPLC-(ESI)-MS STP influents and 
effluents 
SPE and LLE 64 – 92% (different samples) 120 pg L-1 (Vasskog et al., 2006) 
LC-MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 70 ± 6% - 112 ± 8% 0.8 – 5 ng L-1 (Gros et al., 2009) 
UPLC - MS/MS Surface waters SPE 80.1 ± 3.6% 3.29 ng L-1 (Conley et al., 2008) 
UPLC - MS/MS WWTP influents and 
effluents 
SPE 62 ± 4% 15 ng L-1 (Huerta-Fontela et al., 
2010) 
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Method Sample Sample preparation Recovery ± standard deviation LOQ References 
UPLC – MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 53 ± 17% - 74 ± 5% (SPE absolute recovery);  
88 ± 12% - 104 ± 14% (SPE relative recovery) 
3.0 – 5.0 ng L-1 (Baker and Kasprzyk-
Hordern, 2011) 
PAROXETINE 
LC-APCI-MS/MS Fish tissues (n=8) PLE followed by SPE 99.2 ± 3.5% 0.24 ng g-1 (Chu and Metcalfe, 2007) 
LC-(ESI)-MS/MS Surface waters SPE 95 ± 5% (high spiking level); 110 ± 12% (low spiking 
level) 
20 ng L-1 (Gros et al., 2006) 
LC-(ESI)-MS/MS WWTP effluent SPE 65 ± 3% (high spiking level); 76 ± 12% (low spiking 
level) 
26 ng L-1 (Gros et al., 2006) 
LC-(ESI)-MS/MS WWTP influent SPE 96 ± 1% (high spiking level); 84 ± 4% (low spiking 
level) 
22 ng L-1 (Gros et al., 2006) 
HPLC-(ESI)-MS STP influents and 
effluents 
SPE and LLE 71 – 92% (different samples) 120 pg L-1 (Vasskog et al., 2006) 
LC-MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 84 ± 19% - 99 ± 3% 2 – 3 ng L-1 (Gros et al., 2009) 
UHPLC-MS/MS Surface waters and 
WWTP effluents 
SPE 94 ± 9% - 97 ± 9% (surface water);  
91 ± 5% - 92 ± 3% (WWTP effluents) 
0.2 ng L-1 and 3.6 
ng L-1  
(Gracia-Lor et al., 2010) 
VENLAFAXINE 
UHPLC-MS/MS Surface waters and 
WWTP effluents 
SPE 70 ± 8% - 110 ± 2% (surface water);  
91 ± 4% - 88 ± 12% (WWTP effluents) 
19 ng L-1 and 43 
ng L-1  
(Gracia-Lor et al., 2010) 
UPLC – MS/MS WWTP influents and 
effluents 
SPE 72 ± 4% 1.5 ng L-1 (Huerta-Fontela et al., 
2010) 
UPLC – MS/MS Surface waters and 
WWTP influents and 
effluents 
SPE 85 ± 8% - 97 ± 8% (SPE absolute recovery);  
90 ± 6% - 113 ± 7% (SPE relative recovery) 
0.5 – 3.6 ng L-1 (Baker and Kasprzyk-
Hordern, 2011) 
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Method Sample Sample preparation Recovery ± standard deviation LOQ References 
CITALOPRAM 
HPLC-(ESI)-MS STP influents and 
effluents 
SPE and LLE 36 – 72% (different samples) 160 pg L-1 (Vasskog et al., 2006) 
 
FLUVOXAMINE 
HPLC-(ESI)-MS STP influents and 
effluents 
SPE and LLE 56 – 82% (different samples) 150 pg L-1 (Vasskog et al., 2006) 
SETRALINE 
HPLC-(ESI)-MS STP influents and 
effluents 
SPE and LLE 52 – 85% (different samples) 290 pg L-1 (Vasskog et al., 2006) 
UPLC - MS/MS Surface waters SPE 80.6 ± 3.0% 1.92 ng L-1 (Conley et al., 2008) 
NORFLUOXETINE 
LC-APCI-MS/MS Fish tissues (n=8) PLE followed by SPE 85.6 ± 4.2% 0.14 ng g-1 (Chu and Metcalfe, 2007) 
UPLC - MS/MS Surface waters SPE 71.5 ± 4.7% 1.84 ng L-1 (Conley et al., 2008) 
RISPERIDONE 
UHPLC-MS/MS Surface waters and 
WWTP effluents 
SPE 76 ± 11% - 88 ± 6% (surface water);  
91 ± 4% - 114 ± 9% (WWTP effluents) 
2.0 ng L-1 and 5.9 
ng L-1  
(Gracia-Lor et al., 2010) 
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2.8 CONCLUDING REMARKS 
 
 The literature data here presented constitute a clear evidence of the widespread occurrence 
of psychiatric pharmaceuticals in the environment.  
The excretion of the unchanged or conjugated forms by the human body, along with the 
inadequacy of WWTPs removal methods represent the major pathway of entrance of psychiatric 
pharmaceuticals into the environment. Some of the most commonly used methods in wastewater 
treatment have removal efficiencies below 10% and thus, large amounts of psychiatric 
pharmaceuticals pass through WWTPs completely unaffected. In the last 20 years there has been an 
increasing effort to improve the efficiency of WWTPs and to develop new remediation strategies. 
However, these measures were only partially successful and until now, it has not been found a 
viable alternative to overcome the continuous introduction of these compounds into the 
environment. Ultimately, groundwater, which constitutes the largest reservoir of potable water on 
the planet, might be affected as reported by several studies which have already identified these 
pollutants in groundwater samples. Widespread contamination also affects water reuse for 
agricultural purposes and drinking water resources. As a result, one of the main focuses of future 
investigation should comprise prevention of continuous pollution and feasible remediation 
strategies. 
Nowadays, mainly due to major advances in the development of powerful analytical 
methods, there is a considerable knowledge on the occurrence of psychiatric pharmaceuticals (and 
other pharmaceuticals, in general) in several environmental compartments. However, conclusive 
data about the persistence, fate and ecotoxicological effects of psychiatric pharmaceuticals are still 
missing. Very few data is available on the impact of environmental transformations (such as 
biodegradation and photodegradation) in the fate and persistence of these compounds. Moreover, 
for the majority of the referred pharmaceuticals, the identity and relevance of the photoproducts 
generated in the environment remain completely unknown. Comprehensive approaches to this issue 
should, therefore, consider that environmental by-products might also be relevant environmental 
pollutants. Concerning the ecotoxicological importance of these pharmaceuticals, there are some 
evidences that compounds such as diazepam, carbamazepine and fluoxetine are potentially being 
accumulated in aquatic organisms. The study of life cycle toxicity, as well as the investigation of 
the adverse effects caused by the exposure to complex mixtures of psychiatric pharmaceuticals 
with the same mode of action, should also be considered a strong topic to be addressed in a near 
future. 
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 In conclusion, this literature review allows a clear identification of the main research needs 
in this field of concern. The persistence of benzodiazepines (anxiolytic pharmaceuticals) in aquatic 
environments was recognized as a poorly studied topic. In line with this assessment, part of the 
work developed and presented in this thesis is intended to give a significant contribution to better 
understand this subject. Data presented in this chapter also indicate that carbamazepine is a 
potentially adequate marker of anthropogenic pollution. A better knowledge of the environmental 
behavior of this pharmaceutical might constitute a valuable tool for future investigation. Thus, this 
work also aims to clarify the persistence and fate of carbamazepine (namely, photoreactivity and 
partition at water/soil interfaces) as well as to develop a fast and inexpensive screening 
methodology which is of the utmost importance for large environmental screenings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vânia Calisto | Universidade de Aveiro 
62 
 
2.9 REFERENCES 
 
Andreozzi, R., Raffaele, M., Nicklas, P., 2003. Pharmaceuticals in STP effluents and their solar 
photodegradation in aquatic environment. Chemosphere 50, 1319-1330. 
Andreozzi, R., Raffaele, M., Pinto, G., Pollio, A., 2002. Carbamazepine in water: persistence in the 
environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res. 36, 2869-2877. 
Ariffin, M.M., Miller, E.I., Cormack, P.A., Anderson, R.A., 2007. Molecularly imprinted solid-
phase extraction of diazepam and its metabolites from hair samples. Anal. Chem. 79, 256-262. 
Ashton, D., Hilton, M., Thomas, K.V., 2004. Investigating the environmental transport of human 
pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333, 167-184. 
Bahlmann, A., Weller, M.G., Panne, U., Schneider, R.J., 2009. Monitoring carbamazepine in surface 
and wastewaters by an immunoassay based on a monoclonal antibody. Anal. Bioanal. Chem. 395, 1809-
1820. 
Baker, D.R., Kasprzyk-Hordern, B., 2011. Multi-residue analysis of drugs of abuse in wastewater 
and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionisation 
tandem mass spectrometry. J. Chromatogr. A 1218, 1620-1631. 
Bencan, Z., Sledge, D., Levin, E.D., 2009. Buspirone, chlordiazepoxide and diazepam effects in a 
zebrafish model of anxiety. Pharmacol. Biochem. Be. 94, 75-80. 
Benotti, M.J., Trenholm, R.A., Vanderford, B.J., Holady, J.C., Stanford, B.D., Snyder, S.A., 2009. 
Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ. Sci. Technol. 43, 597-
603. 
Boreen, A.L., Arnold, W.A., McNeill, K., 2003. Photodegradation of pharmaceuticals in the aquatic 
environment: a review. Aquat. Sci. 65, 320-341. 
Bound, J.P., Kitsou, K., Voulvoulis, N., 2006. Household disposal of pharmaceuticals and 
perception of risk to the environment. Environ. Toxicol. Phar. 21, 301-307. 
Bringolf, R.B., Heltsley, R.M., Newton, T.J., Eads, C.B., Fraley, S.J., Shea, D., Cope, W.G., 2010. 
Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater 
mussels. Environ. Toxicol. Chem. 29, 1311-1318. 
Brooks, B.W., Chambliss, C.K., Stanley, J.K., Ramirez, A., Banks, K.E., Johnson, R.D., Lewis, R.J., 
2005. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. 
Chem. 24, 464-469. 
Brooks, B.W., Foran, C.M., Richards, S.M., Weston, J., Turner, P.K., Stanley, J.K., Solomon, K.R., 
Slattery, M., La Point, T.W., 2003a. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 142, 169-183. 
Brooks, B.W., Turner, P.K., Stanley, J.K., Weston, J.J., Glidewell, E.A., Foran, C.M., Slattery, M., 
La Point, T.W., Huggett, D.B., 2003b. Waterborne and sediment toxicity of fluoxetine to select organisms. 
Chemosphere 52, 135-142. 
Brunton, L.L., Parker, K.L., Blumenthal, D. K., Buxton, I.L.O. (Ed.), 2008. Goodman & Gilman’s 
Manual of Pharmacology and Therapeutics. McGraw-Hill, San Diego, California. 
Literature Review | Chapter 2 
63 
 
Buchberger, W.W., 2007. Novel analytical procedures for screening of drug residues in water, waste 
water, sediment and sludge. Anal. Chim. Acta 593, 129-139. 
Buchberger, W.W., 2011. Current approaches to trace analysis of pharmaceuticals and personal care 
products in the environment. J. Chromatogr. A A 1218, 603-618. 
Calamari, D., Zuccato, E., Castiglioni, S., Bagnati, R., Fanelli, R., 2003. Strategic survey of 
therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ. Sci. Technol. 37, 1241-1248. 
Calderón-Preciado, D., Jiménez-Cartagena, C., Matamoros, V., Bayona, J.M., 2011. Screening of 47 
organic microcontaminants in agricultural irrigation waters and their soil loading. Water Res. 45, 221-231. 
Caliman, F.A., Gavrilescu, M., 2009. Pharmaceuticals, personal care products and endocrine 
disrupting agents in the environment – A Review. CLEAN – Soil, Air, Water 37, 277-303. 
Calleja, M.C., Persoone, G., Geladi, P., 1994. Comparative acute toxicity of the first 50 multicenter 
evaluation of in-vitro cytotoxicity chemicals to aquatic non-vertebrates. Arch. Environ. Con. Tox. 26, 69-78. 
Caminada, D., Escher, C., Fent, K., 2006. Cytotoxicity of pharmaceuticals found in aquatic systems: 
comparison of PLHC-1 and RTG-2 fish cell lines. Aquat. Toxicol. 79, 114-123. 
Carballa, M., Omil, F., Lema, J.M., 2008. Comparison of predicted and measured concentrations of 
selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 72, 1118-1123. 
Carballa, M., Omil, F., Lema, J.M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M., 
Ternes, T., 2004. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water 
Res. 38, 2918-2926. 
Carlsson, C., Johansson, A.K., Alvan, G., Bergman, K., Kuhler, T., 2006. Are pharmaceuticals 
potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical 
ingredients. Sci. Total Environ. 364, 67-87. 
Chefetz, B., Mualem, T., Ben-Ari, J., 2008. Sorption and mobility of pharmaceutical compounds in 
soil irrigated with reclaimed wastewater. Chemosphere 73, 1335-1343. 
Chenxi, W., Spongberg, A.L., Witter, J.D., 2008. Determination of the persistence of 
pharmaceuticals in biosolids using liquid-chromatography tandem mass spectrometry. Chemosphere 73, 511-
518. 
Chiba, K., Horii, H., Chiba, T., Kato, Y., Hirano, T., Ishizaki, T., 1995. Development and 
preliminary application of high-performance liquid-chromatographic assay of urinary metabolites of 
diazepam in humans. J. Chromatogr. B 668, 77-84. 
Chiron, S., Minero, C., Vione, D., 2006. Photodegradation processes of the antiepileptic drug 
carbamazepine, relevant to estuarine waters. Environ. Sci. Technol. 40, 5977-5983. 
Chouinard, G., Lefko-Singh, K., Teboul, E., 1999. Metabolism of anxiolytics and hypnotics: 
benzodiazepines, buspirone, zoplicone, and zolpidem. Cell. Mol. Neurobiol. 19, 533-552. 
Chu, S., Metcalfe, C.D., 2007. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues 
using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-
tandem mass spectrometry. J. Chromatogr. A 1163, 112-118. 
Vânia Calisto | Universidade de Aveiro 
64 
 
Clara, M., Strenn, B., Kreuzinger, N., 2004. Carbamazepine as a possible anthropogenic marker in 
the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and 
during groundwater infiltration. Water Res. 38, 947-954. 
Coetsier, C.M., Spinelli, S., Lin, L., Roig, B., Touraud, E., 2009. Discharge of pharmaceutical 
products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs? Environ. Int. 35, 
787-792. 
Collier, A.C., 2007. Pharmaceutical contaminants in potable water: Potential concerns for pregnant 
women and children. EcoHealth 4, 164-171. 
Conkle, J.L., White, J.R., Metcalfe, C.D., 2008. Reduction of pharmaceutically active compounds by 
a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 73, 1741-1748. 
Conley, J.M., Symes, S.J., Kindelberger, S.A., Richards, S.A., 2008. Rapid liquid chromatography-
tandem mass spectrometry method for the determination of a broad mixture of pharmaceuticals in surface 
water. J. Chromatogr. A 1185, 206-215. 
Conners, D.E., Rogers, E.D., Armbrust, K.L., Kwon, J.-W., Black, M.C., 2009. Growth and 
development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and 
sertraline, throughout metamorphosis. Environ. Toxicol. Chem. 28, 2671-2676. 
Courtheyn, D., Le Bizec, B., Brambilla, G., De Brabander, H.F., Cobbaert, E., de Wiele, A.V., 
Vercammen, J., De Wasch, K., 2002. Recent developments in the use and abuse of growth promoters. Anal. 
Chim. Acta 473, 71-82. 
Crane, M., Watts, C., Boucard, T., 2006. Chronic aquatic environmental risks from exposure to 
human pharmaceuticals. Sci. Total Environ. 367, 23-41. 
Cunningham, V.L., Buzby, M., Hutchinson, T. , Mastrocco, F. , Parke, N.,  Roden, N. , 2006. Effects 
of human pharmaceuticals on aquatic life: Next steps. Environ. Sci. Technol. 40, 3456–3462. 
Cunningham, V.L., Constable, D.J.C., Hannah, R.E., 2004. Environmental risk assessment of 
paroxetine. Environ. Sci. Technol. 38, 3351-3359. 
Debska, J., Kot-Wasik, A., Namiesnik, J., 2004. Fate and analysis of pharmaceutical residues in the 
aquatic environment. Cr. Rev. Anal. Chem. 34, 51-67. 
Doll, T.E., Frimmel, F.H., 2003. Fate of pharmaceuticals - photodegradation by simulated solar UV-
light. Chemosphere 52, 1757-1769. 
 Drewes, J.E., Heberer, T., Reddersen, K., 2001. Fate of pharmaceuticals during indirect potable 
reuse. 2nd World Water Congress of the International-Water-Association, Berlin, Germany, pp. 73-80. 
Eckel, W.P., Ross, B., and Isensee, R.K, 1993. Pentobarbital found in groundwater. Groundwater 
31, 801-804. 
Ferrari, B., Paxéus, N., Giudice, R.L., Pollio, A., Garric, J., 2003. Ecotoxicological impact of 
pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotox. 
Environ. Safe. 55, 359-370. 
Fong, P.P., 1998. Zebra mussel spawning is induced in low concentrations of putative serotonin 
reuptake inhibitors. Biol. Bull. 194, 143-149. 
Literature Review | Chapter 2 
65 
 
Fong, P.P., Huminski, P.T., D'Urso, L.M., 1998. Induction and potentiation of parturition in 
fingernail clams (Sphaerium striatinum) by selective serotonin re-uptake inhibitors (SSRIs). J. Exp. Zool. 
280, 260-264. 
Fong, P.P., Molnar, N., 2008. Norfluoxetine induces spawning and parturition in estuarine and 
freshwater bivalves. Bull. Environ. Contam. Toxicol. 81, 535-538 
Foran, C.M., Weston, J., Slattery, M., Brooks, B.W., Huggett, D.B., 2004. Reproductive assessment 
of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch. Environ. Con. 
Tox. 46, 511-517. 
Foster, H.R., Burton, G.A., Basu, N., Werner, E.E., 2010. Chronic exposure to fluoxetine (prozac) 
causes developmental delays in Rana pipiens larvae. Environ. Toxicol. Chem. 29, 2845-2850. 
Gaskins, L.A., Massey, J.G., Ziccardi, M.H., 2008. Effect of oral diazepam on feeding behavior and 
activity of Hawai'i 'amakihi (Hemignathus virens). Appl. Anim. Behav. Sci. 112, 384-394. 
Ghasemi, J., Niazi, A., Ghorbani, R., 2006. Determination of trace amounts of lorazepam by 
adsorptive cathodic differential pulse stripping method in pharmaceutical formulations and biological fluids. 
Anal. Lett. 39, 1159-1169. 
Gielen, G.J.H.P., Heuvel, M.R.v.d., Clinton, P.W., Greenfield, L.G., 2009. Factors impacting on 
pharmaceutical leaching following sewage application to land. Chemosphere 74, 537-542. 
Glassmeyer, S., Kolpin, D.W., Furlong, E.T., Focazio, M.T., 2008. Environmental presence and 
persistence of pharmaceuticals: an overview. in: Aga, D.S. (Ed.). Fate of Pharmaceuticals in the 
Environment and in Water Treatment Systems. CRC Press, Taylor & Francis Books, Boca Raton, pp. 3-51. 
Gómez, M.J., Martínez Bueno, M.J., Lacorte, S., Fernández-Alba, A.R., Agüera, A., 2007. Pilot 
survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the 
Mediterranean coast. Chemosphere 66, 993-1002. 
González Alonso, S., Catalá, M., Maroto, R.R., Gil, J.L.R., de Miguel, Á.G., Valcárcel, Y., 2010. 
Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain). Environ. Int. 
36, 195-201. 
Gracia-Lor, E., Sancho, J.V., Hernández, F., 2010. Simultaneous determination of acidic, neutral and 
basic pharmaceuticals in urban wastewater by ultra high-pressure liquid chromatography-tandem mass 
spectrometry. J. Chromatogr. A 1217, 622-632. 
Gracia-Lor, E., Sancho, J.V., Hernández, F., 2011. Multi-class determination of around 50 
pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by ultra-high 
performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1218, 2264-2275. 
Gros, M., Petrovic, M., Barceló, D., 2006. Development of a multi-residue analytical methodology 
based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level 
determination of pharmaceuticals in surface and wastewaters. Talanta 70, 678-690. 
Gros, M., Petrović, M., Barceló, D., 2009. Tracing pharmaceutical residues of different therapeutic 
classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass 
spectrometry and automated library searching. Anal. Chem. 81, 898-912. 
Vânia Calisto | Universidade de Aveiro 
66 
 
Gros, M., Petrovic, M., Ginebreda, A., Barceló, D., 2010. Removal of pharmaceuticals during 
wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 36, 15-26. 
Guler, Y., Ford, A.T., 2010. Anti-depressants make amphipods see the light. Aquat. Toxicol. 99, 
397-404. 
Gust, M., Buronfosse, T., Giamberini, L., Ramil, M., Mons, R., Garric, J., 2009. Effects of 
fluoxetine on the reproduction of two prosobranch mollusks: Potamopyrgus antipodarum and Valvata 
piscinalis. Environ. Pollut. 157, 423-429. 
Halling-Sorensen, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, F., Holten Lutzhoft, H.C., Jorgensen, 
S.E., 1998. Occurrence, fate and effects of pharmaceutical substances in the environment – a review. 
Chemosphere 36, 357-393. 
Hanna, M., de Biasi, V., Bond, B., Salter, C., Hutt, A.J., Camilleri, P., 1998. Estimation of the 
partitioning characteristics of drugs: a comparison of a large and diverse drug series utilizing 
chromatographic and electrophoretic methodology. Anal. Chem. 70, 2092-2099. 
Health, N., 2011. The internet drug index (the top 200 prescriptions for 2009 by number dispensed). 
http://www.rxlist.com (Accessed January 2011). 
Heberer, T., 2002. Tracking persistent pharmaceutical residues from municipal sewage to drinking 
water. J. Hydrol. 266, 175-189. 
Henry, T.B., Black, M.C., 2008. Acute and chronic toxicity of fluoxetine (selective serotonin 
reuptake inhibitor) in western mosquitofish. Arch. Environ. Con. Toxicol. 54, 325-330. 
Henry, T.B., Kwon, J.W., Armbrust, K.L., Black, M.C., 2004. Acute and chronic toxicity of five 
selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ. Toxicol. and Chem. 23, 2229-2233. 
Holm, J.V., Rugge, K., Bjerg, P.L., Christensen, T.H., 1995. Occurrence and distribution of 
pharmaceutical organic-compounds in the groundwater downgradient of a Landfill (Grindsted, Denmark). 
Environ. Sci. Technol. 29, 1415-1420. 
Huerta-Fontela, M., Galceran, M.T., Ventura, F., 2010. Fast liquid chromatography-quadrupole-
linear ion trap mass spectrometry for the analysis of pharmaceuticals and hormones in water resources. J. 
Chromatogr. A 1217, 4212-4222. 
Huo, S.M., Yang, H., Deng, A.P., 2007. Development and validation of a highly sensitive ELISA for 
the determination of pharmaceutical indomethacin in water samples. Talanta 73, 380-386. 
International Narcotics Control Board, 2010. Psychotropic Substances - Report 2009: Statistics for 
2008. New York. 
Jelic, A., Gros, M., Ginebreda, A., Cespedes-Sánchez, R., Ventura, F., Petrovic, M., Barcelo, D., 
2011. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater 
treatment. Water Res. 45, 1165-1176. 
Jjemba, P.K., 2006. Excretion and ecotoxicity of pharmaceutical and personal care products in the 
environment. Ecotoxicol. Environ. Safe. 63, 113-130. 
Johnson, D.J., Sanderson, H., Brain, R.A., Wilson, C.J., Solomon, K.R., 2007. Toxicity and hazard 
of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae. 
Ecotoxicol. Environ. Safe. 67, 128-139. 
Literature Review | Chapter 2 
67 
 
Jones, O.A.H., Lester, J.N., Voulvoulis, N., 2005a. Pharmaceuticals: a threat to drinking water? 
Trends Biotechnol. 23, 163-167. 
Jones, O.A.H., Voulvoulis, N., Lester, J.N., 2001. Human pharmaceuticals in the aquatic 
environment - A review. Environ. Technol. 22, 1383-1394. 
Jones, O.A.H., Voulvoulis, N., Lester, J.N., 2005b. Human pharmaceuticals in wastewater treatment 
processes. Crit. Rev. Env. Sci. Tec. 35, 401-427. 
Jos, A., Repetto, G., Rios, J.C., Hazen, M.J., Molero, M.L., del Peso, A., Salguero, M., Fernández-
Freire, P., Pérez-MartIn, J.M., Cameán, A., 2003. Ecotoxicological evaluation of carbamazepine using six 
different model systems with eighteen endpoints. Toxicol. in Vitro 17, 525-532. 
Joss, A., Zabczynski, S., Gobel, A., Hoffmann, B., Loffler, D., McArdell, C.S., Ternes, T.A., 
Thomsen, A., Siegrist, H., 2006. Biological degradation of pharmaceuticals in municipal wastewater 
treatment: Proposing a classification scheme. Water Res. 40, 1686-1696. 
Kar, A., 2007. Medicinal Chemistry, 4th ed. New age international publishers, New Delhi, India. 
Kasprzyk-Hordern, B., Dinsdale, R.M., Guwy, A.J., 2008. The occurrence of pharmaceuticals, 
personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water 
Res. 42, 3498-3518. 
Kinney, C.A., Furlong, E.T., Zaugg, S.D., Burkhard, M.R., Werner, S.L., Cahill, J.D., Jorgensen, 
G.R., 2006. Survey of organic wastewater contaminants in biosolids destined for land application. Environ. 
Sci. Technol. 40, 7207-7215. 
Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., Buxton, 
H.T., 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-
2000: A national reconnaissance. Environ. Sci. Technol. 36, 1202-1211. 
Kosjek, T., Heath, E., 2010. Tools for evaluating selective serotonin re-uptake inhibitor residues as 
environmental contaminants. TrAC - Trends Anal. Chem. 29, 832-847. 
Kostopoulou, M., Nikolaou, A., 2008. Analytical problems and the need for sample preparation in 
the determination of pharmaceuticals and their metabolites in aqueous environmental matrices. TrAC - 
Trends Anal. Chem. 27, 1023-1035. 
Kot-Wasik, A., Debska, J., Namiesnik, J., 2007. Analytical techniques in studies of the 
environmental fate of pharmaceuticals and personal-care products. TrAC - Trends Anal. Chem. 26, 557-568. 
Kummerer, K. (Ed.), 2008. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. 
Springer-Verlag, Berlin.  
Kwon, J.-W., Armbrust, K.L., 2005. Degradation of citalopram by simulated sunlight. Environ. 
Toxicol. Chem. 24, 1618-1623. 
Kwon, J.W., Armbrust, K.L., 2006. Laboratory persistence and fate of fluoxetine in aquatic 
environments. Environ. Toxicol. Chem. 25, 2561-2568. 
Kwon, J.W., Armbrust, K.L., 2008. Aqueous solubility, n-octanol-water partition coefficient, and 
sorption of five selective serotonin reuptake inhibitors to sediments and soils. Bull. Environ. Contam. 
Toxicol. 81, 128-135. 
Vânia Calisto | Universidade de Aveiro 
68 
 
Kwon, J.W., Armbrust, K.L., Bay, S.M., Vidal-Dorsch, D., Xia, K., 2009. Determination of 17α-
Ethynylestradiol, Carbamazepine, Diazepam, Simvastatin, and Oxybenzone in Fish Livers. J. AOAC Int. 92, 
359-369. 
Lam, M.W., Mabury, S.A., 2005. Photodegradation of the pharmaceuticals atorvastatin, 
carbamazepine, levofloxacin, and sulfamethoxazole in natural waters. Aquat. Sci. 67, 177-188. 
Lam, M.W., Young, C.J., Mabury, S.A., 2005. Aqueous photochemical reaction kinetics and 
transformations of fluoxetine. Environ. Sci. Technol. 39, 513-522. 
Lapen, D.R., Topp, E., Metcalfe, C.D., Li, H., Edwards, M., Gottschall, N., Bolton, P., Curnoe, W., 
Payne, M., Beck, A., 2008. Pharmaceutical and personal care products in tile drainage following land 
application of municipal biosolids. Sci. Total Environ. 399, 50-65. 
Leif, W., Inka, H., Matthias, E., Heinz, H., 2004. Impact of leaky sewers on groundwater quality. 
Acta Hydroch. Hydrob. 32, 361-373. 
Li, Z.-H., Li, P., Rodina, M., Randak, T., 2010. Effect of human pharmaceutical carbamazepine on 
the quality parameters and oxidative stress in common carp (Cyprinus carpio L.) spermatozoa. Chemosphere 
80, 530-534. 
Li, Z.-H., Zlabek, V., Velisek, J., Grabic, R., Machova, J., Kolarova, J., Li, P., Randak, T., 2011. 
Acute toxicity of carbamazepine to juvenile rainbow trout (Oncorhynchus mykiss): Effects on antioxidant 
responses, hematological parameters and hepatic EROD. Ecotoxicol. Environ. Safe. 74, 319-327. 
Lilius, H., Hastbacka, T., Isomaa, B., 1995. A comparison of the toxicity of 30 reference chemicals 
to Daphnia magna and Daphnia pulex. Environ. Toxicol. Chem. 14, 2085-2088. 
Loffler, D., Rombke, J., Meller, M., Ternes, T.A., 2005. Environmental fate of pharmaceuticals in 
water/sediment systems. Environ. Sci. Technol. 39, 5209-5218. 
Loganathan, B., Phillips, M., Mowery, H., Jones-Lepp, T.L., 2009. Contamination profiles and mass 
loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant. 
Chemosphere 75, 70-77. 
Loos, R., Gawlik, B.M., Locoro, G., Rimaviciute, E., Contini, S., Bidoglio, G., 2009. EU-wide 
survey of polar organic persistent pollutants in European river waters. Environ. Poll. 157, 561-568. 
Loos, R., Locoro, G., Comero, S., Contini, S., Schwesig, D., Werres, F., Balsaa, P., Gans, O., Weiss, 
S., Blaha, L., Bolchi, M., Gawlik, B.M., 2010. Pan-European survey on the occurrence of selected polar 
organic persistent pollutants in ground water. Water Res. 44, 4115-4126. 
López-Serna, R., Pérez, S., Ginebreda, A., Petrovic, M., Barceló, D., 2010. Fully automated 
determination of 74 pharmaceuticals in environmental and waste waters by online solid phase extraction-
liquid chromatography-electrospray-tandem mass spectrometry. Talanta 83, 410-424. 
Madureira, T.V., Barreiro, J.C., Rocha, M.J., Cass, Q.B., Tiritan, M.E., 2009. Pharmaceutical trace 
analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry. J. 
Chromatogr. A 1216, 7033-7042. 
Matamoros, V., Duhec, A., Albaiges, J., Bayona, J.M., 2009. Photodegradation of carbamazepine, 
ibuprofen, ketoprofen and 17α - ethinylestradiol in fresh and seawater. Water Air Soil Poll. 196, 161-168. 
Literature Review | Chapter 2 
69 
 
Metcalfe, C.D., Miao, X.-S., Koenig, B.G., Struger, J., 2003. Distribution of acidic and neutral drugs 
in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 
22, 2881-2889. 
Mills, D.S., 2003. Medical paradigms for the study of problem behaviour: a critical review. Appl. 
Anim. Behav. Sci. 81, 265-277. 
Moffat, A.C., Osselton, M.D., Widdop, B., Galichet, L.Y., 2005. Clarke's Analysis of Drugs and 
Poisons, 3rd edition. Pharmaceutical Press, London. 
Moldovan, Z., 2006. Occurrences of pharmaceutical and personal care products as micropollutants 
in rivers from Romania. Chemosphere 64, 1808-1817. 
Nakamura, Y., Yamamoto, H., Sekizawa, J., Kondo, T., Hirai, N., Tatarazako, N., 2008. The effects 
of pH on fluoxetine in Japanese medaka (Oryzias latipes): Acute toxicity in fish larvae and bioaccumulation 
in juvenile fish. Chemosphere 70, 865-873. 
Nassef, M., Matsumoto, S., Seki, M., Khalil, F., Kang, I.J., Shimasaki, Y., Oshima, Y., Honjo, T., 
2010. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka 
fish (Oryzias latipes). Chemosphere 80, 1095-1100. 
Nunes, B., Carvalho, F., Guilhermino, L., 2005. Acute toxicity of widely used pharmaceuticals in 
aquatic species: Gambusia holbrooki, Artemia parthenogenetica and Tetraselmis chuii. Ecotoxicol. Environ. 
Safe. 61, 413-419. 
Oggier, D.M., Weisbrod, C.J., Stoller, A.M., Zenker, A.K., Fent, K., 2010. Effects of diazepam on 
gene expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environ. 
Sci. Technol. 44, 7685-7691. 
Pal, A., Gin, K.Y.-H., Lin, A.Y.-C., Reinhard, M., 2010. Impacts of emerging organic contaminants 
on freshwater resources: Review of recent occurrences, sources, fate and effects. Sci. Total Environ. 408, 
6062-6069. 
Paranychianakis, N.V., Angelakis, A.N., Leverenz, H., Tchobanoglous, G., 2006. Treatment of 
wastewater with slow rate systems: A review of treatment processes and plant functions. Cr. Rev. Environ. 
Sci. Technol. 36, 187-259. 
Pascoe, D., Karntanut, W., Muller, C.T., 2003. Do pharmaceuticals affect freshwater invertebrates? 
A study with the cnidarian Hydra vulgaris. Chemosphere 51, 521-528. 
Paterson, G., Metcalfe, C.D., 2008. Uptake and depuration of the anti-depressant fluoxetine by the 
Japanese medaka (Oryzias latipes). Chemosphere 74, 125-130. 
Pavlic, M., Libiseller, K., Grubwieser, P., Schubert, H., Rabl, W., 2007. Medicolegal aspects of 
tetrazepam metabolism. Int. J. Legal Med. 121, 169-174. 
Pedersen, J.A., Soliman, M., Suffet, I.H., 2005. Human pharmaceuticals, hormones, and personal 
care product ingredients in runoff from agricultural fields irrigated with treated wastewater. J. Agr. Food 
Chem. 53, 1625-1632. 
Péry, A.R.R., Gust, M., Vollat, B., Mons, R., Ramil, M., Fink, G., Ternes, T., Garric, J., 2008. 
Fluoxetine effects assessment on the life cycle of aquatic invertebrates. Chemosphere 73, 300-304. 
Vânia Calisto | Universidade de Aveiro 
70 
 
Peschka, M., Eubeler, J.P., Knepper, T.P., 2006. Occurrence and fate of barbiturates in the aquatic 
environment. Environ. Sci. Technol. 40, 7200-7206. 
Petrovic, M., Barceló, D. (Eds.), 2007. Analysis, Fate and Removal of Pharmaceuticals in the Water 
Cycle. Elsevier, Amsterdam, The Netherlands. 
Pomati, F., Orlandi, C., Clerici, M., Luciani, F., Zuccato, E., 2008. Effects and interactions in an 
environmentally relevant mixture of pharmaceuticals. Toxicol. Sci. 102, 129-137. 
Quinn, B., Gagne, F., Blaise, C., 2004. Oxidative metabolism activity in Hydra attenuata exposed to 
carbamazepine. Fresen. Environ. Bull. 13, 783-788. 
Quinn, B., Gagné, F., Blaise, C., 2009. Evaluation of the acute, chronic and teratogenic effects of a 
mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata. Sci. Total Environ. 407, 1072-1079. 
Rabiet, M., Togola, A., Brissaud, F., Seidel, J.L., Budzinski, H., Elbaz-Poulichet, F., 2006. 
Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters 
of a medium-sized Mediterranean catchment. Environ. Sci. Technol. 40, 5282-5288. 
Ramirez, A.J., Mottaleb, M.A., Brooks, B.W., Chambliss, C.K., 2007. Analysis of pharmaceuticals 
in fish using liquid chromatography-tandem mass spectrometry. Anal. Chem. 79, 3155-3163. 
Rao, N., 2007. The clinical pharmacokinetics of escitalopram. Clin. Pharmacokinet. 46, 281-290. 
Redshaw, C.H., Cooke, M.P., Talbot, H.M., McGrath, S., Rowland, S.J., 2008. Low 
biodegradability of fluoxetine HCl, diazepam and their human metabolites in sewage sludge-amended soil. J. 
Soils Sediments 8, 217-230. 
Richards, S.M., Cole, S.E., 2006. A toxicity and hazard assessment of fourteen pharmaceuticals to 
Xenopus laevis larvae. Ecotoxicology 15, 647-656. 
Sabljic, A., Güsten, H., Verhaar, H., Hermens, J., 1995. QSAR modelling of soil sorption. 
Improvements and systematics of log KOC vs. log KOW correlations. Chemosphere 31, 4489-4514. 
Sacher, F., Lang, F.T., Brauch, H.J., Blankenhorn, I., 2001. Pharmaceuticals in groundwaters - 
Analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany. J. Chromatogr. A 
938, 199-210. 
Sánchez-Argüello, P., Fernández, C., Tarazona, J.V., 2009. Assessing the effects of fluoxetine on 
Physa acuta (Gastropoda, Pulmonata) and Chironomus riparius (Insecta, Diptera) using a two-species water-
sediment test. Sci. Total Environ. 407, 1937-1946. 
Sanderson, H., Johnson, D.J., Wilson, C.J., Brain, R.A., Solomon, K.R., 2003. Probabilistic hazard 
assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR 
screening. Toxicol. Lett. 144, 383-395. 
Scheytt, T., Mersmann, P., Lindstädt, R., Heberer, T., 2005. Determination of sorption coefficients 
of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. 
Chemosphere 60, 245-253. 
Schnell, S., Bols, N.C., Barata, C., Porte, C., 2009. Single and combined toxicity of pharmaceuticals 
and personal care products (PPCPs) on the rainbow trout liver cell line RTL-W1. Aquat. Toxicol. 93, 244-
252. 
Literature Review | Chapter 2 
71 
 
Schultz, M.M., Furlong, E.T., 2008. Trace analysis of antidepressant pharmaceuticals and their 
select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 80, 1756-1762. 
Shelver, W.L., Shappell, N.W., Franek, M., Rubio, F.R., 2008. ELISA for sulfonamides and its 
application for screening in water contamination. J. Agric. Food Chem. 56, 6609-6615. 
Shon, H.K., Vigneswaran, S., Snyder, S.A., 2006. Effluent organic matter (EfOM) in wastewater: 
Constituents, effects, and treatment. Cr. Rev. Env. Sci. Tec. 36, 327-374. 
Sliwka-Kaszynska, M., Kot-Wasik, A., Namiesnik, J., 2003. Preservation and storage of water 
samples. Cr. Rev. Env. Sci. Tec. 33, 31-44. 
Smith-Kielland, A., Skuterud, B., Olsen, K.M., Morland, J., 2001. Urinary excretion of diazepam 
metabolites in healthy volunteers and drug users. Scand. J. Clin. Lab. Inv. 61, 237-246. 
Snyder, S.A., 2008. Occurrence, treatment, and toxicological relevance of EDCs and 
pharmaceuticals in water. Ozone-Sci. Eng. 30, 65-69. 
Snyder, S.A., Kelly, K.L., Grange, A.H., Sovocool, G.W., Snyder, E.M., Giesy, J.P., 2001. 
Pharmaceuticals and Personal Care Products in the Waters of Lake Mead, Nevada, in: Pharmaceuticals and 
Care Products in the Environment. American Chemical Society, Washington, DC, pp. 116-139. 
Stamatelatou, K., Frouda, C., Fountoulakis, M.S., Drillia, P., Kornaros, M., Lyberatos, G., 2003. 
Pharmaceuticals and Health Care Products in Wastewater Effluents: the Example of Carbamazepine. in: 
Angelakis, A.N., Paranychianakis, N.V., Tsagarakis, K.P. (Eds.). Water Recycling in the Mediterranean 
Region, pp. 131-137. 
Stanley, J.K., Ramirez, A.J., Chambliss, C.K., Brooks, B.W., 2007. Enantiospecific sublethal effects 
of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69, 9-16. 
Stein, K., Ramil, M., Fink, G., Sander, M., Ternes, T.A., 2008. Analysis and sorption of 
psychoactive drugs onto sediment. Environ. Sci. Technol. 42, 6415-6423. 
Styrishave, B., Halling-Sørensen, B., Ingerslev, F., 2011. Environmental risk assessment of three 
selective serotonin reuptake inhibitors in the aquatic environment: A case study including a cocktail scenario. 
Environ. Toxicol. Chem. 30, 254-261. 
Ternes, T., Bonerz, M., Schmidt, T., 2001. Determination of neutral pharmaceuticals in wastewater 
and rivers by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 938, 175-
185. 
Ternes, T.A., 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 
32, 3245-3260. 
Ternes, T.A., 2001. Analytical methods for the determination of pharmaceuticals in aqueous 
environmental samples. Trac-Trend Anal. Chem. 20, 419-434. 
Ternes, T.A., Hirsch, R., Mueller, J., Haberer, K., 1998. Methods for the determination of neutral 
drugs as well as betablockers and beta(2)-sympathomimetics in aqueous matrices using GC/MS and 
LC/MS/MS. Fresen. J. Anal. Chem. 362, 329-340. 
Ternes, T.A., Janex-Habibi, M-L., Knacker, T., Kreuzinger, N., Siegrist, H., 2005. Assessment of 
Technologies for the Removal of Pharmaceuticals and Personal Care Products in Sewage and Drinking 
Water Facilities to Improve the Indirect Potable Water Reuse - EU-Project POSEIDON. 
Vânia Calisto | Universidade de Aveiro 
72 
 
Terzic, S., Senta, I., Ahel, M., Gros, M., Petrovic, M., Barcelo, D., Muller, J., Knepper, T., Marti, I., 
Ventura, F., Jovancic, P., Jabucar, D., 2008. Occurrence and fate of emerging wastewater contaminants in 
Western Balkan Region. Sci. Total Environ. 399, 66-77. 
Thomas, K.V., Hilton, M.J., 2004. The occurrence of selected human pharmaceutical compounds in 
UK estuaries. Mar. Pollut. Bull. 49, 436-444. 
Togola, A., Budzinski, H., 2007. Analytical development for analysis of pharmaceuticals in water 
samples by SPE and GC-MS. Anal. Bioanal. Chem. 388, 627-635. 
Togola, A., Budzinski, H., 2008. Multi-residue analysis of pharmaceutical compounds in aqueous 
samples. J. Chromatogr. A 1177, 150-158. 
Unceta, N., Gomez-Caballero, A., Sanchez, A., Millan, S., Sampedro, M.C., Goicolea, M.A., Salles, 
J., Barrio, R.J., 2008. Simultaneous determination of citalopram, fluoxetine and their main metabolites in 
human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography. 
J. Pharm. Biomed. Anal. 46, 763-770. 
Valentini, F., Compagnone, D., Gentili, A., Palleschi, G., 2002. An electrochemical ELISA 
procedure for the screening of 17β - estradiol in urban waste waters. Analyst 127, 1333-1337. 
van den Brandhof, E.-J., Montforts, M., 2010. Fish embryo toxicity of carbamazepine, diclofenac 
and metoprolol. Ecotox. Environ. Safe. 73, 1862-1866. 
van der Ven, K., Keil, D., Moens, L.N., Hummelen, P.V., van Remortel, P., Maras, M., De Coen, 
W., 2006. Effects of the antidepressant mianserin in zebrafish: molecular markers of endocrine disruption. 
Chemosphere 65, 1836-1845. 
van der Ven, K., Van Dongen, W., Maes, B.U., Esmans, E.L., Blust, R., De Coen, W.M., 2004. 
Determination of diazepam in aquatic samples by capillary liquid chromatography-electrospray tandem mass 
spectrometry. Chemosphere 57, 967-973. 
Vasskog, T., Berger, U., Samuelsen, P.-J., Kallenborn, R., Jensen, E., 2006. Selective serotonin 
reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. J. Chromatogr. A 1115, 187-
195. 
Vernouillet, G., Eullaffroy, P., Lajeunesse, A., Blaise, C., Gagné, F., Juneau, P., 2010. Toxic effects 
and bioaccumulation of carbamazepine evaluated by biomarkers measured in organisms of different trophic 
levels. Chemosphere 80, 1062-1068. 
Wells, M.J.M., 2006. Log DOW: Key to understanding and regulating wastewater-derived 
contaminants. Environ. Chem. 3, 439-449. 
Westerhoff, P., Yoon, Y., Snyder, S., Wert, E., 2005. Fate of endocrine-disruptor, pharmaceutical, 
and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. 
Technol. 39, 6649-6663. 
Wille, S.M.R., Maudens, K.E., Van Peteghem, C.H., Lambert, W.E.E., 2005. Development of a 
solid phase extraction for 13 new generation antidepressants and their active metabolites for gas 
chromatographic-mass spectrometric analysis. J. Chromatogr. A 1098, 19-29. 
Literature Review | Chapter 2 
73 
 
Xia, K., Bhandari, A., Das, K., Pillar, G., 2005. Occurrence and fate of pharmaceuticals and personal 
care products (PPCPs) in biosolids. Conference on Sustainable Land Application. American Society 
Agronomy, Orlando, FL, pp. 91-104. 
Yamamoto, H., Nakamura, Y., Moriguchi, S., Nakamura, Y., Honda, Y., Tamura, I., Hirata, Y., 
Hayashi, A., Sekizawa, J., 2009. Persistence and partitioning of eight selected pharmaceuticals in the aquatic 
environment: Laboratory photolysis, biodegradation, and sorption experiments. Water Res. 43, 351-362. 
Yu, L., Fink, G., Wintgens, T., Melin, T., Ternes, T.A., 2009. Sorption behavior of potential organic 
wastewater indicators with soils. Water Res. 43, 951-960. 
Zhang, Y., Geißen, S.-U., Gal, C., 2008. Carbamazepine and diclofenac: removal in wastewater 
treatment plants and occurrence in water bodies. Chemosphere 73, 1151-1161. 
Zhang, Z.L., Zhou, J.L., 2007. Simultaneous determination of various pharmaceutical compounds in 
water by solid-phase extraction-liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1154, 
205-213. 
Zuccato, E., Calamari, D., Natangelo, M., Fanelli, R., 2000. Presence of therapeutic drugs in the 
environment. Lancet 355, 1789-1790. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vânia Calisto | Universidade de Aveiro 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
Direct photodegradation of the anti-epileptic carbamazepine 
 
 
 
Carbamazepine, a widely consumed anti-epileptic pharmaceutical, is one of the most 
commonly detected pharmaceuticals in the environment and has been repeatedly proposed as an 
adequate marker of anthropogenic pollution. To better assess the environmental persistence of 
carbamazepine in aqueous matrices, the effect of pH and dissolved oxygen on its direct 
photodegradation rate was evaluated, using simulated solar irradiation. The photodegradation 
kinetics were followed by micellar electrokinetic chromatography and a total of seven 
photodegradation products were identified by mass spectrometry. The results indicate that acidic 
pH, combined with the absence of dissolved oxygen, results in very high direct photodegradation 
rates. On the other hand, at basic pH, dissolved oxygen does not interfere with the process and 
very low rates were observed. At environmentally relevant conditions, carbamazepine has shown to 
persist to direct photolysis with half-life times between 4.5 and 25 summer sunny days. 
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3.1 CONTEXTUALIZATION 
 
Carbamazepine is an anti-epileptic pharmaceutical commonly detected in the environment. 
As concluded in chapter 2, carbamazepine has been proposed by several authors as a possible 
marker of anthropogenic pollution, due to its widespread occurrence and high persistence in aquatic 
environments (Clara et al., 2004; Yu et al., 2009). A correct evaluation of the adequacy of 
carbamazepine as an anthropogenic pollution marker implies a comprehensive study of its 
environmental fate. As its solid-water distribution coefficient is low, carbamazepine is expected to 
be present in the aqueous phase in significant amounts (Ternes et al., 2004). Thus, taking into 
account its preference to remain in the aqueous phase, photodegradation might be the most relevant 
process which determines the persistence of this compound in surface waters, particularly in those 
exposed to sunlight (Boreen et al., 2003; Arnold and McNeill, 2007). In this context, the work here 
presented intends to assess the relevance of direct photodegradation processes in the environmental 
persistence of carbamazepine, and to study the effect of relevant environmental factors (such as pH 
and dissolved oxygen) on the photodegradation rates and on the emergence of photoproducts. In 
order to follow the photodegradation of carbamazepine and the formation of photodegradation 
products, a new micellar electrokinetic chromatography (MEKC) method was developed; also, 
several photodegradation products were identified by mass spectrometry. Some brief introductory 
considerations about the main topics and concepts involved in this work are presented below. 
 
3.1.1 Relevance of photodegradation processes in the environment 
 
Once in the environment, the fate of organic pollutants is, in general, potentially affected 
by the same degradation and transportation processes which are more or less relevant according to 
the compounds’ specific characteristics (Petrovic and Barceló, 2007; Glassmeyer et al., 2008). 
However, pharmaceuticals differ from other contaminants in a particular point: the occurrence of 
pharmaceuticals in the environment implies that, in most cases, they have passed completely or 
partially unaffected through the digestive system of humans or animals and through WWTPs 
biological treatments. This means that they are resistant to acid and enzyme-promoted 
biodegradation and thus, biodegradation is not expected to be the main process in the elimination of 
these compounds from the environment; consequently, photodegradation might play a key role on 
their environmental persistence (Petrovic and Barceló, 2007; Kummerer, 2008). The importance of 
photochemical processes is, obviously, dependent on the sensitivity of a compound towards light 
and on the exposure to light (for instance, pharmaceuticals adsorbed onto soils or sediments should 
not be equally affected by photodegradation due to the lack of light penetration in those matrices 
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(Kummerer, 2008)). Thus, photodegradation should be considered particularly relevant in surface 
waters and WWTP which are considerably exposed to solar light irradiation. Concerning the 
sensitivity of these compounds towards light, they are reasonably expected to undergo 
photodegradation as they generally possess aromatic moieties and heteroatoms (Boreen et al., 
2003). However, there are other factors of extreme importance which dictate the occurrence and 
extension of photochemical processes, such as the amount of solar light reaching the pollutant, 
spatio-temporal distribution of the solar light and atmospheric optical properties (Zafiriou et al., 
1984).  
When exposed to solar radiation, pharmaceuticals can undergo direct or indirect photolysis. 
Direct photolysis occurs when a compound absorbs a photon which is then able to induce a 
chemical transformation (Schwarzenbach et al., 2003; Boule et al., 2005). The induction of a 
chemical change as a direct consequence of absorbing a photon is conceptually the simplest type of 
photochemical reaction (Zafiriou et al., 1984). On the other hand, indirect photolysis can play an 
important role on the degradation of pollutants that poorly absorb solar radiation or that resist to 
direct photolysis and occurs when the phototransformation is indirectly caused by excitation of 
chromophores present in natural waters (Zafiriou et al., 1984; Boule et al., 2005) (more details 
about indirect photolysis in the environment will be given in chapter 4).  
The presence of oxygen and the pH value are two main factors affecting photodegradation 
processes in aquatic environments. Oxygen leads to the generation of reactive oxygen species (such 
as singlet oxygen, superoxide, hydrogen peroxide, hydroxyl radicals) which usually play a major 
role on mediating photochemical transformations. Moreover, as pharmaceuticals commonly have at 
least one pH sensitive functional group, pH affects the speciation of ionized and non-ionized forms, 
which might have distinct photodegradation rates (Boreen et al., 2003). In fact, the main factors 
affecting direct photodegradation rates (light absorption rate and quantum efficiency of the process 
- see section 3.1.3) are pH dependent (Arnold and McNeill, 2007). The effect of pH and dissolved 
oxygen in the direct photodegradation rate of carbamazepine and its environmental repercussions 
will be discussed along this chapter. 
 
3.1.2 Outdoor exposure versus simulated photodegradation studies 
 
Nowadays, photodegradation studies are often performed using solar light simulators, most 
commonly equipped with arc xenon lamps and appropriate filters (Vione et al., 2006; Guerard et 
al., 2009; Sevilla-Morán et al., 2010). Simulating environmental conditions is always a huge 
challenge due to the high number and complexity of the involved variables. The simulation of 
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sunlight outdoor exposure is not an exception; yet, the numerous advantages offered by solar 
simulators should also be taken into account when one has to choose between the two possibilities. 
A summary of the main factors to consider when comparing sunlight outdoor exposure and the use 
of solar simulators is presented in Table 3.1. One of the main problems involving simulated solar 
light sources is the difficulty in reproducing the solar spectrum. In Figure 3.1, the solar spectrum 
and a 1500 W arc xenon lamp spectrum (lamp used in the photodegradation tests here described) 
are presented. In this context, the most relevant difference is the lower spectral irradiance of the arc 
xenon lamp, particularly between 290 and 305 nm, which is the most significant wavelength 
interval for the majority of pharmaceuticals (in terms of sensitivity towards light). On the other 
hand, solar light simulators offer predictability, repeatability, steady output and the possibility of 
carrying out tests for uninterrupted time. Ultimately, real environmental conditions, in what 
concerns solar irradiation, can only be offered by outdoor exposure of samples. However, the 
performance of solar simulators is often considered to be satisfactory. A proper conversion of 
kinetic parameters obtained by using solar simulators into real outdoor values is a key point in 
producing results with environmental significance when using these devices. 
 
Table 3.1. Comparison between solar light outdoor exposure and the use of solar simulators to perform 
photodegradation tests. 
Outdoor exposure – solar light Solar simulators 
Exposure to the real solar spectrum Difficulty in properly simulating the entire range of 
the solar light spectrum 
Limited availability of solar radiation: day/night 
cycle  
Possibility of carrying out tests 24 h/day 
Diurnal and seasonal variations of global solar 
irradiance 
Steady output and control over the total irradiance 
Unpredictable weather conditions Predicable conditions; possible control over 
temperature, humidity, etc 
Impossible to repeat the same test under the exact 
same conditions 
Repeatable conditions 
Real outdoor  results are directly obtained Obtained results need to be properly converted into 
environmentally relevant data 
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Figure 3.1. a) Spectral irradiance of a 1500 W arc xenon lamp when using an outdoor UV filter, as given by 
the manufacturer (Solarbox 1500, Co.fo.me.gra, Italy). The spectrum is referred to a total irradiance of 550 
W m-2 between 290-800 nm. b) Solar spectral irradiance obtained under the SORCE project (NASA, 2008). 
The spectrum is referred to 23rd July 2008; the values were averaged in order to provide daily solar 
irradiance. 
 
3.1.3 Quantum yield determination 
 
The quantum yield (ϕ) of a photolysis process can be defined as the number of moles of 
consumed reactant for each mole of photons absorbed by the same reactant. Alternatively, it can 
also be described as the ratio between the photodegradation rate and the rate of light absorption 
(Boule et al., 2005; Braslavsky, 2007). An important detail about this definition should be 
emphasized: it does not distinguish between the quantum efficiency of the primary photochemical 
processes and subsequent secondary reactions. To avoid misconceptions, the term overall quantum 
yield is commonly used and is referred to the yield of removal of a specific reactant. Quantum yield 
values are, in general, between 0 and 1; values higher than 1 strongly suggest the occurrence of 
secondary reactions (Boule et al., 2005). However, quantum yields between 0.0001 and 0.1 are 
usually found for pharmaceuticals with environmental photodegradation half-lives between several 
days and minutes (Arnold and McNeill, 2007). When considering the environmental relevance of 
photodegradation processes, this parameter is of crucial importance to assess the persistence of a 
contaminant and its determination also allows a valid comparison between other studies reported in 
the literature. 
The determination of photodegradation quantum yields requires a method to measure the 
photon flux emitted by the light source. The two most common approaches found in literature are 
Wavelength/ nm
300 400 500 600 700 800
Sp
ec
tr
al
 Ir
ra
di
an
ce
/ (
W
 m
-2
 n
m
-1
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
Wavelength/ nm
250 500 750 1000 1250 1500 1750 2000 2250
0.0
0.5
1.0
1.5
2.0
2.5
300 400 500 600 700 800
0.0
0.5
1.0
1.5
2.0
2.5a) b)
Direct photodegradation of the anti-epileptic carbamazepine | Chapter 3 
 
81 
 
chemical actinometry and radiometry. Chemical actinometers are chemical systems that suffer a 
photochemical reaction for which the quantum yield is accurately known. By subjecting the 
actinometer to the same irradiation conditions of the samples, it is possible to determine the 
intensity of the incident light through the determination of its photodegradation kinetics (Kuhn et 
al., 2004; OECD, 2008). The other approach consists on the direct measurement of irradiance using 
a calibrated radiometer. In this work, the determination of the quantum yield was performed by 
radiometry, following the approach detailed in the subsequent paragraphs, adapted from Chiron et 
al. (2006) and Neamtu and Frimmel (2006). 
Considering rate λi the photodegradation rate of a compound induced by the absorption of 
radiation with wavelength λi and Iλiabs the rate of light absorption at λi, the photolysis quantum yield 
is given by equation 3.1:  
ϕλ i = rate λiIλ iabs     (3.1)  
 
Moreover, Iλiabs, the rate of light absorption at λi, can be determined according to equation 
3.2: Iλ iabs = Iλ i0 × �1 − 10−ελ i ×b×C0�   (3.2) 
 
where C0 is the initial concentration of the compound in solution (mol L-1), Iλi0 is the lamp emission 
intensity at the wavelength λi (Ein L-1 s-1), ε is the molar absorptivity of the compound at λi (L mol-1 
cm-1) and b is the path length inside the photoreactor (cm). Iλi0 can be directly determined by 
converting the spectral irradiance of the lamp (usually given in W m-2 nm-1) into number of photons 
emitted per unit of sample volume per unit of time (Ein L-1 s-1). One Einstein (Ein) corresponds to 
one mole of photons. The use of this unit is considered obsolete and is not recommended by 
IUPAC; however, it is still universally used within this context. 
According to equations 3.1 and 3.2, the photolysis quantum yield at λi is given by equation 
3.3: 
ϕλ i = C0 × kiIλ i0 × (1 − 10−ελ i ×b×C0 )      (3.3) 
 
with ki corresponding to the first order rate constant (s-1) at λi. However, taking into account the 
experimental impossibility of determining the rate constant of a photodegradation process 
corresponding to the absorption of a single wavelength (when the light source is not 
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monochromatic), the photodegradation quantum yield is often determined considering an overall 
average over the lamp emission wavelength range as given by equation 3.4: 
 
ϕave = C0 × k∑(Iλ i0 × (1 − 10−ελ i ×b×C0 ))     (3.4) 
 
where k is the apparent first order rate constant (s-1). According to these equations, the units of the 
average quantum yield should be mol Ein-1. Taking into account that one Ein is equivalent to one 
mole of photons, the quantum yield is a dimensionless quantity. 
  
3.1.4 Basic concepts of capillary electrophoresis 
 
The main principle of electrophoresis is the separation of charged molecules based on their 
movement through a fluid when an external constant electric field is applied (Weinberger, 2000; 
Marina et al., 2005). Capillary electrophoresis is one of the several possible formats of 
electrophoretic techniques and consists on the usage of a thin capillary as the physical support for 
the electrophoretic separation. Instrumental requirements to conduct capillary electrophoresis 
separations are relatively simple. In fact, in the early beginning of this technique, the work was 
majorly performed using homemade equipments. Nowadays, basic instrumental configuration 
mainly consists on (Marina et al., 2005): 
- High voltage power supply; 
- Reservoirs containing electrolytic solutions and samples, often incorporated in auto 
sampler devices; 
- Two electrodes at the inlet and outlet, generally made of platinum; 
- Capillary, usually inside a thermostated compartment; 
- Detection system; 
- Software to control the instrument and manage data acquisition and processing. 
Overall, capillary electrophoresis offers several advantages when compared to 
chromatographic techniques such as HPLC. It requires much smaller quantities of reagents and 
only a few nanoliters of sample. Moreover, capillaries are less expensive than HPLC columns and 
are much more versatile (the surface of the capillary columns, which is determinant in the 
separation process, can be easily modified by manipulating the pH, using capillary coatings or even 
(pseudo)stationary phases). Capillary electrophoresis also allows the separation of molecules 
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within a wide range of molecular weights and charges (Weinberger, 2000). In general, it is 
characterized by better efficiency and separation resolution than HPLC (Marina et al., 2005). 
Briefly, electrophoretic separations are driven by two major components: electrophoretic 
mobility and electroosmotic flow (EOF) (Marina et al., 2005). The electrophoretic mobility (µep) of 
charged species in an electrolytic solution is a consequence of the electrostatic force exerted when 
a constant electric field is applied. At constant velocity, the electrophoretic mobility (cm2 V-1 s-1) 
can be expressed as:  μep = υepE     (3.5) 
where E (V cm-1) is the electric field strength and υep (cm s-1) is the migration velocity of the ionic 
species. The electrophoretic mobility depends on the charge and size ratio (q/r) and on the viscosity 
(η) of the electrolytic solution (and therefore on temperature and nature of the electrolytic solution), 
according to the following equation: 
μep = q6πηr    (3.6) 
The EOF is the liquid flow originated by the presence of an electric field, when an 
electrolytic solution is in contact with the charged inner capillary wall (Marina et al., 2005). Before 
the first use, capillaries are usually conditioned, consisting on the ionization of the silanol groups of 
its inner wall. As a consequence, the capillary surface remains negatively charged and a high 
number of counterions, placed adjacently to the capillary wall, originate an electric double layer. 
This double layer is constituted by ions that are strongly bound and immobilized and by a second 
mobile cationic layer that, under an electric field, migrates towards the cathode, mobilizing the 
electrolytic solution inside the capillary and resulting on the EOF (Skoog et al., 1998; Weinberger, 
2000; Marina et al., 2005). The EOF depends on the zeta potential (ζ, potential across the double 
layer), the dielectric constant of the solution (ε) and on the viscosity (η) of the electrolytic solution 
according to: 
υeo = εEζ4πη     (3.7) 
As a consequence of equation 3.7, there is a large number of experimental variables that might be 
manipulated to modify the EOF, such as pH, nature and concentration of the electrolytic solution, 
addition of organic modifiers, temperature or composition of the capillary inner wall surface 
(Weinberger, 2000; Marina et al., 2005). The EOF is a key concept in capillary electrophoresis as it 
has the ability to modify the migration velocity of species depending on whether they are moving 
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in the same or in the opposite direction of the EOF. In fact, the real electrophoretic mobility of 
charged species is a function of the EOF, according to the following equation: 
μep =  μa  ± μeo    (3.8) 
where µa and µeo are the apparent (experimentally measurable) electrophoretic mobility of ionic 
species and of the EOF, respectively (Skoog et al., 1998; Weinberger, 2000; Marina et al., 2005). 
The control and reproducibility of the EOF is absolutely critical to capillary electrophoresis as it 
can control the whole separation process. It is also the flat profile of the EOF across the capillary 
diameter which enables the high resolution and peak efficiency which characterizes capillary 
electrophoresis (Weinberger, 2000). 
Capillary electrophoresis appears in a variety of separation modes. The simplest separation 
mode, capillary zone electrophoresis (CZE), consists on the usage of a capillary filled with an 
electrolytic solution (also commonly designated as running buffer) and the separation of charged 
molecules is based on differences on their electrophoretic mobility (Marina et al., 2005). 
Obviously, this separation mode is limited to charged molecules, which considerably restricts the 
applicability of this technique: neutral molecules migrate through the capillary at the same velocity 
of the EOF, without any separation (Marina et al., 2005). The expansion of capillary 
electrophoresis to the separation of neutral molecules was possible by the development of 
electrokinetic capillary chromatography (EKC) (Terabe et al., 1984; Terabe et al., 1985). 
Ultimately, this separation mode is a combination of the concepts involved both in CZE and 
chromatography and consists on the introduction of a pseudostationary phase into the running 
buffer. Electrophoretic mobility and EOF continue to be the driving forces responsible for the 
movement of the pseudostationary phase and solutes through the capillary. However, in this case, 
the separation of neutral molecules is dictated by their partition between the pseudostationary and 
the aqueous phases (Marina et al., 2005). The pseudostationary phase might consist on a large 
variety of additives in the running buffer. Most commonly, a surfactant is used and, in this case, the 
micelles (aggregates of surfactant molecules spontaneously formed in aqueous solution) are the 
pseudostationary phase. This separation mode is known as micellar electrokinetic chromatography 
(MEKC) and separation is based on the partition of the analytes between the micelle and the 
aqueous phase (Weinberger, 2000). Sodium dodecylsulphate (SDS) is often used as surfactant 
agent due to its high water solubility, degree of lipid solubilizing power and also due to its low 
critical micellar concentration (8 mM) which are the main criteria to take into account for the 
selection of an adequate surfactant (Weinberger, 2000). When using SDS, negatively charged 
micelles are formed which will, consequently, migrate towards the anode. Thus, the presence of the 
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EOF is of crucial importance to enable the movement of the micelles towards the detector at the 
cathode end (Pranaityté and Padarauskas, 2006). 
MEKC methods are widely used in the analysis of anti-epileptic pharmaceuticals and their 
metabolites in biological samples (Smyth and McClean, 1998; Thormann et al., 2001; Pucci and 
Raggi, 2005). In this work, it is described the application of a MEKC methodology to the 
separation of the anti-epileptic carbamazepine from its photodegradation products. 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Chemicals 
 
All chemicals used were of analytical grade: carbamazepine (99%, Sigma), sodium 
dodecylsulphate (99%, for electrophoresis, Sigma-Aldrich), hexadimethrine bromide (polybrene, 
Sigma-Aldrich), sodium chloride, ethylvanillin (99%, Aldrich), sodium tetraborate (borax, Riedel-
de Haën), sodium hydroxide (Fluka), formic acid (98%, Fluka) and acetonitrile (HPLC gradient 
grade, VWR, Prolabo). 
 Ultra-pure water, used in the preparation of standard solutions, running buffer and 
irradiation samples, was obtained using a Milli-Q Millipore system (Milli-Q plus 185). 
  
3.2.2 Irradiation experiments 
 
3.2.2.1 Irradiation apparatus 
 
The irradiation experiments were performed with the Solarbox 1500 (Co.fo.me.gra, Italy) 
equipped with a 1500 W arc xenon lamp and special outdoor UV filters that restrict the 
transmission of light with wavelengths below 290 nm. The uniformity of the irradiation was 
provided by a parabolic reflection chamber, whereas the temperature of the irradiation chamber 
was maintained by an air cooled system. During the irradiation, the irradiance was kept constant at 
550 W m-2 (290 - 800 nm); a multimeter (Co.fo.me.gra, Italy) equipped with a black standard 
temperature sensor and a UV 290 - 400 nm large band sensor was used to monitor the irradiance 
levels and temperature. A schematic representation of the irradiation chamber is shown in Figure 
3.2.  
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Figure 3.2. Scheme representing a lateral cross-section of the solar light simulator used in the irradiation 
experiments (Solarbox 1500, Co.fo.me.gra, Italy). 
 
3.2.2.2 Sample preparation and sampling 
 
Carbamazepine stock solutions were prepared with ultra-pure water with a final 
concentration of 9.5 mg L-1 (approximately half of its solubility in water) and were stored in dark 
glass bottles at 4 ºC, for no more than 1 month.   
Stock solutions were irradiated in triplicate using 25 mL quartz tubes with a diameter of 1.5 
cm. Each set of experiments was accompanied by dark controls inside the irradiation chamber, also 
in triplicate, foiled several times with aluminum paper. The quartz tubes were suspended inside the 
chamber using a homemade metallic holder which guaranteed that samples were homogeneously 
irradiated. Irradiation experiments were carried out up to 24 h. Sampling consisted on the 
collection of 2 mL aliquots of all the irradiated samples at specific time intervals. The aliquots were 
stored at 4 ºC and analyzed by MEKC within the next 3 days. 
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3.2.2.3 Study of the effect of pH and dissolved oxygen 
 
To study the photodegradation behavior of carbamazepine under different conditions, 
experiments were conducted at four different pH: 2.9, 4.0, 5.8 and 9.0. The pH of the stock 
solutions was adjusted using 1 M sodium hydroxide or formic acid prior to irradiation. Also, the 
effect of the dissolved oxygen in the aqueous solutions was evaluated. Accordingly, each 
experiment was repeated after sparging the solutions with nitrogen or oxygen in order to remove or 
saturate the solutions with oxygen, respectively. The samples were sparged with the referred gases 
during approximately 1 min per mL of solution. During the sampling procedure, the quartz tubes 
were kept under oxygen or nitrogen atmosphere depending on the sample under study.   
 
3.2.3 Capillary electrophoresis 
 
To follow the degradation of carbamazepine and the appearance of its photodegradation 
products, a MEKC based methodology was developed. The capillary electrophoresis analyses were 
performed using a commercial instrument (Beckman P/ACE MDQ (Fullerton, CA, USA)), 
equipped with a photodiode array UV-Vis detection system.  
 
3.2.3.1 Capillary column conditioning and coating 
 
A fused-silica capillary with a total length of 50 cm (40 cm to detector) and 75 μm of 
internal diameter was used. Approximately 1 mm of the capillary external coating was removed by 
burning the extremities prior to conditioning; the capillary extremities were then polished to 
increase the efficiency of the method and decrease the baseline noise. The new capillaries were first 
conditioned with 1 M NaOH for 30 min followed by ultra-pure water for 15 min. Subsequently, to 
proceed with the capillary coating, it was flushed with hexadimethrine bromide (polybrene) 0.5% 
(w/v) in 0.5 M NaCl for 20 min, as described by Pranaityté and Padarauskas (2006). Then, the 
capillary was washed with ultra-pure water for 2 min, followed by a 20 min flushing with running 
buffer. All the capillary conditioning and coating steps were performed at a pressure of 20 psi.   
 The capillary was washed with running buffer for 20 min at the beginning of each working 
day and with ultra-pure water for 5 min at the end of the day. When not in use the capillary 
extremities were left immersed in ultra-pure water to ensure the stability of the capillary coating.  
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3.2.3.2 Standard solutions and running buffer 
 
 Ethylvanillin was used as internal standard (IS) in the MEKC analysis. IS stock solution 
was prepared by dissolving ethylvanillin in acetonitrile (approximately 10% of the total volume) 
and further diluting it with ultra-pure water to a final concentration of 167 mg L-1. The solution was 
stored at 4 ºC under N2 atmosphere.  
 For the MEKC calibration curve, six standard solutions, with concentrations ranging from 
0.5 to 8 mg L-1, were prepared by diluting the carbamazepine stock solution. Standard solutions 
also contain IS (final concentration of 3.34 mg L-1), SDS and borax with the same concentrations of 
the running buffer. Standard solutions were analyzed in quadruplicate. 
 The running buffer consisted on 25 mM borax and 50 mM SDS, pH 9.2, freshly prepared 
every 2 days and stored at 4º C. 
 All the solutions were filtered through a membrane filter (pore size 0.22 μm, Millex-GV) 
before analysis. 
 
3.2.3.3 Sample preparation prior to MEKC analysis 
 
MEKC samples were prepared by adding SDS, borax and IS to the irradiated samples in 
order to obtain a final concentration of 50 mM, 25 mM and 3.34 mg L-1, respectively.  
 
3.2.3.4 Separation conditions 
 
Samples were injected for 4 s at 0.5 psi. Electrophoretic separations were performed in 
direct polarity with a positive potential supply of 20 kV for 13 min. The temperature of the 
capillary was maintained at 25 ºC. The resulting current was approximately 110 μA. Detection of 
carbamazepine and carbamazepine photodegradation products were monitored at 210 nm. Running 
buffer vials were changed every 3 runs. 
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3.2.4 Identification of photodegradation products by mass 
spectrometry 
 
The identification of carbamazepine photodegradation products was performed by 
electrospray mass spectrometry (ESI-MS), using N2-sparged samples collected after 30 min of 
irradiation at pH 2.9, and not sparged samples collected after 24 h of irradiation at pH 5.8. Positive-
ion ESI-MS and ESI-MS2 were carried out on a Micromass (Manchester, UK) Q-TOF2 hybrid 
tandem mass spectrometer. For ESI analysis, irradiated samples were diluted in methanol (0.1% 
formic acid v/v). Samples were introduced at a flow rate of 10 μL min-1 into the ESI source. In the 
MS and MS2 experiments, the time-of-flight (TOF) mass resolution was set to approximately 9000. 
The cone voltage was 35 V, and the capillary voltage was 3 kV. The source temperature was 80 ºC 
and the desolvation temperature was 150 ºC. MS2 spectra were obtained using argon as the 
collision gas with the collision energy set between 18 and 40 eV. In order to calibrate the MS 
spectra, the lock mass was the calculated monoisotopic mass/charge of the carbamazepine ion 
[M+H]+. The data was processed using MassLynx software (version 4.0). 
 
3.3 RESULTS AND DISCUSSION 
 
3.3.1 Optimization of the MEKC method 
 
The performance of the adopted methodology was evaluated by comparing the results 
obtained using uncoated and coated capillary columns.  
 Initially, irradiated samples were analyzed with an uncoated capillary after being 
conditioned with 1 M NaOH for 30 min followed by ultra-pure water for 10 min. In Table 3.2, 
results of repeated injections of a carbamazepine standard solution (mean peak area, migration time 
and relative standard deviation) are displayed. The results show that the method provides good 
repeatability of the evaluated parameters when using standard solutions. However, resolution of the 
peaks due to carbamazepine and to its photodegradation products was unsatisfactory in the samples 
irradiated for long periods of time. Also, when analyzing these samples, the repeatability of peak 
area was strongly affected, showing the lack of efficiency of the methodology under these 
conditions. Taking into account the obtained results, a dynamically coated capillary was used. 
Dynamically coated capillaries have the advantage of improving the reproducibility (Vanhoenacker 
et al., 2004; Pranaityté and Padarauskas, 2006) by decreasing the interaction between the analytes 
and the capillary inner wall, avoiding variations due to possible modifications in the chemical 
Vânia Calisto | Universidade de Aveiro 
 
90 
 
structure of the bare silica capillary surface between repeated injections. Moreover, this type of 
coating has already been reported as a promising tool to improve the separation efficiency (Erny et 
al., 2009). This procedure is easy to implement and, on the whole, consists on coating the capillary 
surface with a buffer containing a multiple charged polycation (polybren) and then flushing the 
positively charged surface with an anionic surfactant (SDS). The first layer of SDS interacts with 
the cationic surface of polybren and a second layer of SDS is formed by establishing hydrophobic 
interactions with the first one, resulting in a highly negatively charged surface. The chemical 
modifications of the capillary surface during the procedure are illustrated in Figure 3.3. 
 
Table 3.2. Comparison of the MEKC methodology repeatability considering the usage of a coated and an 
uncoated capillary: mean and relative standard deviations (R.S.D.) of the ratio between carbamazepine (CBZ) 
and internal standard (IS) peak areas and CBZ migration time (n = 4). 
Composition of the standard solution 
CBZ /IS peak areas CBZ migration time 
Mean (a. u.) R.S.D. % Mean (min) R.S.D. % 
Uncoated Capillary 
CBZ stock + IS 9.36 1.61 10.67 0.04 
Coated Capillary 
CBZ stock + IS 9.29 4.08 10.36 0.10 
50% CBZ stock + 50% running buffer + IS 4.26 0.44 9.95 0.25 
90% CBZ stock + 10% running buffer + IS 7.13 0.78 10.29 0.35 
 
After coating, the performance of the new methodology was evaluated (results presented in 
Table 3.2). Similarly to the previous case, the method proved to have good repeatability, however, 
in this case, it was possible to separate carbamazepine from its photo-irradiation products. The 
comparison of the electrochromatograms of a sample irradiated for 24 h, obtained with a coated 
capillary (A) and an uncoated capillary (B) is shown in Figure 3.4. The hypothesis of co-migration 
of carbamazepine and photodegradation products in the latter case, as well as the ability of the 
coated capillary to perform the separation efficiently, is clearly demonstrated. Consequently, all the 
subsequent analyses were performed using the capillary coating here described.  
Furthermore, the addition of running buffer to the irradiated samples, prior to MEKC 
analysis (as referred in the experimental section), substantially improved the repeatability of the 
ratio between carbamazepine and IS peak areas. The addition of 10% of the running buffer was 
chosen (instead of 50%) to avoid a substantial dilution of the samples. 
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Figure 3.3. Schematic representation of the capillary coating used in the developed methodology. 
 
 The method turned out to be repeatable between successive runs without the need to recoat 
the capillary. It was also possible to use an efficient and faster washing procedure between runs (2 
min) when compared to traditional MEKC methodologies, increasing even more the speed of 
analysis that characterize capillary electrophoresis methods. It was also verified the good stability 
of the coating for several weeks, for which it is indispensable the storage of the capillary filled with 
water and with its extremities immersed in ultra-pure water.  
 
Figure 3.4. Electrochromatograms of samples resulting from the irradiation of carbamazepine for 24 h, 
obtained using a coated capillary (A) and an uncoated capillary (B). Peak identification: 1- Ethylvaniline 
(internal standard); 2 – Carbamazepine; 3 and 4 – photodegradation products. Experimental conditions: 
capillary 0.5 m length (0.4 to detector), 75 µm internal diameter, applied voltage 20 kV, capillary 
temperature 25 ºC, running buffer 50 mM SDS and 25 mM borax, detection at 210 nm. 
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3.3.2 Calibration curve for MEKC 
 
A linear calibration curve was obtained, by means of a least-squares linear regression, 
using six standard solutions with concentrations ranging from 0.5 to 8.0 mg L-1. The linear 
regression was based on the mean ratio between the peak area of carbamazepine and the peak area 
of the IS that resulted from four replicate injections of each standard solution as a function of the 
standard solution concentration. The equation of the regression curve is given by y = (0.923 ± 
0.002) x – (0.075 ± 0.009). The correlation coefficient takes the value of 1.000, confirming the 
excellent linear response of the adopted methodology in the studied range of concentrations. 
Additionally, the limit of detection (LOD) and of quantification (LOQ) were determined according 
to 3sx/y /b and 10sx/y /b, respectively, where b is the slope and sx/y is the residual standard deviation of 
the determined linear regression (J.N. Miller and Miller, 2005). Accordingly, the LOD and LOQ 
values are 0.040 and 0.134 mg L-1, respectively. 
 
3.3.3 Carbamazepine photodegradation under simulated solar 
irradiation 
 
The direct photodegradation rate of carbamazepine was evaluated in aqueous solutions 
with a concentration of 9.5 mg L-1 and pH values of 2.9, 4.0, 5.8 and 9.0. To better understand the 
role of oxygen and reactive oxygen species in the photodegradation process of this pharmaceutical, 
carbamazepine solutions were irradiated in an oxygen saturated medium (solutions sparged with O2 
prior to irradiation) and in a nitrogen-deoxygenated medium (solutions sparged with N2). In Figure 
3.5, the percentages of carbamazepine photodegradation as a function of irradiation time for 
samples not sparged (a), sparged with O2 (b) and sparged with N2 (c) are shown. It is clearly 
evident that higher percentages of photodegradation were attained at pH 2.9 for all the irradiated 
solutions. Moreover, it is also clear that the photodegradation process strongly depends on the 
amount of dissolved oxygen present in test solutions. For example, at pH 2.9 the oxygenated 
solutions reached approximately 85% of degradation after 24 h of irradiation, while in the nitrogen-
deoxygenated solution the same value was observed in a period of 1 h. However, this dependence 
is only observed at low pH; significant differences in the photodegradation extent tend to disappear 
at high pH values. Very low photodegradation was observed at the highest pH studied (9.0) in all 
oxygenation levels.  
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Figure 3.5. Photodegradation of carbamazepine as a function of the irradiation time at different pH: pH 2.9, 
4.0, 5.8 and 9.0 represented in blue, green, orange and red, respectively. a) Not sparged; b) sparged with O2; 
c) sparged with N2. Each point corresponds to the mean percentage of photodegradation of three sample 
replicates. Relative standard deviations are below 10%.  
 
 To allow a better comparison of results obtained under distinct experimental conditions, the 
determination of kinetics parameters was performed by fitting a first order kinetics to each set of 
results.  Considering the Naperian logarithm of the ratio between the concentration of 
carbamazepine at a give irradiation time (Ct) and the initial concentration of carbamazepine (C0) as 
a function of the irradiation time, linear regressions were obtained (according to equation 3.9). 
Correlation values (r) for solutions sparged with O2 and not sparged range from 0.97 to 0.99; 
solutions sparged with N2 have lower correlation values (between 0.89 and 0.98). The satisfactory 
linearity of the regressions allowed the determination of the apparent pseudo-first order 
photodegradation rate constants (k) and half-life times (t1/2). The results are presented in Table 3.3.  
ln CtC0 = −kt   (3.9) 
The most relevant result was obtained for degradation in deoxygenated solutions at pH 2.9 
in which the photodegradation rate of carbamazepine was increased by a factor of 6 and 17 when 
compared with non-sparged and O2-sparged test solutions, respectively. A considerable increase on 
the photodegradation rate (by a factor of 6) was also observed at pH 4.0 in nitrogen-deoxygenated 
solutions. The pH dependence of the photodegradation rates is illustrated in Figure 3.6. The 
presence of oxygen undoubtedly inhibits the degradation process; the higher the concentration of 
dissolved oxygen, the lower the photodegradation rate. However, and as it was stated before, the 
effect of the oxygenation level of the medium is negligible at pH 9.0. 
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Table 3.3. Correlation coefficient (r), half-life time (t1/2) and apparent photodegradation rate constant (k) of 
carbamazepine obtained by fitting a first order kinetics model to the photodegradation data, considering 
different pH and dissolved oxygen conditions. n represents the number of points used in the linear regression 
and σ represents the standard deviation. Half-life times converted to units equivalent to summer sunny days 
(SSD) and average quantum yields (ϕave) of carbamazepine photolysis are also presented (discussed in section 
3.3.4). 
  pH r n t1/2 ± σ /(h) k ± σ /(h-1) t1/2 ± σ /(SSD*) Φave 
Not 
Sparged 
2.9 0.994 4 2.9 ± 0.2 0.24 ± 0.02 - 6.4 × 10-5 
4.0 0.986 5 63 ± 6 0.011 ± 0.001 - 2.9 × 10-6 
5.8 0.992 7 17 ± 1 0.040 ± 0.002 4.5 ± 0.3 1.1 × 10-5 
9.0 0.987 5 95 ± 9 0.007 ± 0.001 25 ± 2 2.0 × 10-6 
Sparged 
with O2 
2.9 0.996 5 8.6 ± 0.5 0.081 ± 0.004 - 2.1 × 10-5 
4.0 0.971 6 58 ± 7 0.012 ± 0.001 - 3.2 × 10-6 
5.8 0.975 5 36 ± 5 0.019 ± 0.003 9 ± 1 5.1 × 10-6 
9.0 0.993 6 67 ± 4 0.010 ± 0.001 18 ± 1 2.7 × 10-6 
Sparged 
with N2 
2.9 0.925 4 0.5 ± 0.1 1.3 ± 0.3 - 3.5 × 10-4 
4.0 0.980 6 12 ± 1 0.060 ± 0.006 - 1.6 × 10-5 
5.8 0.888 5 66 ± 20 0.011 ± 0.003 17 ± 5 2.9 × 10-6 
9.0 0.924 5 63 ± 15 0.011 ± 0.003 17 ± 4 2.9 × 10-6 
* 1SSD – unit equivalent to 1 summer sunny day (clear sky) at 45ºN latitude. Results are shown only for 
experiences performed at relevant pH values for surface waters (5.8 and 9.0) 
 
 
Figure 3.6. pH dependence of the apparent photodegradation rate constant of carbamazepine under different 
experimental conditions. 
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 The described results point out that reactive oxygen species (such as singlet oxygen) do not 
have a significant role on the degradation pathway of carbamazepine, seeing that the presence of 
molecular oxygen did not increase the rate of the degradation process. In addition, and considering 
the fact that at low pH and in the presence of oxygen, significantly lower degradation rates were 
observed and that triplet excited states are efficiently quenched by oxygen, it is predictable that one 
of the most significant photodegradation pathways of carbamazepine arises from its triplet excited 
states that were quickly deactivated in highly oxygenated solutions. Another tentative hypothesis to 
explain the observed phenomenon is the possible formation of hydrated electrons. Hydrated 
electrons, unitary negative charges chemically unbounded to any particular atom, are considered 
the most elementary and reactive nucleophiles (Anbar and Hart, 1964). Hydrated electrons have 
been shown to be photoproduced by a wide variety of aromatic compounds, and quickly react with 
organic compounds that have electronegative atoms (Anbar and Hart, 1964; Joschek and 
Grossweiner, 1966; Zepp et al., 1987). One known compound that photoproduces hydrated 
electrons is acridine (Joschek and Grossweiner, 1966; Kellmann and Tfibel, 1980, 1982) which is 
one of the most common direct photodegradation product of carbamazepine (Chiron et al., 2006) 
and was identified in this study (see section 3.3.6). The possible production of hydrated electrons 
during the irradiation experiments, and its reactivity towards carbamazepine, is a possibility that 
would also explain the degradation decrease in highly oxygenated mediums, taking into account 
that hydrated electrons are effectively scavenged by molecular oxygen (Zepp et al., 1987). 
 Another reasonable explanation (but again, tentative) arises from the pH dependence of the 
results suggesting that different forms of carbamazepine could be implicated. Several cases of 
pharmaceuticals that have different direct degradation rates which vary with the predominant form 
in solution (cationic or anionic forms) have been reported (Arnold and McNeill, 2007). It is also 
reported in the literature that the quantum yield of a degradation process could be pH dependent 
when different anionic or cationic forms are present (Arnold and McNeill, 2007). In the particular 
case of carbamazepine, it has a pKa of 13.9 (Jones et al., 2002) related to the deprotonation of the 
NH2 group and a pKa of 2.3 (Nghiem et al., 2005) related to the protonation of the amino groups 
(carbamazepine structure is shown in Figure 8, section 3.3.6). This means that at environmentally 
relevant pH, carbamazepine should be present in its neutral form. However, at the tested pH 2.9, a 
protonated form of carbamazepine exists in equilibrium with the neutral form at a concentration 
which might be high enough to interfere with the photodegradation rate. Nevertheless, taking into 
account the observed pH dependence, the existence of a protonated form of carbamazepine at very 
low pH might not be enough to explain the obtained results, suggesting that a different pH 
dependent mechanism might be operating. To fully elucidate this point, further research is needed, 
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including the mechanistic study of the photodegradation processes of carbamazepine at different 
pH. 
 
3.3.4 Determination of the apparent quantum yield of carbamazepine 
 
The determination of the quantum yield is crucial to allow the comparison of results 
between different studies. Moreover, the quantum yield is an important parameter to explain 
differences in photodegradation rates of compounds with similar spectral overlap with the sunlight. 
Note that compounds with very similar spectral overlap with the sunlight spectrum and with 
distinct quantum yields should resist to photodegradation processes differently. 
The carbamazepine’s photodegradation quantum yield was determined considering an 
overall average over the lamp emission wavelength range (290 – 800 nm) and respective emission 
intensities, directly extracted from the lamp spectrum (as given by the manufacturer), for the 
irradiance level used during the experiments (average value: 550 W m-2, 290 – 800 nm). Emission 
lamp spectrum and absorption spectrum of carbamazepine are shown in Figure 3.1a) (section 3.1.2) 
and Figure 3.7, respectively. The calculation of the quantum yield was made considering a 
diameter of the cylindrical photoreactor of 1.5 cm, a volume of irradiated solution of 25 mL and a 
solution exposure area of 53 cm2.  
 
Figure 3.7. Absorbance spectrum of carbamazepine (c = 3.945 × 10-5 mol L-1). No differences were found in 
the absorption spectra of carbamazepine at the four studied pH values (2.9, 4.0, 5.8 and 9.0). The spectrum 
was obtained using a UV-Vis Shimadzu spectrophotometer and an optical path length of 1 cm. 
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The quantum yield values obtained for all the experimental conditions are presented in 
Table 3.3 and varied between 2.0×10-6 and 3.5×10-4, being consistent with previously published 
literature data (Andreozzi et al., 2003; Lam and Mabury, 2005; Chiron et al., 2006). In comparison 
with available data for other pharmaceuticals (Arnold and McNeill, 2007), the results here obtained 
highlight that carbamazepine has one of the lowest quantum yields under environmentally relevant 
conditions. 
 
3.3.5 Environmental relevance of the results 
 
The results presented in Table 3.3 (half-life times and apparent pseudo-first order rate 
constants) are related to specific experimental conditions: samples were irradiated with an average 
irradiance of 55 W m-2 in the range 290-400 nm (or 550 W m-2 in the range 290-800 nm, according 
to the manufacturer specifications). As the adopted lamp aims to simulate sunlight, it is reasonable 
to convert the obtained results to outdoor half-life times. Vione et al. (2006) and Minero et al. 
(2007) had shown that on a cloudless summer day (15th July, 45 ºN latitude) the total energy 
reaching the ground is 7.5×105 J m-2 (290-400 nm), by measuring the solar irradiance at the ground 
level. These measurements were made using the same multimeter model from Co.fo.me.gra. 
Therefore, it is possible to convert the half-life times of carbamazepine in units equivalent to 
summer sunny days: the total energy reaching the ground during 24 h under the referred conditions 
are equivalent to 3.8 h of irradiance under the conditions adopted in this study. Thus, results 
obtained at pH values considered environmentally relevant to surface waters (5.8 and 9.0) were 
converted to equivalents to summer sunny days (SSD) and are also presented in Table 3.3. Note 
that this conversion takes into account the day/night cycle, as explained by Vione et al. (2006). 
With this approach it is possible to estimate the real behavior of carbamazepine in the environment. 
According to the obtained set of results and only considering direct photodegradation, this 
pharmaceutical can persist in the environment between 4.5 and 25 summer cloudless days, 
depending on the surface water pH and its level of aeration. These results are of great significance 
to assess the persistence of this pharmaceutical, for example, in atmosphere open aeration tanks, 
commonly found in urban WWTPs, where pH values usually oscillate between 6 and 9.  
In general, considering only the contribution of direct photodegradation processes for the 
elimination of carbamazepine from aquatic environments exposed to sunlight, it could be 
reasonably expected that carbamazepine would take approximately 1 to 4 weeks of sunny weather 
to be eliminated.  
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3.3.6 Identification of photodegradation products by mass 
spectrometry 
 
Various photodegradation products of carbamazepine were identified by mass spectrometry 
(compounds I-VII, Figure 3.8). The samples were analyzed by ESI(+)MS without a prior 
separation process, using not sparged samples collected after 24 h of irradiation at pH 5.8 (sample 
A) and N2-sparged samples collected after 30 min of irradiation at pH 2.9 (sample B). The mass 
spectra of the selected samples were compared with a carbamazepine solution not exposed to 
simulated solar radiation and the ions [M+H]+ and/or [M+Na]+ of possible photodegradation 
products were identified in both samples. Subsequently, the structure of the photoproducts was 
tentatively assigned to each ion based on the fragmentation pathway observed in the ESI-MS2 
spectra (results reported in Table 3.4). Some examples of ESI-MS and ESI-MS2 spectra of 
carbamazepine before and after irradiation are shown in Figure 3.9. 
 
 
 
 
Figure 3.8. Proposed structures for the photodegradation products of carbamazepine identified by ESI(+)MS 
and MS2. 
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Table 3.4. Mass spectrometry data for the identification of carbamazepine photodegradation products: 
molecular weight (Mw), ions detected in ESI(+)MS and fragment ions detected in ESI(+)MS2. For each case, 
relative abundance of the relevant fragment ions and respective losses are also presented. The identification 
of the photoproducts using roman numbers I to VII is in accordance with Figure 3.8. 
Compound Mw 
ESI(+)MS 
m/z 
ESI(+)MS2 
m/z (relative abundance %, loss) Samples 
CBZ 236 237 [M+H]+ 220(2, -NH3) 
194 (100, -NHCO)  
179 (2, -NHCO and -NH) 
 165 (1, -NHCO, -NH  and -CH2) 
- 
I 179 180 [M+H]+ 152 (80, -H2CN) 
128 (10) 
A* and B** 
II 195 196 [M+H]+ 195 (25, -H) 
180(3, -NH2) 
168 (15, -CO) 
167 (100, -HCO) 
B 
III 207 208 [M+H]+ 180 (100, -CO) 
179 (25, - HCO) 
178 (20, -H2CO)  
152 (10, -H2CN and -CO) 
B >> A 
IV 209 210 [M+H]+ 182 (85, -CO)  
180 (100, -H2CO) 
B >> A 
V 225 226 [M+H]+ 208(90, -H2O) 
180(93, -H2O and CO) 
182(100, -CHOHCH2) 
B 
VI 270 293 [M+Na]+ 276 (3, -NH3) 
275 (8, -H2O) 
250 (28, -NHCO) 
248 (25, - COHNH2) 
232 (100, -NHCO and -H2O) 
A and B 
VII 450 473 [M+Na]+ 456 (10, -NH3) 
439 (28,-NH3 and -NH3) 
428 (48, -COHNH2) 
413 (60, - COHNH2 and -NH) 
411 (100, - COHNH2 and -NH3) 
383 (15,- COHNH2 and -COHNH2) 
B >> A 
*Sample A: CBZ solution irradiated during 24 h, 55 W m-2 (290-400 nm), in ultra-pure water; 
**Sample B: CBZ solution irradiated during 30 min, 55 W m-2 (290-400 nm), in ultra-pure water sparged 
with N2, pH 2.9 (pH adjusted with formic acid). 
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a1) a2) 
  
b1) b2) 
  
c1) c2) 
 
Figure 3.9. ESI-MS spectra of a1) carbamazepine standard solution, b1) carbamazepine solution irradiated 
during 24 h, in ultra-pure water and c1) carbamazepine solution irradiated during 30 min, in ultra-pure water 
sparged with N2, pH 2.9. a2), b2) and c2) are detailed views of a1), b1) and c1), respectively. Red arrows draw 
attention to m/z values which correspond to photodegradation products. 
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As far as photodegradation product I (Mw 179, [M+H]+ = 180) is concerned, ESI-MS and 
ESI-MS2 spectra patterns are consistent with acridine, one of the most common carbamazepine 
photoproducts, known to have mutagenic and carcinogenic activities. The [M+H]+ ion of 
photoproduct II (Mw 195) at m/z 196 could correspond to acridone or 9-hydroxy-acridine. 
Nevertheless, this product was identified as acridone seeing that its ESI-MS2 spectrum is 
characterized by a base peak at m/z 167 that could be assigned to the loss of a CO group (-28 Da) 
and it is not possible to observe the loss of a water molecule (-H2O, -18 Da) characteristic of 
hydroxylated products. The ESI-MS2 spectrum of the photodegradation product III (Mw 207, 
[M+H]+ = 208) allows identifying it as acridine-9-carbaldehyde. The increase of the molecular 
weight by 28 units in comparison to acridine and the base peak at m/z 180 is fully consistent with 
an acridine moiety containing a carbonyl group. Other alternatives for photodegradation products 
with the same molecular weight were not supported by the ESI-MS2 spectrum. Photoproduct IV 
(Mw 209, [M+H]+ = 210) is structurally similar to photoproduct III. The increase of the molecular 
weight by two units corresponds to two hydrogen atoms. Photoproduct V corresponds to a 
hydroxylation of compound IV; the ESI-MS2 spectrum pattern is similar to the one found for 
compound IV with an extra ion at m/z 208 that arises from the loss of a water molecule, which 
reinforces the presence of the OH group in the proposed structure. Compound VI was attributed to 
one of the possible dihydroxicarbamazepine isomers. The ESI-MS2 spectrum of VII (Mw 450, 
[M+Na]+ = 473) is characterized by the loss of one and two NH3 groups (m/z 456 and 439), and 
also the loss of one and two COHNH2 groups (m/z 428 and 383); the ion attributed to the base peak 
corresponds to a combined loss of one group NH3 and one group COHNH2 (at m/z 411). 
 The proposed identification of carbamazepine’s photodegradation products was further 
validated by exact mass measurement and elemental composition determination of the new ions, 
observed in the ESI-MS spectra. For this purpose, the exact calculated monoisotopic masses, 
corresponding to the suggested molecular formulas, were compared with the masses observed in 
the ESI-MS spectra. Detailed results for each photodegradation product are gathered in Table 3.5. 
The errors between observed and calculated masses are below 10 mDa for the majority of the 
photoproducts which confirms with good accuracy the presented molecular formulas. 
Overall, the identified carbamazepine´s photodegradation products I-III and V-VII are in 
accordance with previously published studies (Chiron et al., 2006; Kosjek et al., 2009). However, 
photoproduct IV has not been identified until now. It is also important to highlight that the two 
distinct analyzed experimental conditions differed on the presence of products II and V that were 
not detected in sample A but appeared in sample B. In addition, experimental conditions applied to 
sample B resulted on the appearance of products III, IV and VII in more significant quantities than 
in sample A. 
Vânia Calisto | Universidade de Aveiro 
 
102 
 
Table 3.5. Calculated and observed mass, mass error and double bond equivalents (DBE) for the predicted 
formulas of the identified photodegradation products of carbamazepine. Predicted formulas correspond to the 
[M+H]+ ions of compounds I – V and to the [M+Na]+ ions of compounds VI and VII. The designation of the 
photodegradation products is in accordance with Figure 3.8. 
 
Compound Predicted Formula 
Calculated 
mass/ Da 
Observed 
mass/ Da Error/ mDa Error/ ppm DBE 
I C13H10N 180.0813 180.0877 6.4 35.4 9.5 
II C13H10NO 196.0762 196.0870 10.8 54.9 9.5 
III C14H10NO 208.0762 208.0835 7.3 34.9 10.5 
IV C14H12NO 210.0919 210.0983 6.4 30.5 9.5 
 V C14H12NO2 226.0868 226.0956 8.8 38.9 9.5 
 VI C15H14N2O3Na 293.0902 293.0865 -3.7 -12.7 9.5 
VII C28H26N4O2Na 473.1953 473.2119 16.6 35.0 17.5 
       
 
 
3.4 CONCLUSIONS 
 
This study has shown that the direct photodegradation rate of carbamazepine is pH 
dependent. Low pH results in increased rates, while high pH is compatible with very slow 
degradation processes. Moreover, especially at acidic pH, it was clearly shown that the oxygenation 
level of waters also has a noteworthy influence on the process: the presence of oxygen is 
responsible for a significant decrease on the photodegradation rate of carbamazepine. Despite the 
fact that the extremely high photodegradation rates were obtained at pH values that are not 
significant in an environmental context, this study highlighted new aspects of the direct 
photodegradation of this pharmaceutical that have not been explored until now, particularly the role 
played by oxygen on the photodegradation. However, there is still much to be understood, 
especially concerning the mechanisms involved in the pH dependent photodegradation and in the 
inhibition of photodegradation driven by the presence of oxygen. 
 Considering the studied environmentally relevant pH conditions (5.8 and 9.0), the 
photodegradation rate of carbamazepine is relatively slow. The elimination of this pharmaceutical 
by direct photodegradation processes could take from 4.5 to 25 equivalents to sunny summer days. 
These results clearly consolidate previous knowledge that this pharmaceutical is being potentially 
accumulated in the environment and are fully consistent with the high number of occurrences of 
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this compound in several environmental matrices. Furthermore, the results here presented also 
contribute to strengthen the adequacy of carbamazepine as a marker of anthropogenic pollution due 
to its high persistence to direct photodegradation.  
In this study, it was also possible to identify seven photodegradation products, including 
acridine (known due to its mutagenic and carcinogenic activities) and one newly identified 
compound.  
  Overall, the described aspects of carbamazepine degradation constitute a helpful tool to 
develop further investigation in what concerns the environmental persistence and relevant 
elimination methodologies of this widely spread contaminant. 
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CHAPTER 4 
Photodegradation of benzodiazepines in aquatic environments 
 
 
 
In this study, the relevance of photodegradation processes on the environmental 
persistence of four benzodiazepines (oxazepam, diazepam, lorazepam and alprazolam) was 
investigated. Benzodiazepines were irradiated under simulated solar irradiation and direct and 
indirect (together with three different fractions of humic substances) photodegradation kinetics 
were determined. Lorazepam was shown to be quickly eliminated by direct solar radiation; on the 
contrary, oxazepam, diazepam and alprazolam showed to be highly resistant to photodegradation 
with half-life times of 4, 7 and 228 sunny summer days, respectively. Humic acids were consistently 
responsible for a decrease in the photodegradation rates while fulvic acids and XAD4 fraction 
caused an enhancement of the photodegradation rate. Overall, the results highlight that 
photodegradation might not be an efficient pathway to prevent the aquatic environmental 
accumulation of oxazepam, diazepam and alprazolam. Also, nineteen direct photodegradation 
products were identified by mass spectrometry; this identification is crucial for a more complete 
understanding of the environmental impact of benzodiazepines in aquatic systems. 
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4.1 CONTEXTUALIZATION 
 
Benzodiazepines belong to the group of psychiatric substances which act on the central 
nervous system, having anxiolytic, sedative and hypnotic effects and are one of the most prescribed 
groups of pharmaceuticals throughout the world (International Narcotics Control Board, 2010; 
Health, 2011).  
Literature data presented in chapter 2 clearly demonstrate that, over the last decade, there 
have been a significant number of studies reporting the occurrence of benzodiazepines in 
environmental matrices. However, and when compared to other groups of pharmaceuticals, data 
concerning the environmental persistence and fate of benzodiazepines is scarce. In order to 
correctly evaluate the real ecological impact of these pollutants, it is mandatory to widen the 
knowledge related to this area of concern. 
The work presented in this chapter intends to approach, for the first time, to the extent of 
our knowledge, the persistence of benzodiazepines in aquatic environments. For this purpose, the 
photodegradation of four benzodiazepines (oxazepam, diazepam, lorazepam and alprazolam) was 
studied. Direct and indirect photodegradation (in the presence of different fractions of humic 
substances: humic acids, fulvic acids and XAD4 fraction) were evaluated under simulated solar 
irradiation. To follow the photodegradation kinetics of these compounds, the micellar electrokinetic 
chromatography method developed to study carbamazepine photodegradation (presented in the 
previous chapter) was adapted. Moreover, taking into account that the available literature studies 
about the photodegradation products of benzodiazepines are not environmentally relevant, focusing 
only on drug-development, storage and handling of these pharmaceuticals (Cabrera et al., 2005; 
Castaneda et al., 2009), this study also aims to be the first at identifying direct photodegradation 
products of the four benzodiazepines by mass spectrometry, under environmentally relevant 
conditions. 
Some of the main concepts essential to the understanding of the work here presented can be 
found in the previous chapter (section 3.1). A brief introduction to the topics that will be addressed 
for the first time is presented below.    
 
4.1.1 Indirect photodegradation 
 
In the previous chapter the importance of direct photodegradation was studied. There are, 
however, other environmentally relevant light initiated reactions that do not result from the direct 
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absorption of photons by pollutants (Schwarzenbach et al., 2003). These are considered indirect 
photodegradation processes and the phototransformation is indirectly caused by the excitation of 
chromophores present in natural waters (Boule et al., 2005). In opposition to direct 
photodegradation, the efficiency of indirectly mediated phototransformations does not depend on 
the absorption spectrum of the contaminant and can play an important role on the degradation of 
pollutants that poorly absorb solar radiation or that resist to direct photolysis. The relevance of 
indirect photodegradation is then dependent on the number and type of reactive species produced 
by the excitation of chromophores and on their subsequent ability to react and cause a chemical 
change in a specific contaminant (Zafiriou et al., 1984; Boule et al., 2005). In comparison with 
molecular oxygen, these reactive species are usually strong oxidants; photoreduction in natural 
waters is also possible but it is less common to occur. These photo-oxidants are commonly short-
lived species which can be quickly deactivated by psychical or chemical processes and commonly 
include HO˙, 1O2, alkyl-O˙, alkyl-OO˙, aryl-O˙, O2˙-, NO3˙, with reactive oxygen species playing a 
major role. Amongst the natural constituents that may yield these reactive species, the most well 
known are dissolved organic matter, nitrates, nitrites and Fe(II)/ Fe(III) complexes (Schwarzenbach 
et al., 2003).   
Although direct photodegradation studies are of extreme importance, they do not give 
enough information concerning the environmental persistence of a contaminant. The 
photochemical fate of a pollutant might differ significantly when in presence of naturally occurring 
constituents which can have light absorbing, quenching or sensitizing effects (Zepp et al., 1985; 
Zeng et al., 2002). The study of indirect photodegradation under environmentally relevant 
conditions can be performed by using representative natural water samples or synthetic field water 
(produced in laboratory). The use of natural water samples has the advantage of providing an 
authentic reproduction of field conditions. On the other hand, the use of synthetic field waters 
allows testing the individual role and influence of each component in the photodegradation (Arnold 
and McNeill, 2007). 
 
4.1.2 The role of dissolved organic matter on indirect 
photodegradation 
 
Dissolved organic matter (DOM) is the most abundant fraction of natural organic matter in 
aquatic environments and result from the metabolism or decomposition of living organisms (Boule 
et al., 2005). The main constituents of DOM are humic substances which can be divided in several 
fractions, classified according to their solubility in water (such as humic acids, fulvic acids, 
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hydrophilic fractions - XAD4 fraction - and humins). DOM is involved in a huge number of 
environmental processes, including photochemical reactions. For this reason, the study of DOM 
characteristics and effects leads to a better understanding of important environmental phenomena 
(Leenheer and Croué, 2003). 
DOM can be defined as a complex heterogeneous mixture of aromatic and aliphatic 
hydrocarbons that possess a large variety of functional groups (mainly, carboxyl, hydroxyl, ester, 
ether and ketone groups). These relatively small primary molecular structures (100 – 2000 Da) are 
held together by hydrogen bonding, non-polar and cation interactions resulting in aggregates with 
macromolecular characteristics, with up to 100 000 Da of molecular weight (Leenheer and Croué, 
2003; Boule et al., 2005). DOM composition, concentration and characteristics are highly variable 
according to the provenience of the organic matter (allochthonous or autochthonous) and to the 
physical and chemical properties of water (Leenheer and Croué, 2003). Differences on the DOM 
source and composition usually imply differences on its photoreactivity (Boreen et al., 2008; 
Guerard et al., 2009). DOM, and particularly, humic substances are responsible for the yellow or 
brown color of natural waters. This fact underlines the light absorbing ability of DOM and its 
consequent photochemical activity (Schwarzenbach et al., 2003). Some of the main photochemical 
processes mediated by DOM are summarized in Figure 4.1.  
 
 
Figure 4.1. Main pathways for indirect photodegradation of an organic compound caused by excitation of 
naturally occurring dissolved organic matter (DOM). Dashed arrows represent radiationless transitions. 
Adapted from Zafiriou et al. (1984) and Schwarzenbach et al. (2003).  
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After absorbing a photon, DOM chromophores are promoted to their excited singlet state 
which, in the presence of molecular oxygen, can lead to the formation of singlet oxygen and other 
reactive oxygen species (Boule et al., 2005). The same phenomenon is possible due to the 
formation of excited triplet states of DOM chromophores (3DOM*). The produced reactive oxygen 
species include DOM derived oxyl and peroxyl radicals (ROO˙, RO˙), superoxide radical anions 
(O2˙-), hydroxyl radicals (HO˙) and hydrogen peroxide (H2O2). These reactive species are then 
responsible for promoting indirect photodegradation by interacting with the contaminants (Zafiriou 
et al., 1984; Zepp et al., 1985; Guerard et al., 2009; Dalrymple et al., 2010). Direct reactions with 
excited triplet states of DOM are also possible through energy transfer (which may cause, for 
example, the cis-trans isomerization of double bonds) or electron/hydrogen transfer reactions which 
lead to the oxidation of the contaminants (Schwarzenbach et al., 2003). However, the effect of 
DOM on the photodegradation is not trivial: DOM chromophores can also act as inhibitors by 
scavenging the reactive intermediates mentioned and by screening the radiation (Zepp et al., 1985; 
Boule et al., 2005; Xia et al., 2009; Sturini et al., 2010). The evaluation of DOM effects in the 
aquatic environmental persistence of organic pollutants is a rather complex issue that is strictly 
dependent on DOM properties, concentration and chemical structure of the contaminants.  
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Chemicals 
 
All chemicals used were of analytical grade: alprazolam, lorazepam, diazepam e oxazepam 
(Sigma-Aldrich), sodium dodecylsulphate (SDS, 99%, for electrophoresis, Sigma-Aldrich), 
hexadimethrine bromide (polybrene, Sigma-Aldrich), sodium chloride, ethylvanillin (99%, 
Aldrich), sodium tetraborate (borax, Riedel-de Haën), sodium hydroxide (Fluka), and acetonitrile 
(HPLC gradient grade, VWR, Prolabo). All solutions were prepared using ultra-pure water, 
obtained from a Milli-Q Millipore system (Milli-Q plus 185). 
 
4.2.2 Irradiation experiments 
 
4.2.2.1 Irradiation apparatus 
 
Samples were irradiated under simulated solar radiation using Solarbox 1500 
(Co.fo.me.gra, Italy). The irradiation device was equipped with a 1500 W arc xenon lamp and 
Photodegradation of benzodiazepines in aquatic environments | Chapter 4 
 
113 
 
outdoor UV filters that restrict the transmission of light with wavelengths below 290 nm (a 
schematic representation of the irradiation chamber is shown in Figure 3.2). The irradiance of the 
lamp was kept constant during all the experiments at 55 W m-2 (290-400 nm). To monitor the 
irradiance level and temperature, a multimeter (Co.fo.me.gra, Italy), equipped with a UV 290-400 
nm large band sensor and a black standard temperature sensor, was used. The device was 
refrigerated by an air cooled system and the uniformity of the irradiation inside the chamber was 
guaranteed by a parabolic reflection system. 
 
4.2.2.2 Sample preparation and sampling 
 
Irradiated samples consisted on benzodiazepines’ aqueous solutions with a concentration of 
10 mg L-1. Due to the low solubility of the studied compounds in water, acetonitrile was used as an 
auxiliary solubilising agent. The concentration of acetonitrile did not exceed 1% (v/v) of the 
irradiated solution, in order to guarantee that acetonitrile does not influence the photodegradation 
rates, as recommended by the OCDE guideline TG316 (OECD, 2008). The pH of the irradiated 
solutions was not adjusted and samples were not buffered in order to avoid influences of the 
buffering agent in the photodegradation process. Solutions were irradiated in triplicate using 25 mL 
quartz tubes with an internal diameter of 1.5 cm. For each set of experiments, dark controls were 
also irradiated, in triplicate; for this purpose, quartz tubes were covered with several layers of 
aluminum foils. A homemade metallic holder was used to maintain the quartz tubes suspended 
inside the irradiation chamber, allowing for homogeneous irradiation. 
The extent of the irradiation experiments depended on the phototransformation rates of 
each pharmaceutical, varying between 12 and 304 h. 2 mL aliquots of the irradiated samples (and 
dark controls) were collected at specific time intervals, stored at 4 ºC and subsequently analyzed by 
MEKC, within 2 days, as described below. 
 
4.2.2.3 Influence of dissolved organic matter on photodegradation 
 
To study the influence of different fractions of dissolved organic matter on the 
photodegradation rates of benzodiazepines, solutions containing 1 mg L-1 of humic acids, fulvic 
acids or XAD4 fraction were irradiated in the conditions described above. For this purpose, fulvic 
acids and XAD4 solutions (20 mg L-1) were prepared in ultra-pure water. In the case of humic 
acids, due to the low solubility in water, an aqueous solution (50 mg L-1) 5% (v/v) NH4OH 1 M was 
prepared and set to pH 6.0 with formic acid 1 M. The stock solutions were further diluted (20 and 
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50 fold) in order to attain a final concentration of 1 mg L-1, as referred above. Similarly to direct 
photodegradation studies, irradiated solutions were not buffered and the pH was not adjusted. 
The humic substances were extracted and isolated from a riverine water sample, collected 
in a freshwater stream that flows into the Aveiro lagoon, Portugal (40º39’N, 8º44’W). Humic 
substances of this riverine aquatic system are mainly derived from the decomposition of 
herbaceous plants. The extraction and characterization of the humic substances had been previously 
performed by the research group. Briefly, the different fractions of humic substances were 
extracted and isolated by using a system of XAD resins (XAD8 and XAD4) connected in series. 
This procedure is described in detail in Santos et al. (1994) and Esteves et al. (1995). The purified 
fractions (humic acids, fulvic acids or XAD4) were subsequently characterized by elemental 
analysis and solid-state 13C-CPMAS NMR, using the procedure described in Esteves et al. (2009). 
 
4.2.3 Capillary electrophoresis 
 
The kinetics of photodegradation was followed by MEKC. The analyses were carried out 
using a commercial instrument Beckman P/ACE MDQ (Fullerton, CA, USA), equipped with a 
photodiode array UV-Vis detector. The methodology was adapted from the work presented in 
chapter 3, where a MEKC method was developed to follow the kinetics and emergence of 
photodegradation products of the anti-epileptic carbamazepine. This method is based on the use of 
a dynamically coated capillary column (Figure 3.3) with the aim of improving reproducibility and 
separation efficiency.  
 
4.2.3.1 Capillary column conditioning, coating and separation conditions 
 
A fused-silica capillary with a total length of 50 cm (40 cm to detector) and 75 µm of 
internal diameter was used. Capillaries were first conditioned with 1 M NaOH for 30 min, followed 
by ultra-pure water for 15 min. Capillary coating was performed by flushing a solution of 
polybrene 0.5% (w/v) in 0.5 M NaCl for 20 min, followed by ultra-pure water for 2 min and 
running buffer for 20 min. The capillary was washed with ultra-pure water, for 5 min, at the end of 
each working day and with running buffer, for 20 min, at the beginning of the day. All the 
conditioning and coating steps were performed at 20 psi. 
Samples were injected for 4 s at 0.5 psi. Separation was carried out in direct polarity with a 
positive potential supply of 20 kV for 13 min. The capillary temperature was controlled and 
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maintained at 25 ºC. Detection of benzodiazepines and its photodegradation products was 
monitored at 210 nm. Before every run, the capillary was washed with running buffer for 2 min. 
Running buffer vials were changed every 6 runs. 
 
4.2.3.2 Running buffer, standard solutions and sample preparation for 
MEKC analysis 
 
The running buffer consisted on 25 mM sodium tetraborate and 50 mM SDS, pH 9.2, 
freshly prepared every 3 days and stored at 4 ºC.  
For the MEKC calibration curves, seven standard solutions of each benzodiazepine, with 
concentrations ranging between 0.5 and 10 mg L-1, were prepared by diluting an aqueous stock 
solution with concentration of 200 mg L-1 (20% acetonitrile). Standard solutions also contained 
3.34 mg L-1 ethylvanillin, used as internal standard (IS), and 12.5 mM sodium tetraborate, used to 
improve the repeatability of the ratio between benzodiazepines and IS peak areas. Standard 
solutions were analyzed in quadruplicate.  
Similarly to the standard solutions, irradiated samples were prepared by adding sodium 
tetraborate and IS with a final concentration of 12.5 mM and 3.34 mg L-1, respectively.  
All solutions were filtered through a 0.22 µm membrane filters (Millex-GV, Millipore). 
 
4.2.4 Identification of photodegradation products by mass 
spectrometry 
 
The direct photodegradation products of benzodiazepines were identified by electrospray 
mass spectrometry (ESI-MS). Irradiated samples of each pharmaceutical were collected after 6, 24, 
24 and 304 hours of irradiation for lorazepam, oxazepam, diazepam and alprazolam, respectively. 
The irradiation time was selected according to the half-life time of each compound and considering 
the time at which a larger number of photodegradation products could be clearly identified in the 
electrochromatogram. Positive-ion ESI-MS and ESI-MS2 were performed on a Micromass Q-TOF2 
hybrid tandem mass spectrometer (Manchester, UK). For ESI analysis, samples were prepared by 
diluting the irradiated solutions in methanol (0.1% formic acid v/v). Samples were introduced into 
the ESI source using a syringe pump at a flow rate of 10 µL min-1. The time-of-flight (TOF) mass 
resolution was set to approximately 9000, the cone voltage was 35 V and the capillary voltage was 
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3 kV. The source and the desolvation temperatures were 80 and 150 ºC, respectively. The MS2 
spectra were acquired using argon as the collision gas and collision energy was set between 10 and 
32 eV. To calibrate the MS spectra, the lock mass was the calculated monoisotopic mass/charge of 
the ion [M+H]+ of each pharmaceutical. The data was processed using MassLynx software, version 
4.0. 
 
4.3 RESULTS AND DISCUSSION 
 
4.3.1 Performance of the MEKC methodology 
 
The adopted MEKC method proved to be efficient in the separation of each benzodiazepine 
from its photodegradation products. As concluded in the previous chapter, the use of a dynamically 
coated capillary column highly improved the repeatability of both migration times and peak areas 
since the coating avoids fluctuations due to the modification of the chemical structure of the inner 
surface of the capillary between successive runs. Nevertheless, there is a fundamental difference 
from the method used in chapter 3 that must be emphasized. In the previous work, it was concluded 
that the addition of running buffer to samples also improved the repeatability of the analyte peak 
areas. However, in this case, instead of adding the running buffer (SDS and sodium tetraborate), 
only sodium tetraborate was added. The removal of SDS from the samples and standard solutions 
resulted in a significant tighten of the peaks (as shown in Figure 4.2), thus increasing peak 
resolution. Separation of benzodiazepines from its photodegradation products was only achieved 
after introducing this modification in the sample preparation procedure, prior to MEKC analysis.    
Under the optimized conditions, the migration times (from 10 repeated injections) of the 
studied benzodiazepines are presented in Table 4.1. Relative standard deviations did not exceed 
0.55%, showing a good repeatability between successive runs. Moreover, relative standard 
deviations of the ratio between the analyte and the IS peak areas were always below 3%, for all 
benzodiazepines. A linear calibration curve was obtained for each benzodiazepine using seven 
standard solutions with concentrations ranging from 0.5 to 10 mg L-1, analyzed in quadruplicate. 
The results were fitted to a least-squares linear regression by plotting the ratio between the peak 
area of the analyte and the peak area of the IS as a function of the analyte concentration. The 
statistical parameters of the obtained calibration curves are presented in Table 4.1. The obtained 
correlation coefficients range from 0.9997 to 0.9999, thus corroborating the excellent linear 
response of the method in the studied range of concentrations. The limits of detection (LOD) and 
limits of quantification (LOQ) were also determined, defined as 3sx/y/b and 10sx/y/b, respectively, 
where b is the slope and sx/y is the residual standard deviation of the linear regression (J.N. Miller 
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and Miller, 2005). LOQs between 0.598 mg L-1 for alprazolam and 0.318 mg L-1 for diazepam 
allow following the kinetics of photodegradation up to, approximately, 95% of degradation of the 
benzodiazepines, confirming the adequacy of the methodology for this purpose. 
 
Figure 4.2. Electrochromatograms of diazepam stock solutions (10 mg L-1), obtained using a coated 
capillary, with the addition of running buffer (SDS and sodium tetraborate) – A, and sodium tetraborate – B. 
Peak identification: 1 - ethylvanilin (internal standard) and 2 – diazepam; peak areas are similar in both 
electrochromatograms. Experimental conditions: capillary 0.5 m length (0.4 to detector), 75 µm internal 
diameter, applied voltage 20 kV, capillary temperature 25 ºC, running buffer 50 mM SDS and 25 mM borax, 
detection at 210 nm.  
 
Table 4.1. Linear regression equation, correlation coefficient (r), limit of detection (LOD) and limit of 
quantification (LOQ) of the MEKC methodology for oxazepam, diazepam, lorazepam and alprazolam. 
Migration time (± standard deviation) of each pharmaceutical is also presented. 
 Linear regression equation r LOD /(mg L-1) LOQ /(mg L-1) mt /(min), n=10 
Oxazepam y = (0.861 ± 0.002) x - 0.005 ± 0.007 0.9999 0.103 0.343 10.94 ± 0.06 
Diazepam y = (0.917 ± 0.003) x - 0.003 ± 0.007 0.9999 0.0953 0.318 11.12 ± 0.02 
Lorazepam y = (0.886 ± 0.004) x + 0.00 ± 0.01 0.9998 0.154 0.512 10.74 ± 0.02 
Alprazolam y = (0.830 ± 0.004) x - 0.01 ± 0.01 0.9997 0.179 0.598 11.34  ± 0.03 
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4.3.2 Photodegradation of benzodiazepines in the presence and in 
the absence of dissolved organic matter 
 
Direct and indirect photodegradation of oxazepam, diazepam, lorazepam and alprazolam 
were individually evaluated in aqueous solutions of 10 mg L-1, with triplicate experiments, under 
simulated solar irradiation. Indirect photodegradation was studied in the presence of humic acids, 
fulvic acids and XAD4 fraction of humic substances from a freshwater sample, at a final 
concentration of 1 mg L-1. Dark controls, obtained under the exact same conditions, were 
performed for all the irradiation experiments. Degradation in the dark, due to thermal or hydrolytic 
processes, was not observed for oxazepam, lorazepam and alprazolam; on the other hand, diazepam 
suffered a decrease in concentration up to 10% during 24 h. The observed degradation of diazepam 
in the dark may be attributed to the temperature rise inside the irradiation chamber (35 – 40 ºC) as 
the same phenomenon was not observed in refrigerated or room temperature solutions. Diazepam 
photodegradation data were corrected in order to account for non-photolytic processes occurring in 
samples. 
 The extent of the irradiation experiments depended on the photodegradation rates of each 
benzodiazepine, which varied from 12 to 304 h. The determination of kinetic parameters was 
performed by fitting a pseudo-first order kinetic model to each set of results. Accordingly, the 
natural logarithm of the ratio between the benzodiazepines’ concentration, at a given irradiation 
time, and its initial concentration was plotted as a function of the irradiation time and a linear 
regression was obtained (Figure 4.3). Correlation coefficients (r), apparent pseudo-first order rate 
constants (k) and half-lives (t1/2) are presented in Table 4.2. For both direct and indirect 
photodegradation, r ranges from 0.961 to 0.999, confirming the adequacy of the pseudo-first order 
model to describe the benzodiazepines’ photodegradation kinetics. 
Direct photodegradation half-lives of the studied benzodiazepines greatly differ. 
Lorazepam was the least photo resistant, with a half-life time of 2.6 ± 0.1 h; oxazepam and 
diazepam had intermediate half-life times of 15.1 ± 0.2 and 28 ± 2 h, respectively. Note that these 
compounds are structurally very similar (especially lorazepam and oxazepam, see Figure 4.7 
ahead) and, yet, exhibit a distinct resistance to photodegradation. Alprazolam showed to be highly 
resistant to direct photodegradation with a half-life time of 865 ± 41 h. This value was determined 
by an extrapolation based on 200 h of irradiation, due to the extremely high number of irradiation 
hours needed (more than 1000 h). Notwithstanding, the conducted experiment is clearly conclusive 
about the behavior of alprazolam when exposed to sunlight. In order to determine the half-life 
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times of lorazepam, diazepam and oxazepam, these were irradiated until at least 75% of 
degradation was achieved. 
 
Figure 4.3. Pseudo-first order photodegradation kinetics of a) oxazepam, b) diazepam, c) lorazepam and d) 
alprazolam in ultra-pure water and in the presence of several fractions of humic substances. Each dot 
corresponds to one replicate (total of three replicates for each condition at a given time). 
 
In what concerns indirect photodegradation, the half-life times obtained in the presence of 
different fractions of humic substances are of the same order of magnitude of those in pure water. 
For alprazolam, half-life times were not determined seeing that no photodegradation was observed 
after 48 h of irradiation. Considering the conclusions taken concerning alprazolam´s direct 
photodegradation, irradiations under indirect degradation conditions were not extended for a longer 
period. However, for oxazepam, diazepam and lorazepam, the addition of humic substances (1 mg 
L-1) caused a clear and consistent influence on the photodegradation rates: humic acids (the most 
hydrophobic fraction) decreased the degradation rates while fulvic acids and XAD4 fraction (the 
most hydrophilic fractions) enhanced the photo-induced transformations. These results suggest the 
existence of a correlation between the hydrophobicity of the humic substances and the effect on the 
photodegradation rates of benzodiazepines. As stated before, the effects of humic substances on 
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photodegradation processes are of extreme complexity as they can exert, simultaneously, 
enhancing and reducing effects (production and/or scavenging of reactive intermediates and 
screening of reactive light wavelengths). In addition, the function of humic substances on 
photochemical processes is highly dependent on its concentration and chemical composition; 
however, a direct correlation between chemical composition and photochemical function is very 
often difficult to establish (Boule et al., 2005; Garbin et al., 2007; Guerard et al., 2009).  
 
Table 4.2. Kinetic parameters for the photodegradation of oxazepam, diazepam, lorazepam and alprazolam 
under different experimental conditions: correlation coefficient (r), half-life time (t1/2) and apparent 
photodegradation rate (k) for a pseudo-first order kinetics. n represents the number of experimental points 
used in the fitting and σ represents the standard deviation. Half-life time in units equivalent to summer sunny 
days (SSD) and average apparent quantum yields (φave) are also shown (discussed in section 4.3.3). 
 DOM r n k ± σ/h-1 t1/2 ± σ/h t1/2 ± σ/SSD Φave 
O
xa
ze
pa
m
 - 0.999 24 0.0458 ± 0.0005 15.1 ± 0.2 3.98 ± 0.04 4.45 × 10-6 
Fulvic acids 0.989 21 0.056 ± 0.002 12.4 ± 0.4 3.2 ± 0.1 - 
XAD4 0.995 21 0.053 ± 0.001 13.2 ± 0.3 3.47 ± 0.08 - 
Humic acids 0.998 24 0.0380 ± 0.0004 18.2 ± 0.2 4.80 ± 0.06 - 
D
ia
ze
pa
m
 - 0.961 21 0.025 ± 0.002 28 ± 2 7.3 ± 0.5 4.3 × 10-6 
Fulvic acids 0.984 18 0.044 ± 0.002 15.6 ± 0.7 4.1 ± 0.2 - 
XAD4 0.974 18 0.035 ± 0.002 20 ± 1 5.2 ± 0.3 - 
Humic acids 0.982 21 0.0154 ± 0.0007 45 ± 2 11.8 ± 0.5 - 
Lo
ra
ze
pa
m
 - 0.983 18 0.27 ± 0.01 2.6 ± 0.1 0.68 ± 0.03 7.8 × 10-5 
Fulvic acids 0.996 21 0.302 ± 0.007 2.29 ± 0.05 0.60 ± 0.01 - 
XAD4 0.999 21 0.330 ± 0.004 2.10 ± 0.02 0.552 ± 0.006 - 
Humic acids 0.991 18 0.113 ± 0.004 6.2 ± 0.2 1.62 ± 0.06 - 
A
lp
ra
zo
la
m
 - 0.980 20 0.00080 ± 0.00004 865 ± 41 228 ± 11 3.4 × 10-6 
Fulvic acids n.d.* n.d. n.d. n.d. n.d. - 
XAD4 n.d. n.d. n.d. n.d. n.d. - 
Humic acids n.d. n.d. n.d. n.d. n.d. - 
* n.d.: not determined 
 
To complement this discussion, the structural characterization of the used humic substances 
(Elemental Analysis and 13C-CPMAS NMR data) is displayed in Tables 4.3 and 4.4 (Esteves, 
1995). The presented data revealed that differences in the 13C-CPMAS NMR spectra of humic 
substances might suggest a higher prevalence of aromatic moieties in humic acids than in fulvic 
acids or XAD4 (spectra range between 108-145 and 145-160 ppm). Moreover, fulvic acids and 
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XAD4 fractions seem to have a higher number of carboxylic and ester groups (chemical shift range 
160-190 ppm) and also a higher carbon/nitrogen ratio. The influence of these compositional 
differences on the distinct effect of humic acids and fulvic acids/XAD4 on the photodegradation of 
benzodiazepines cannot be clearly defined without further research concerning the photoreaction’s 
mechanisms. Also, it must be noted that apart from several evidences of an apparent correlation 
between the 13C-CPMAS NMR signal strength and the abundance of the respective chemical 
groups, these data should always be cautiously interpreted, especially when looking for small 
differences (Newman, 2007) since CPMAS experiments are known to be not quantitative. 
 
Table 4.3. Elemental analysis (in percentage) of humic substances selected to study the effect of DOM on 
photodegradation rates. Results are corrected for humidity at 60 ºC and ashes at 750 ºC (Esteves, 1995). 
 C  H  N  S  O  Ratio C/N 
Humic acids 51.4 4.3 4.2 2.1 32.1 12.2 
Fulvic acids 54.0 4.8 1.9 1.5 35.2 28.4 
XAD-4 49.2 4.4 2.9 1.5 40.0 17.0 
 
Table 4.4. Solid-state 13C-CPMAS NMR data of humic acids, fulvic acids and XAD4 fraction (Esteves, 
1995). The data represents the area (in percentage) of the fraction of the 13C-CPMAS NMR spectra due to the 
carbons in the specified chemical shift range (in ppm). Typical functional groups whose carbons resonate in 
the specified range are given in parenthesis. 
Chemical shift range/ ppm 
13C-CPMAS NMR spectra fraction (%) 
Humic acids Fulvic acids XAD-4 
0-60 
(alkyl and methoxyl carbons) 
51.3 61.1 55.9 
60-90 
(O-alkyl carbons) 
14.4 14.0 21.5 
90-108 
(Anomeric carbons; carbon hydrates) 
3.2 2.4 3.6 
108-145 
(Aromatic carbons) 
18.6 10.3 7.4 
145-160 
(O-substituted aromatic carbons) 
3.4 1.7 1.4 
160-190 
(Carboxylic and ester carbons) 
7.3 8.4 9.1 
190-220 
(Carbonyl carbons; ketones and quinones) 
1.8 2.1 1.1 
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In order to evaluate the influence of light absorption by the different DOM fractions in the 
photodegradation rates, inner-filter effects were quantified. For this purpose, a wavelength specific 
screening factor (Sλ) was determined, according to equation 4.1 (Schwarzenbach et al., 2003; 
Guerard et al., 2009):  
Sλ = (1 − 10−αλ×b)2.303 × αλ × b   (4.1)  
where αλ (cm-1) is the wavelength specific attenuation coefficient (considered as the absorbance of 
each DOM fraction, for each wavelength, when the path length is 1 cm – spectra shown in Figure 
4.4) and b (cm) is the path length of the irradiated quartz tubes (1.5 cm). The integrated area of a 
plot of Sλ versus λ was determined and divided by the corresponding area when no inner-filter 
effects occur (Sλ equals 1 for all wavelengths); the obtained value represents the overall screening 
factor (S). Accordingly, S (between 290 and 800 nm) due to the presence of humic acids, fulvic 
acids and XAD4 fraction was 0.993, 0.996 and 0.998, respectively. The determined screening 
factors allowed to conclude that inner-filter effects due to the absorption of light by DOM is 
negligible. Thus, the higher incidence of aromatic moieties in humic acids, which results in a 
higher absorption of UV reactive light (Figure 4.4), cannot explain the decrease in the 
photodegradation rates observed in the presence of this DOM fraction. In general, the distinct 
effects caused by the different fractions of humic substances (both enhancing and inhibitory) seem 
to be exclusively related to the production and/or scavenging of reactive intermediates differently 
favored by each fraction. 
 
Figure 4.4. UV-Vis spectra of the different dissolved organic matter fractions used in indirect 
photodegradation studies. The spectra were obtained with a UV-Vis Shimadzu spectrophotometer and a cell 
with an optical path length of 1 cm was used. 
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Overall, different fractions of humic substances exerted distinctive effects on the 
photodegradation rates of benzodiazepines. Nevertheless, half-life times obtained under indirect 
photodegradation conditions were comparable to those obtained under direct photodegradation, 
showing that the presence of naturally occurring DOM, at low concentrations (1 mg L-1), is not 
responsible for a drastic change on the environmental half-life times of these compounds. 
Interestingly, the photo resistance of alprazolam was not influenced by indirect photodegradation 
driven by the presence of humic substances, at a reasonable time scale.  
 
4.3.3 Determination of the apparent quantum yield 
 
The average apparent quantum yield (φave) of direct photolysis of the studied 
benzodiazepines was determined using the approach described in chapter 3 (section 3.1.3). Briefly, 
the determination was based on the overall average of lamp emission intensities in the wavelength 
range between 290 and 800 nm, by means of the following equation: 
ϕave = C0 × k∑ Iλ i0 × (1 − 10−ελ i ×b×C0 )   (4.2) 
 
where k is the apparent first order rate constant (s-1), C0 is the initial concentration of each 
benzodiazepine in solution (mol L-1), Iλi0 is the lamp emission intensity at the wavelength λi (Ein L-1 
s-1), ε is the molar absorptivity of each benzodiazepine at λi (L mol-1 cm-1) and b is the path length 
inside the photoreactor (cm) (diameter of the cylindrical quartz tubes, 1.5 cm). Emission lamp 
spectrum is presented in Figure 3.1a); absorption spectra of each benzodiazepine are presented in 
Figure 4.5.  
The direct photolysis apparent quantum yields are displayed in Table 4.2. Apparent 
quantum yields of oxazepam, diazepam and alprazolam are in the same order of magnitude (10-6). 
Consequently, the significantly higher half-life time of alprazolam is explained by poor absorption 
of solar light and not by a lower photolysis quantum yield. On the other hand, absorption of 
lorazepam (for wavelengths above 290 nm) is similar to diazepam and oxazepam (or even slightly 
lower); nevertheless, lorazepam has an apparent quantum yield approximately 20 times higher (in 
the order of 10-5), justifying the increase on the photodegradation rates of this compound. No 
literature data is available to compare with the results obtained in this study. 
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Figure 4.5. UV-Vis spectra of the studied benzodiazepines in aqueous solution. Spectra in the upper right 
corner are a detailed view of the region between 290 and 350 nm. The spectra were obtained with a UV-Vis 
Shimadzu spectrophotometer and a cell with an optical path length of 1 cm was used. 
 
4.3.4 Environmental relevance of the results 
 
Half-life times and apparent pseudo-first order rate constants were determined under 
simulated solar irradiation and are, consequently, strictly related to the specific experimental 
conditions adopted. Similarly to the procedure adopted in chapter 3, results can be converted into 
outdoor half-life times, in units equivalent to summer sunny days (SSD) by assuming that the lamp 
properly simulates sunlight. Considering that the total energy reaching the ground (290 – 400 nm) 
on a cloudless summer day (15th July, 45ºN latitude) is 7.5×105 J m-2 (Vione et al., 2006; Minero et 
al., 2007), one summer sunny day (a 24 h day/night cycle) corresponds to 3.8 h of irradiation. 
Results converted to SSD are presented in Table 4.2. Under direct photodegradation conditions, 
half-life times range between 0.68 ± 0.03 and 228 ± 11 SSD for lorazepam and alprazolam, 
respectively. While lorazepam might not be considered a persistent compound in the environment, 
it is expected that the elimination of alprazolam from surface waters by photodegradation processes 
would take several months. Moreover, diazepam and oxazepam, exhibit half-life times of several 
days (7.3 ± 0.5 and 3.98 ± 0.04 SSD, respectively), which is also considered environmentally 
relevant, especially if we take into consideration the continuous introduction of these compounds in 
the environment by WWTPs. Note that diazepam has a higher environmental half-life time than 
carbamazepine (4.5 SSD), which is pointed out in the literature as significantly resistant to 
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photodegradation. The environmental half-life times obtained under indirect photodegradation 
conditions are consistent with the conclusions taken for direct photodegradation. In general, these 
results highlight that photodegradation processes might not be efficient elimination pathways to 
prevent from the accumulation of oxazepam, diazepam and alprazolam in aquatic environments. 
On the contrary, lorazepam is quickly eliminated by photodegradation.  
In order to allow a better understanding of the persistence of benzodiazepines in aquatic 
environments, further studies involving the role of other constituents of natural waters (such as 
chloride and nitrates) in the photodegradation processes are mandatory. Furthermore, the 
environmental relevance of these results is strictly related to the fate of these pharmaceuticals in the 
water/sediment or soil interface. Once they are introduced into the environment, photodegradation 
might be more or less relevant depending on the partition of these compounds between aqueous 
and solid matrices. Literature data regarding sorption of psychiatric pharmaceuticals onto 
sediments evidenced their complex behavior (Stein et al., 2008), emphasizing that sorption and 
degradation phenomena should be faced as complementary; only this approach would allow 
attaining valid conclusions.   
 
4.3.5 Identification of photodegradation products by mass 
spectrometry 
 
The identification of the photodegradation products was performed by comparing 
ESI(+)MS spectra of each sample before and after irradiation (examples of ESI-MS spectra used 
for this purpose are shown in Figures 4.6a) - d)). Subsequently, the molecular ions [M+H]+ and/or 
[M+Na]+ of possible photodegradation products were selected. The molecular formula and structure 
of the products were then tentatively assigned based on the fragmentation patterns observed in the 
ESI-MS2 spectra (detailed data in Table 4.5). Structures of the studied benzodiazepines and 
proposed structures for photoproducts are presented in Figure 4.7. A total of 19 benzodiazepines 
photodegradation products were identified. All photoproducts, with only one exception, have lower 
molecular weight than the parent compound and photo-induced dimerization was not observed. In 
general, the majority of the identified compounds is monochlorinated and clearly exhibited (in the 
ESI-MS spectra) the typical pattern of compounds containing one chlorine atom. Also, the loss of a 
chlorine radical (-35 Da) or of a HCl molecule (-36 Da) were frequently observed in the respective 
ESI-MS2 spectra. Photodegradation products of oxazepam, diazepam and lorazepam mainly 
resulted from the opening of the diazepinone seven-membered ring followed by a rearrangement 
into a highly stabilized six-membered ring (as it is the case of OXZ IV-VI, DZP I and LRZ VI), or 
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even into an aromatic system of 3 adjacent 6 (or 7)-membered rings (DZP III, LRZ II-IV). 
Differentiation of compounds containing the phenyl ring was possible due to the commonly 
observed loss of the phenyl group (-78 Da). Oxidation to alcohols and ketones was also frequently 
observed; the existence of carbonyl and hydroxyl groups was confirmed by the presence of ESI-
MS2 base peaks which correspond to the loss of a CO group (-28 Da) or a H2O molecule (-18 Da). 
Interestingly, and despite from only differing on the presence of one chlorine atom in the 
phenyl ring, photodegradation of oxazepam and lorazepam resulted in the appearance of distinct 
photoproducts, showing that the extra ortho-chlorine atom in lorazepam plays a decisive role on 
photo-induced transformations. The major photodegradation product of lorazepam was LRZ V (Mw 
265, [M+H]+ = 266); the emergence of the compound LRZ II (Mw 213, [M+H]+ = 214) should also 
be highlighted due to its structural similarity with acridine, which is known for its carcinogenic 
activity (Chiron et al., 2006) (LRZ II corresponds to chloroacridine). In addition, it is important to 
emphasize that it was possible to differentiate photoproducts with the same molecular weight (OXZ 
V, [M+H]+ = 257 and LRZ IV, [M+H]+ = 257) based on their different ESI-MS2 fragmentation 
patterns. 
In the case of alprazolam, the aromatic triazole ring seems to have a protective effect in the 
seven-membered ring opening and only 2 photodegradation products were identified (ALP I, Mw 
297, [M+H]+ = 298 and ALP II, Mw 299, [M+H]+ = 300), also explaining the extremely low 
photodegradation rate of this compound. These 2 photoproducts also resulted from the opening of 
the seven-membered ring followed by oxidation to a ketone or alcohol. 
In order to further validate the suggested identification of the photoproducts, proposed 
molecular formulas were confirmed by exact mass measurement and elemental composition 
determination of the new ions, observed in the ESI-MS spectra after photodegradation. For the 
determination of the exact mass measurement of the new ions, lock mass was the calculated 
monoisotopic mass/charge of the non-modified benzodiazepines. The exact calculated 
monoisotopic masses were compared with observed masses in the ESI(+)MS spectra (detailed 
results for each photoproduct are displayed in Table 4.6). For a large number of predicted formulas, 
the errors between the observed and calculated masses are below 9 mDa (OXZ III-V, VII; DZP I, 
III and LRZ I-VI), confirming with good accuracy the elemental composition of the photoproducts. 
In the remaining cases, errors between observed and calculated masses did not overcome 28.4 
mDa; these higher errors might be, in some cases, explained by the overlap of the isotopic 
contribution of 13C or 37Cl of other identified products (OXZ VI, DZP IV).  
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Table 4.5. Ions detected in ESI(+)MS and fragment ions detected in ESI(+)MS2 used in the identification of 
the photodegradation products of oxazepam (OXZ), diazepam (DZP), lorazepam (LRZ) and alprazolam 
(ALP). Relative abundance and respective losses of the relevant fragment ions are also presented. The 
designation of the photodegradation products is in accordance with Figure 4.7.  
Compound Mw ESI(+)MS m/z* ESI(+)MS
2 m/z (relative abundance %, loss) 
OXZ 286 287 269 (100, -H2O); 145 (100, -H2O and -CO) 
OXZ – I 144 145 119 (18, -CN˙); 101 (100, -HCONH˙) 
OXZ – II 190 191 163 (63, -CO); 145 (100, -CO and -H2O);  
101 (23, -CO, -H2O and - HCONH˙) 
OXZ – III 231 232 154 (100, -C6H6); 126 (2, -C6H6 and -CO); 105 (7, -C6H4NH2Cl) 
OXZ – IV 240 241 214 (2, -HCN); 205 (13, -HCl); 163 (100, -C6H6);  
138 (10, -C6H6 and -HCN) 
OXZ – V 256 257 239 (55, -H2O); 179 (70, -C6H6); 151 (100, -C6H6 and -CO) 
OXZ – VI 257 258 240 (8, -H2O); 180 (100, -C6H6) 
OXZ – VII 302 325 308 (3, -OH˙); 280 (100, -H2NCHO); 254 (6, -H2NCHO and -HCN) 
DZP 284 285 257 (30, -CO); 228 (42, -H3CNCO); 222 (73, -CO and -Cl˙); 
193 (100, -H3CNCO and -Cl˙) 
DZP – I 223 224 179 (8, -HNCHOH); 171 (100, -CH2CHCN); 
153 (41, -CH2CHCN and -H2O) 
DZP – II 227 228 193 (100, -Cl˙); 125 (3, C6H6CCH2˙) 
DZP – III 243 244 229 (15, -CH3˙); 209 (100, -Cl˙); 208 (2, -HCl) 
DZP – IV 245 246 228 (100, -H2O); 193 (93, -H2O and –Cl˙); 168 (20, -C6H6) 
LRZ 320 321 303 (47, -H2O); 275 (100, -H2O and –CO) 
LRZ – I 153 154 126 (100, -CO) 
LRZ – II 213 214 179 (100, -Cl˙); 178 (50, -HCl); 152 (17, -HCN); 151 (28, -H2CN) 
LRZ – III 229 230 195 (100, -Cl˙); 167 (3, -CO) 
LRZ – IV 256 257 230 (75, -HCN); 229 (100, -CO) 
LRZ – V 265 266 230 (30, -HCl); 154 (100, -C6H6Cl); 139 (13, -C6H6NH2Cl) 
LRZ – VI 290 291 273 (100, -H2O); 179 (18, -C6H5Cl); 151 (8, -C6H5Cl and -CO) 
ALP 308 309 281 (100, -N2); 274 (28, -Cl˙); 205 (19, -C6H5CHN) 
ALP – I 297 298 281 (5, -OH˙); 280 (100, -H2O) 
ALP – II 299 300 282 (28, -H2O); 247 (100, -H2O and -Cl˙);  
240 (5, -H2O and –CHNNH); 206 (91, -H2O and -C6H4);  
205 (36, -H2O and –C6H5˙); 204 (22, -H2O and C6H6) 
* m/z values of ESI(+)MS ions correspond to [M+H]+, with the exception of photoproduct OXZ - VII which 
corresponds to[M+Na]+. 
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a1) b1) 
 
  
a2) b2) 
 
  
a3) b3) 
 
 
 
Figure 4.6. ESI-MS spectra of a) oxazepam and b) diazepam. 1) Pharmaceutical standard solution 2) solution 
irradiated during 24 h, 55 W m-2 (290-400 nm), in ultra-pure water; 3) is a detailed view of spectrum 2). Red 
arrows draw attention to significant differences in the spectra which correspond to ions of photodegradation 
products.   
 
 
m/z
150 200 250 300 350 400 450 500
%
0
100 287.1
269.1
241.1
289.1
309.0
371.0
m/z
150 200 250 300 350 400 450 500
%
0
100 285.0
274.3
287.1
287.2 318.3
 
m/z
150 200 250 300 350 400 450 500
%
0
100 287.1
269.1
241.1
214.9191.0
145.0
289.1
318.3
325.0
435.2371.0 415.3
m/z
150 200 250 300 350 400 450 500
%
0
100 285.1
224.1 274.3
246.1
287.1
318.3
302.3 362.4
 
m/z
140 160 180 200 220 240 260
%
0
100 241.1
214.9
191.0
145.0
129.1 132.1
186.9
163.0 194.9
232.1
218.2
230.9
257.1
243.1
258.0
259.0
m/z
205 210 215 220 225 230 235 240 245 250
%
0
100 224.1
218.2
246.1
224.5
228.1
230.1
246.3
Photodegradation of benzodiazepines in aquatic environments | Chapter 4 
 
129 
 
c1) d1) 
 
  
c2) d2) 
 
  
c3) d3) 
 
 
 
Figure 4.6 (cont.). ESI-MS spectra of c) lorazepam and d) alprazolam. 1) Pharmaceutical standard solution 
2) solution irradiated during 24 h, 55 W m-2 (290-400 nm), in ultra-pure water; 3) is a detailed view of 
spectrum 2). Red arrows draw attention to significant differences in the spectra which correspond to ions of 
photodegradation products.   
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Figure 4.7. Structures of the studied benzodiazepines and proposed structures for photodegradation products. 
OXZ I – VII, DZP I – IV, LRZ I – VI and ALP I – II correspond to photodegradation products of oxazepam, 
diazepam, lorazepam and alprazolam, respectively. Molecular weight (Mw) of each compound is also shown. 
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Table 4.6. Calculated and observed mass, mass error and double bond equivalents (DBE) for the predicted 
formulas of the identified photodegradation products of oxazepam, diazepam, lorazepam and alprazolam. 
Predicted formulas correspond to the [M+H]+ ions. The designation of the photodegradation products is in 
accordance with Figure 4.7. 
 
Compound Predicted Formula 
Calculated 
mass/ Da 
Observed 
mass/ Da Error/ mDa Error/ ppm DBE 
OXZ – I C8H5N2O 145.0402 145.0181 -22.1 -152.3 7.5 
OXZ – II C9H7N2O3 191.0457 191.0219 -23.8 -124.4 7.5 
OXZ – III C13H11NOCl 232.0529 232.0544 1.5 6.4 8.5 
OXZ – IV C14H10N2Cl 241.0533 241.0554 2.1 8.9 10.5 
OXZ – V C14H10N2OCl 257.0482 257.0513 3.1 12.2 10.5 
OXZ – VI C15H13NOCl 258.0686 258.0415 -27.1* -104.9 9.5 
OXZ – VII C15H12N2O3Cl 303.0536 303.0623 8.7 28.6 10.5 
DZP – I C15H14NO 224.1075 224.1115 4.0 17.7 9.5 
DZP – II C14H11NCl 228.0580 228.0845 26.5 116.2 9.5 
DZP – III C15H15NCl 244.0893 244.0859 -3.4 -13.9 8.5 
DZP – IV C14H13NOCl 246.0686 246.0963 27.7** 112.7 8.5 
LRZ – I C7H5NOCl 154.0060 154.0034 -2.6 -16.7 5.5 
LRZ – II C13H9NCl 214.0424 214.0362 -6.2 -28.7 9.5 
LRZ – III C13H9NOCl 230.0373 230.0356 -1.7 -7.2 9.5 
LRZ – IV C14H10N2OCl 257.0482 257.0468 -1.4 -5.3 10.5 
LRZ – V C13H10NOCl2 266.0139 266.0124 -1.5 -5.8 8.5 
LRZ – VI C14H9N2OCl2 291.0092 291.0117 2.5 8.6 10.5 
ALP – I C16H13N3OCl 298.1031 298.0747 28.4 95.2 11.5 
ALP – II C16H15N3OCl 300.0904 300.1137 23.3 77.8 10.5 
       
* Higher mass error due to the isotopic contribution of 13C from the ion at m/z 257. 
** Higher mass error due to the isotopic contribution of 37Cl from the ion at m/z 244. 
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4.4 CONCLUSIONS 
 
In this study, the relevance of photodegradation processes on the aquatic environmental 
persistence of benzodiazepines was evaluated for the first time. This work allowed to conclude that 
photodegradation might not prevent the environmental accumulation of oxazepam, diazepam and 
alprazolam which were shown to be considerably resistant to direct photodegradation (with half-
life times equivalents to 4, 7 and 228 summer sunny days, respectively). On the other hand, 
lorazepam is susceptible to direct photodegradation, showing a half-life time of less than 1 summer 
sunny day. The presence of dissolved organic matter resulted in observed half-life times of the 
same order of magnitude from those obtained under direct photodegradation conditions. 
Nevertheless, the presence of humic acids was consistent with a decrease in the observed 
photodegradation rates (which was not due to inner-filter effects), while fulvic acids and XAD-4 
fraction caused an enhancement of the photodegradation.  
One of the main focuses of this work consisted on the identification of the direct 
photodegradation products of the studied benzodiazepines, by mass spectrometry. It was possible to 
identify a total of 19 photodegradation products, the majority of which are reported here for the 
first time. The identification of the photoproducts is crucial to a more complete understanding of 
the environmental impact of the presence of benzodiazepines in aquatic systems. The 
photoproducts originated in the environment should also be considered as relevant environmental 
pollutants and, optimally, their impact in the environment should also be evaluated. The persistence 
and/or toxicity of these products might, in some cases, cause a more significant concern than the 
parent compounds. Thus, the identification of the main photodegradation products, under 
environmentally relevant conditions, constitutes the first step to allow more comprehensive 
approaches when assessing scarcely studied pharmaceuticals. 
The results presented in this chapter are a valuable tool for the development of further 
research concerning this topic. 
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CHAPTER 5 
Quantification of carbamazepine in the environment by ELISA 
 
 
 
In this chapter, a previously developed enzyme-linked immunosorbent assay (ELISA) was 
applied to the quantification of carbamazepine in ground, surface and wastewaters. The 
performance of the applied ELISA methodology was tested in the presence of high concentrations 
of sodium chloride and dissolved organic matter. The method was not significantly affected by 
matrix effects, being adequate for the quantification of carbamazepine in environmental samples, 
in the range of 0.03 - 10 μg L-1, even without sample pre-treatment. Due to a pH dependent cross-
reactivity with cetirizine, an antihistaminic drug, the assay also enabled the quantification of 
cetirizine in the samples. The developed method was applied to real samples with different 
matrices, collected in the geographical area of Ria de Aveiro, an estuarine system located in the 
North of Portugal. Carbamazepine was detected in all the analyzed wastewater samples and one 
surface water with concentrations between 0.1 and 0.7 μg L-1. Validation with LC-MS/MS revealed 
that results obtained by ELISA are 2 to 28% overestimated, which was considered highly 
satisfactory due to the absence of sample pre-treatments.  
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5.1 CONTEXTUALIZATION 
 
In opposition to other countries located in Occidental and Central Europe (such as Spain, 
France, Italy and Germany), very limited data is available about the presence of pharmaceuticals in 
the environment in Portugal. Until now, only a few recent studies were published reporting surface 
water contamination with endocrine disruptors in the Douro river, the Ria of Aveiro, the Mondego 
and the Sado estuarine systems (Ribeiro et al., 2009a; Ribeiro et al., 2009b; Ribeiro et al., 2009c; 
Jonkers et al., 2010). In the specific case of the anti-epileptic carbamazepine, the available 
literature data is restricted to the works recently published by Madureira et al. (2009, 2010) which 
reported carbamazepine contamination levels around 178 ng L-1 in surface waters (Douro River, 
Northern Portugal).  
As pointed out in previous chapters, carbamazepine has been proposed, in several studies, 
as an indicator of anthropogenic pollution. In order to suit this purpose at a regional/national scale, 
apart from carbamazepine´s resistance to degradation and persistence in aquatic environments, 
local rates of consumption should also be taken into consideration. In Portugal, during the last 
years, carbamazepine was consistently amongst the most prescribed pharmaceuticals with an 
estimated consumption of at least 400 000 packages per year (Infarmed, 2008, 2009). 
Consequently, in the case of Portugal, the assessment of carbamazepine contamination levels might 
constitute a valuable tool for the identification of relevant focal points of pollution. 
In this research, an enzyme-linked immunosorbent assay (ELISA) was applied to the 
quantification of carbamazepine in ground, surface and wastewaters, collected in Aveiro (Northern 
Portugal). The ELISA methodology, based on a commercial monoclonal antibody, was previously 
developed by Bahlmann et al. (2009). Taking into consideration the nature of the collected 
samples, this study aimed at the evaluation and optimization of the performance of the assay in the 
presence of high concentrations of organic matter and high salinities in order to develop an ELISA 
method adequate to perform large environmental screenings. This work also intends to present, for 
the first time, some results concerning carbamazepine contamination levels in the district of 
Aveiro. This work was performed in close collaboration with BAM Federal Institute for Materials 
Research and Testing, Berlin, Germany. 
The core concepts involved in the development and application of immunoassays, and 
ELISA in particular, are presented below. This section also includes a brief characterization of the 
sampling area.   
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5.1.1 Immunoassays  
 
The term “immunoassay” comprises a large number of analytical techniques all based on 
the interaction between an antibody and an antigen (Gault and McClenaghan, 2009). Originally 
applied to biochemical and clinical analyses (and subsequently to food analyses), immunoassays 
are now also being used in the quantification of environmental contaminants (Schneider, 2003; 
Law, 2005; Nunes, 2005). As concluded in chapter 2, the monitorization of pharmaceutically active 
substances in the environment implies the use of techniques with adequately low limits of 
quantification (between ng/L and μg/L). In this context, and considering the high sensitivity and 
specificity that characterize immunoassays, their application to environmental analysis is a growing 
field of research (Huo et al., 2007; Emon et al., 2008; Shelver et al., 2008; Carvalho et al., 2010). In 
comparison with reference techniques such as LC-MS/MS or GC-MS/MS, immunoassay 
methodologies allow the analysis of a large number of samples in a very limited amount of time, 
revealing their suitability to perform high-throughput environmental screenings (Buchberger, 
2007). Moreover, these methods are commonly characterized by operational simplicity and require 
low-cost equipments; sample pre-treatments (such as pre-concentration procedures, most often 
coupled to LC and GC methods) are usually not required, which constitutes one of the most 
striking advantages of immunoassays (Schneider, 2003). Immunoassay techniques are, thus, an 
inexpensive and time-efficient alternative/complement to chromatographic techniques. The main 
disadvantage of these methods is their tendency to produce false-positive results (Nunes, 2005; 
Bahlmann et al., 2011) and, in cases of highly complex matrices (such as wastewater or soil 
samples) matrix effects might be significant. These points will be object of a closer look through 
the work presented in this chapter. Additionally, immunoassays are single-analyte techniques and, 
contrary to chromatographic methods, multi-analyte analyses are only possible by repeated 
analyses of the same samples. 
Immunoassays are not universally accepted as a valuable tool in environmental analysis 
and, in some cases, examples of application of immunoassays are still scarce. The assay presented 
here is, to date, the only example reported in literature of an immunoassay method that is being 
applied to the quantification of a psychiatric pharmaceutical in the environment. 
 
5.1.2 The antibody – main concepts and interaction with the antigen 
 
Antibodies are large glycoproteins of the immune system that belong to the family of 
immunoglobulins. These biomolecules are intended to specifically bind to an antigen, which is any 
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substance able to activate an immune response (thus, leading to antibody production) (Harlow and 
Lane, 1999; Gault and McClenaghan, 2009). 
Antibodies contain four polypeptide chains (two identical heavy chains and two identical 
light chains) and they are grouped in five main classes (IgG, IgM, IgA, IgE and IgD), classified 
according to the type of the heavy chain. Antibodies are usually described based on the structure of 
the immunoglobulin G (IgG) which is the most abundant immunoglobulin in the serum (a 
schematic representation of the IgG is presented in Figure 5.1) (Harlow and Lane, 1999). The light 
and heavy chains are held together by covalent disulfide bonds and by non-covalent bonds (such as 
hydrogen bonding). An antibody can be divided in three regions, forming a Y-shaped molecule. 
The two arms of the Y constitute two identical antigen binding sites (the antibodies are, as a result, 
bivalent molecules) which are called the Fab domains; the Fab domain is formed by the heavy and 
light chain variable regions (Harlow and Lane, 1999). The third part of the molecule is constituted 
by the “tail” of the Y (usually considered the “foot” of the antibody) and is responsible for 
interacting with other specific molecules of the immune system; it is designated as the Fc domain. 
The Fc and the Fab domains are connected by a region called “hinge” which allows the Fab 
domains to perform lateral and rotational movements, conferring to the antibody the ability to 
undergo conformation-mediated recognition (Harlow and Lane, 1999; Gault and McClenaghan, 
2009). 
 
 
 
Figure 5.1. Schematic representation of the basic structure of an antibody (immunoglobulin G, IgG), also 
illustrating the specific interaction between an antibody and an antigen. 
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Antibodies are produced by the plasma cells of the immune system. The production of 
antibodies used in immunoanalytical techniques is done by immunization of laboratory animals 
such as mice, sheep, rabbits or pigs with an immunoconjugate containing the antigen (Nunes, 2005; 
Gault and McClenaghan, 2009). The presence of the antigen will then induce the production of 
antibodies by the animals’ immune system. After a certain period of time, blood samples are taken, 
and the antibodies are subsequently purified from the blood serum. However, during the 
immunologic response, different clones of plasma cells will produce antibodies that will recognize 
different epitopes (the region of an antigen that is recognized by an antibody and interacts with it) 
but each clone will only secrete antibodies intended to bind the same epitope. Consequently, the 
blood serum is a source of polyclonal antibodies (Harlow and Lane, 1999). Monoclonal antibodies, 
which recognize only a specific epitope, have the main advantage of being highly specific against 
the selected antigen. To obtain monoclonal antibodies, a culture of a single clone of plasma cells is, 
however, needed (Gault and McClenaghan, 2009). Due to the complexity involved in the 
monoclonal antibodies production, there are much more applications based on polyclonal 
antibodies (Harlow and Lane, 1999). 
Frequently, the analytes of interest (antigens) in environmental analysis are not able to 
elicit an immunological response due to their low molecular weight. Yet they can be recognized 
and bound by an antibody. So these compounds are called haptens (van Emon, 2007). To overcome 
this problem, an immunoconjugate is produced by covalently linking the analyte/hapten to a carrier 
protein (most commonly). When the analyte molecule does not have any functional group that 
allows the establishment of this covalent link, an extra experimental step is needed: the production 
of a linkable hapten - a molecule similar to the analyte but modified with a functional group 
capable of covalently binding to a protein. Consequently, the immune response is not caused by the 
analyte itself, but by an immunoconjugate that derived from it (Nunes, 2005).  
The antibody-antigen interaction is the key to understanding and developing an 
immunochemical method. It can be accompanied by conformational changes in one, both or none 
of the molecules. The interaction is mediated by non-covalent bonding which stabilize the 
antibody-antigen complex and the strength of the interaction is highly dependent on small changes 
in the antigen structure (Harlow and Lane, 1999).   
 
5.1.3 Enzyme-linked immunosorbent assay (ELISA) 
 
Immunoassays exist in a vast number of formats. “Enzyme immunoassays” is the 
designation of a group of methodologies that uses an enzyme label (attached either to the antigen or 
Quantification of carbamazepine in the environment by ELISA | Chapter 5 
 
141 
 
the antibody) which, in conjunction with a substrate, constitutes the basis of production of the 
analytical signal. These enzyme labels, designated as “tracers”, are most commonly constituted by 
horseradish peroxidase or alkaline phosphatase (Law, 2005; Nunes, 2005). The classification of the 
different types of enzyme immunoassays is lacking some clarity; yet, in general, they can be 
classified into competitive/ non-competitive (whether or not there is competition between the 
analyte and the tracer for a limited number of antibody binding sites) and heterogeneous/ 
homogenous (when one of the reagents is immobilized onto a solid support and bound and free 
reagents should be separated by performing washing steps or the immunoreaction takes place in 
solution, without any separation of the bound and free reagents, respectively) (van Emon, 2007; 
Gault and McClenaghan, 2009). One of the most popular formats in environmental analysis is the 
enzyme-linked immunosorbent assay (ELISA) which is a heterogeneous assay with one of the 
components (the antigen or the antibody) bound to a solid phase (Law, 2005). 
The principle of a direct competitive ELISA (the format optimized in this work) is 
illustrated in Figure 5.2.  In this case, the antigen and a known quantity of tracer directly compete 
for the antibody binding sites (immobilized onto a solid support, a 96-well microtiter plate). After 
removing the remaining free reagents in solution (not bound to the antibody) the addition of a 
substrate results in the development of color (catalyzed by the enzyme tracer). The signal (optical 
density) is then proportional to the amount of tracer bound to the antibody and inversely 
proportional to the amount of antigen present in samples/standards. 
 
 
 
 
Figure 5.2. Principle of a direct competitive ELISA: a) samples containing the analyte (represented in dark 
blue) and the tracer (analogue of the analyte and enzyme-labeled, represented in yellow) are added to the 
microtiter plate, where the antibody is immobilized; b) the analyte and tracer directly compete to occupy the 
available binding positions of the antibody; c) the addition of a substrate, in the presence of the enzyme-
labeled tracer, results in an enzyme catalyzed colorimetric reaction which enables the quantification of the 
analyte. 
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5.1.4 ELISA calibration curve 
 
The use of appropriate calibration models is fundamental to the overall quality of an 
immunoassay, as for all analytical methods. In ELISA, the relationship between the response and 
the analyte concentration is characterized by non-linear relationships. As the calibration curve 
fitting is non-linear, choosing an appropriate fitting model demands special attention. Additionally, 
the response can be directly or inversely proportional to the analyte concentration, depending on 
the format of the assays (Findlay and Dillard, 2007).  
Typically, ELISA calibration curves are sigmoidal with a lower and an upper asymptote 
which correspond to infinite and zero analyte concentrations, respectively. The 4-parameter logistic 
(4PL) model is the most commonly used for fitting ELISA calibration curves (equation 5.1). 
 y = D + A − D1 + �xC�B     (5.1)   
 
where, y is the response, D is the response at infinite analyte concentration, A is the response at 
zero analyte concentration, x is the analyte concentration, C is the abscissa of the inflection point 
(the test midpoint) and B is a slope parameter (which defines the steepness of the fitting). The curve 
is symmetric around the test midpoint. The 4PL model is considered to provide the best fit across 
the entire calibration range. Other models, such as linear, exponential and quadratic are also 
referred to in literature. Nevertheless, they are characterized by a reasonable fitting only in reduced 
areas and the fitting is most often unsatisfactory at higher and lower concentration ranges (Findlay 
and Dillard, 2007). 
The quality of the calibration curve also reflects the adequacy of the assay design and plate 
layout. Some of the main aspects to take into account when performing ELISA are (Ekins, 1981; 
Findlay and Dillard, 2007): 
- Use between five and eight calibrators to allow a proper curve fitting but, at the same time, 
avoid reducing the number of samples that can be analyzed in the same experiment; 
- Distribute the calibrator concentrations logarithmically and analyze each of them, ideally, 
in triplicate; 
- Include calibrators with concentrations that are outside the working range; 
- Assign the calibrators and samples as randomly as possible to the microtiter plate wells, in 
order to avoid systematic errors due to position in plate and drift effects. 
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In the fitting process, it is also important to consider that the variance of the response is a 
function of the response; the variance is, thus, heteroscedastic. Consequently, weighted calibration 
curves, where response with higher variation have a minor relative importance in the fitting when 
compared to points with lower variation, should be applied. 
 
5.1.5 Cross-reactivity 
 
As previously explained, the region of an antigen that is recognized by an antibody and 
interacts with it is the epitope. The epitope is not a property of any compound and its definition 
only makes sense when referred to the interaction with a specific antibody. Epitopes are very often 
relatively small regions of the antigen and, thus, it is not uncommon that antibodies interact with 
other compounds that have structures related to the epitope (or sometimes detect spatial 
arrangements similar to the one of the epitope). This recognition of compounds other than the 
antigen is known as cross-reactivity (Harlow and Lane, 1999).   
The cross-reactivity is the basis of the specificity of an immunoassay. For this reason, the 
validation of an immunoassay should always comprise an evaluation of the cross-reactivity levels 
with potential cross-reactants. The potential interfering compounds should be selected amongst 
chemicals that show structural similarities with the antigen, such as metabolites and degradation 
products. However, for obvious reasons, it is impossible to effectively select and test all the 
compounds that might possibly interact with the antibody, resulting in ignoring possible cross-
reactants that are not obviously structurally correlated with the antigen (Law, 2005; Bahlmann et 
al., 2011). 
To evaluate the cross-reactivity towards a battery of compounds, these should be assayed 
as if they were the analyte of interest. The calibration curve obtained for each compound is then 
compared with the curve of the analyte (Law, 2005). Most commonly, the comparison of both 
curves is done by using the 50% displacement method: the cross-reactivity is expressed as the 
relative dose, in percentage, required to cause a 50% displacement of the maximum tracer binding 
(50% maximum inhibition concentration, IC50), as follows (Law, 2005): 
 Cross reactivity = IC50 analyteIC50 competitor × 100%    (5.2) 
 
Note that the IC50, that is equivalent (but not equal) to the test midpoind (the ELISA curve 
inflection point), is also very often used to express the sensitivity of the assays (Nunes, 2005). 
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When interpreting the results, cross-reactivities should be expressed in terms of molar 
concentrations. This is particularly relevant when the molecular weights of the analyte and the 
competitor significantly differ (Law, 2005). 
One of the main disadvantages of immunoassays is a direct consequence of the cross-
reactivity: the assays might have a tendency to produce false-positive results, due to the recognition 
of compounds that are not the analyte. However, for some purposes, it is also possible to take 
advantage of the cross-reactivity as it might enable the determination of a whole class of 
compounds or multi-analyte approaches (Schneider et al., 1992; Harlow and Lane, 1999). 
 
5.1.6 Assay precision – the precision profile and the working range 
 
The determination of the precision profile is considered to be the best method to evaluate 
the precision both within and between ELISA experiments (Law, 2005). This method was first 
developed by Ekins (1981), who defined the precision profile as “a graphical representation of the 
random error in the analyte measurement at each value of the analyte concentration”. Thus, it 
represents the relationship between the concentration of the analyte and its measured precision 
(O'Malley, 2008).    
As concluded in a previous section, the calibration curve of ELISA is not linear and, 
consequently, the error of the concentration is not a linear function of the response error. Both the 
error of the response and the slope of the calibration curve vary from point to point (Ekins, 1981; 
Law, 2005). So, as proposed by Ekins, at a certain point, the error of the concentration (errorx), is 
given by: 
error𝑥𝑥 = σyslope of the calibration funtion   (5.3)   
 
where σy is the standard deviation of the response for replicate measurements. The determination of 
this quotient for a number of points along the ELISA calibration curve allows building the 
precision profile. The slope of the calibration curve, at a certain concentration, is given by the first 
derivative of the calibration curve (Law, 2005). One possible representation of the precision profile 
is in terms of relative error of concentration (coefficient of variation, C.V.). Therefore, at each 
point, the precision profile is given by: 
C. V. = σyslope  × 1𝑥𝑥 × 100%  (5.4)   
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with x representing the concentration of the analyte. When the data is fitted to a 4PL model 
(equation 5.1), the precision profile can be determined as follows: 
 C. V. = −σy × 1B(D − A) × �2 + �𝑥𝑥C�B + �C𝑥𝑥�B� × 100%  (5.5)   
 
The precision profile can be obtained by analyzing a series of calibrators, including at least 
one calibrator outside the expected upper and lower limits of the quantitation range. It is also 
mandatory to perform a reasonable number of replicates of the calibrators analysis, to allow 
obtaining a reliable estimate of the concentration error (Law, 2005). The precision profile is also 
considered the best method to determine the quantitation or working range that is defined as the 
highest and lowest concentrations which can be determined with an acceptable degree of precision 
(Ekins, 1981; Law, 2005). 
 
5.1.7 Characterization of the sampling area 
   
 Ground, surface and wastewaters were collected in and around Aveiro (NW Portugal). 
Aveiro is a small city, surrounded by the Ria de Aveiro, a coastal lagoon adjacent to the Atlantic 
Ocean. It is one of the most important estuarine systems of Portugal, with approximately 45 km2 of 
surface area, characterized by the existence of a large and complex network of branches and narrow 
canals which cross both urban and rural areas. 
 Domestic wastewaters from Aveiro and the surrounding area are processed at three main 
wastewater treatment plants (WWTPs). The treated wastewater is discharged into the Atlantic 
Ocean, at a distance of 3.2 km from the coast, at approximately 17 m depth. The effluent from this 
outfall (“São Jacinto”) corresponds to approximately 28 million m3 of treated effluent per year 
(SimRia, 2010). North and south WWTPs are the two main treatment plant facilities, responsible 
for receiving wastewaters of 272 000 and 159 000 inhabitant equivalents, respectively. In these 
WWTPs, wastewaters are currently subjected to a pre-treatment, primary decantation, biological 
treatment and secondary decantation before effluent rejection. The described wastewater treatment 
system is the result of significant improvements during the last decade, which are still taking place 
(SimRia, 2010). Before these enhancements, the system was organized in a larger number of 
smaller WWTPs, from which at least one (located in the center of Aveiro) was directly discharging 
the effluent into the Ria de Aveiro (Sousa et al., 2010).  
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5.2 MATERIALS AND METHODS 
 
5.2.1 Chemicals 
 
The polyclonal antibody against mouse (IgG F(c) domain, from goat, lot 20185) and the 
anti-carbamazepine monoclonal antibody (mouse IgG1, clone B3212M, lot 5 K32007) were 
purchased from Acris Antibodies (Germany) and BIODESIGN International (Meridian Life 
Science Inc., USA), respectively. The tracer was previously produced and characterized as 
described in Bahlmann et al. (2009). 3,3’,5,5’-Tetramethylbenzidine (TMB, puriss.) and 
tetrabutylammonium borohydride (TBABH, >97%) were purchased from Fluka. Sodium phosphate 
dibasic dihydrate (>99%), sodium phosphate monobasic dihydrate (>99%), potassium sorbate 
(>99%), potassium dihydrogen citrate (>99%), hydrogen peroxide (30%) and TweenTM 20 were 
also from Fluka. Ethylenediaminetetraacetic acid disodium salt dihydrate (p.a.), and sodium 
chloride (99.5%) were from Panreac (Spain). Dimethylacetamide (DMA), tris(hydroxymethyl) 
aminomethane (TRIS, p.a.) and bovine serum albumin (BSA, for electrophoresis, 98%) were 
purchased from Sigma. Commercial humic acids (technical) were also obtained from Sigma. 
Glycine (99.8%) was purchased from VWR Prolabo and sodium hydroxide (>98.0%) was obtained 
from José Manuel Gomes dos Santos (Lisbon, Portugal). Carbamazepine (99%), cetirizine 
dihydrochloride (>98.0%), epoxy-carbamazepine (98%) were purchased from Sigma. 2-OH-
carbamazepine (98%), 10,11-dihydro-10-OH-carbamazepine (10-OH-carbamazepine, 98%), 10,11-
dihydro-trans-10,11-dihydroxy-carbamazepine (DiOH-carbamazepine, 98%) and 3-OH-
carbamazepine (98%) were supplied by Toronto Research Chemicals (Toronto, Canada). 
 Ultra-pure water, used in the preparation of all the solutions, was obtained using a 
Millipore water purification system (Milli-Q plus 185). 
 
5.2.2 Materials 
 
Transparent 96 flat-bottom well microtiter plates with high binding capacity (MaxiSorpTM) 
were purchased from Nunc (Thermo Scientific). Membrane filters (pore size 0.22 μm, Millex-GV) 
and paper filters (pore size 0.45 μm) were purchased from Millipore. A Titramax 100 plate shaker 
(Heidolph, Germany) and an automatic 8-channel plate washer (Biochrom, ASYS Atlantis) were 
also used. Optical density was read using a microplate spectrophotometer (Biochrom, ASYS 
UVM340). 
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 The LC-MS/MS experiments were performed on an Agilent 1100 LC system consisting of 
a degasser, binary pump, autosampler and column heater. The outlet of the column was coupled to 
an API 4000 mass spectrometer from Applied Biosystems. A Turbo VTM ion source was used in 
electrospray positive mode.  
 
5.2.3 Sample collection and preparation 
 
Water samples (250 mL) were collected in and around Aveiro (NW Portugal), in sites 
geographically distributed as shown in Figure 5.3.  
 
 
Figure 5.3. Schematic representation of the sampling region around Ria de Aveiro. Circles represent 
collection sites of ground water samples from wells (W1-W4), riverine bank filtration systems (BF) and 
mines (M1 and M2); surface water samples from Ria de Aveiro (S1-S11) and wastewater samples from the 
two main WWTPs of Aveiro (North, NWW1-3 and South, SWW1-3). The dark square represents the 
location of the final effluent discharge of the two WWTPs. 
 
Ground water samples were collected from 4 wells (W1 – W4), 2 mines (M1, M2)  and 1 
riverine bank filtration system on Vouga river (BF), mainly located in rural areas, which are 
currently used for the water supplies of the municipal drinking water system. Also, 11 surface 
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water samples (S1 – S11) were collected from North to South of Ria de Aveiro, including samples 
from rural areas (S2, S3, S8), urban areas (S4-S7) and touristic coastal areas (S1, S9-S11). 
Wastewater samples were collected from the two main WWTPs of Aveiro (“North” and “South”) 
and three collection points were selected: after primary decantation, after secondary biological 
treatment and after secondary decantation (corresponding to the final treated effluent). Samples 
were collected during spring (between April and May 2010). All the samples were filtered through 
0.45 μm nitrocellulose membrane filters (Millipore), immediately after collection, and stored at -20 
ºC until analysis. Samples were not subjected to any other cleaning procedure, extraction or 
enrichment process.  
 
5.2.4 Immunoassay procedure 
 
The ELISA procedure applied in this study was previously developed; detailed information 
about tracer characterization and assay development is presented in Bahlmann et al. (2009). 
High binding capacity microtiter plates were first coated with polyclonal antibody (anti-
mouse IgG, 1 mg L-1, 200 μL per well), covered with Parafilm® to prevent evaporation and 
incubated overnight (approximately 16 to 18 hours) on a plate shaker at 750 rpm. The antibody 
dilution was prepared in PBS (10 mM sodium dihydrogen phosphate, 70 mM sodium hydrogen 
phosphate and 145 mM sodium chloride, pH 7.6). The plates were then washed thrice with PBS 
0.05% TweenTM 20 using an 8-channel plate washer. Subsequently, monoclonal antibody against 
carbamazepine, also diluted in PBS (12.9 μg L-1, 200 μL per well), was incubated for 1 h. After 
another three-cycle washing procedure, the tracer solution was added to the plates (177 pmol L-1 in 
sample buffer, 50 μL per well). Sample buffer consisted of 1 M glycine, 3 M sodium chloride and 
2% (w/v) of ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA), pH 10.5. Variations 
in the sample buffer composition, introduced to study its influence on the performance of the 
assays, are detailed in Sections 5.2.6 and 5.2.7. Then, carbamazepine standard solutions and 
samples (150 μL per well) were added; the plates were incubated for 30 min and submitted to a 
final three-cycle washing step. Afterwards, substrate solution (200 μL per well) was pipetted and 
incubated for another 30 min. The substrate solution consisted of 540 μL of a TMB-based solution 
(41 mM TMB, 8 mM TBABH in DMA, prepared under nitrogen atmosphere) in 21.5 mL of 
substrate buffer (200 mM citric acid, 0.01% sorbic acid potassium salt and 3 mM hydrogen 
peroxide, pH 4.0) and was freshly prepared for each plate. Finally, the reaction was stopped by 
adding sulfuric acid (1 M, 100 μL per well) and the optical density was read (at 450 nm and 
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referenced to 650 nm) on a microplate spectrophotometer. Data was analyzed using SoftMax® Pro 
Software (version 5.3, Molecular Devices). 
 
5.2.5 ELISA calibration curve and precision profile 
 
To obtain ELISA calibration curves, a 100 mg L-1 stock solution of carbamazepine was 
prepared in methanol. The calibrators were subsequently prepared by diluting the stock solution in 
ultra-pure water, ensuring that the concentration of methanol did not exceed 1% (v/v). For 
quantification purposes, 8 standard solutions, logarithmically distributed, were used with 
concentrations ranging from 0 to 100 μg L-1. To determine the quantitation range, 16 standard 
solutions were assayed (with 6 replicates each). Subsequently, the relative error of the 
carbamazepine concentration was calculated to obtain the precision profile of the assay as 
described in section 5.1.6. A maximum allowable relative error of 30% for the quantification of 
carbamazepine in a sample was established as the criterion to define the quantitation range of the 
assays. The inverse of the square of the standard deviation of replicates was used to allocate the 
weight of a calibrator in the fitting process. Standard solutions were randomly distributed over the 
96 wells of the microtiter plates to level out the influence of possible systematic errors that might 
arise from signal drifts across the plate. 
  
5.2.6 Determination of cross-reactivity with cetirizine 
 
The antihistaminic pharmaceutical cetirizine was previously identified as an important 
cross-reactant of this assay (Bahlmann et al., 2011). The study of the immunoassay selectivity for 
carbamazepine relative to cetirizine was performed by establishing an ELISA curve for cetirizine, 
using seven standard solutions of this compound with concentrations ranging from 0.03 to 100 μg 
L-1, and for carbamazepine itself. 
  The molar cross-reactivity of cetirizine towards carbamazepine was calculated considering 
the ratio of the molar concentrations of the two compounds at the test midpoint of the 
correspondent calibration curves, expressed in percentage relatively to the carbamazepine 
midpoint, according to: 
  CR = IC 50  (Carbamazepine )IC 50  (Cetirizine ) × 100%    (5.6)      
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 In order to evaluate the pH effect on the affinity of the assay towards cetirizine, the cross-
reactivity tests were performed at 3 pH values: 4.5, 7.6 and 10.5. A sample buffer, added at the 
same time of sample incubation, was used to control the pH and ionic strength of the assays. Tested 
sample buffers have the following compositions: 1 M citrate and 3 M NaCl (pH 4.5); 1 M TRIS, 
2% (w/v) EDTA and 3 M NaCl (pH 7.6) and 1 M glycine, 2% (w/v) EDTA and 3 M NaCl (pH 
10.5). 
 
5.2.7 Salinity and dissolved organic matter effects 
 
To study matrix effects on the performance of the assays, the influence of dissolved 
organic matter (particularly relevant for the analysis of wastewater samples) and sodium chloride 
concentration (relevant for surface waters collected in Ria de Aveiro) were evaluated. 
 Considering dissolved organic matter effects, ELISA calibration curves were obtained for 
carbamazepine standard solutions containing 0.1, 1.0 and 10.0 mg L-1 of commercial humic acids. 
Similarly, for salinity effects, carbamazepine standard solutions with 1.0, 10.0 and 30.0 g L-1 of 
sodium chloride were assayed. In both cases, results were compared with those obtained with 
carbamazepine standard solutions in the absence of humic acids or sodium chloride. The effect of 
pH and composition of the sample buffers on these experiments was also tested. Organic matter 
and salinity tests were performed using sample buffers with pH 7.6 and 10.5 with and without the 
addition of BSA 1% (w/v). After selecting the optimal conditions of the assay, some additional tests 
to check for matrix effects, using real samples, were carried out. Wastewater samples were spiked 
with 0.5, 1.0 and 1.5 μg L-1 of carbamazepine and analyzed by ELISA.  
 
5.2.8 LC-MS/MS method 
 
Samples were analyzed by LC-MS/MS, established as a reference methodology, in order to 
validate results obtained by ELISA. The LC-MS/MS methodology was adapted from Bahlmann et 
al. (2009). The instrument’s sensitivity was high enough to allow injection of samples without 
performing any SPE-enrichment procedure. It was previously concluded that results obtained by 
SPE-LC-MS/MS and LC-MS/MS are not significantly different (Bahlmann et al., 2009). 
 The chromatographic separation was carried out on a Purospher RP-C18 column (250×3 
mm; 5 μm; VDS Optilab, Berlin, Germany) and a guard column was used (10×3 mm). The 
temperature of the column oven was kept at 40 ºC. The flow rate was maintained at 400 μL min-1 
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and the sample injection volume was 20 μL. A binary gradient consisting of 5×10-3 M ammonium 
acetate in water (A) and methanol (B) was used. The separation started with 40% of B, maintained 
at isocratic conditions for 3 min, linearly increased to 95% of B for the period of 15 min, kept at 
95% of B during 10 min, linearly decreased to 40% of B within 1 min and finally these conditions 
were maintained during 10 min, with a total running time of 39 min. 
 The mass spectrometry detector was used with the following parameters: collision gas 41 
kPa, curtain gas 172 kPa, ion source gas 1 and 2 at 345 kPa and 414 kPa, respectively. The source 
temperature was 400 ºC, entrance potential was set to 10 V and declustering potential set to 60 V. 
The ion spray voltage was adjusted to 4.5 kV. For the quantification and identification of 
carbamazepine in the samples, multiple-reaction monitoring mode (MRM) was chosen, monitoring 
the transitions m/z 237→194 and 237→179 for carbamazepine and m/z 239→196 and 239→180 
for carbamazepine-d2, used as internal standard. The quantification of some metabolites of 
carbamazepine was also simultaneously performed, by using the same LC-MS/MS method. The 
analyzed metabolites (and chosen MRM transitions) are: 10-OH-carbamazepine (m/z 237→194 and 
255→237), 2-OH-carbamazepine and 3-OH-carbamazepine (m/z 253→210 and 253→208), di-OH-
carbamazepine (m/z 253→180 and 271→253) and epoxy-carbamazepine (m/z 253→180 and 
253→236). 
 Acquisition and analysis of data were performed using the AnalystTM 1.4.1 software 
(Applied Biosystems). 
 
5.3 RESULTS AND DISCUSSION 
 
5.3.1 Cross-reactivity towards cetirizine – pH effect 
 
The specificity of the monoclonal antibody, considering 14 potential cross-reactants, has 
been studied before (cross-reactivities of some selected compounds are presented in Table 5.1) 
(Bahlmann et al., 2009). Only epoxy-carbamazepine and 2-hydroxy-carbamazepine, with molar 
cross-reactivities, at pH 7.6, of 73 ± 9% and 14 ± 1%, respectively, were considered to potentially 
affect the quantification of carbamazepine in environmental samples; these 2 metabolites are also 
known to occur in the environment, although usually in lower concentrations than carbamazepine 
(Miao and Metcalfe, 2003; Miao et al., 2005; Leclercq et al., 2009). However, further investigation 
performed by the same authors resulted in the discovery of an important cross-reactant that has no 
obvious structural correlation with carbamazepine; this cross-reactant is cetirizine (Figure 5.4), an 
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antihistaminic pharmaceutical (Bahlmann et al., 2011). Cetirizine was also recently found in the 
environment (Kosonen and Kronberg, 2009; Huerta-Fontela et al., 2010; Loos et al., 2010); 
consequently, it is important to investigate the possible influence of this compound in the analysis 
of carbamazepine in the collected samples. 
 
Table 5.1. Mean values (± standard deviations) of molar cross-reactivities of the main carbamazepine 
metabolites at pH 4.5, 7.6 and 10.5. Brackets represent the number of experiments used in the calculation. 
Data published in Bahlmann et al. (2009, 2011). 
Compound pH 4.5 pH 7.6 pH 10.5 
Epoxy-CBZ 67 ± 6% (5) 73 ± 9% (6) 68 ± 4% (4) 
2-OH-CBZ 14 ± 1% (4) 14 ± 1% (5) 0.81 ± 0.15% (3) 
3-OH-CBZ 2.2 ± 0.7% (4) 1.7 ± 0.1% (4) 0.14 ± 0.01% (3) 
10-OH-CBZ 0.56 ± 0.01% (2) 0.47 ± 0.16% (3) 0.50 ± 0.07% (2) 
DiOH-CBZ 0.010% (1) 0.014 ± 0.01% (3) 0.009% (1) 
 
 
 
Figure 5.4. Structure of the antihistaminic pharmaceutical cetirizine. 
 
The affinity of the monoclonal antibody towards cetirizine is highly dependent on the pH 
during the interaction step. This pH dependence is clearly demonstrated in Figure 5.5, where 
carbamazepine and cetirizine calibration curves at a) pH 4.5, b) pH 7.6 and c) pH 10.5 are 
presented. The affinity of the antibody towards cetirizine greatly increased from high to low pH, 
with experimental molar cross-reactivities of 15, 153 and 340% at pH 10.5, 7.6 and 4.5, 
respectively. These results highlight that carbamazepine concentrations determined at a given pH 
might be significantly overestimated by the presence of cetirizine in the samples. However, and 
interestingly, this brings the possibility of the simultaneous determination of cetirizine and 
carbamazepine with the same ELISA methodology (see Section 5.3.5). To better clarify this matter, 
all the collected samples were analyzed at pH 4.5 and 10.5. This preliminary study showed that the 
observed concentrations of carbamazepine at pH 4.5 were up to 180% higher than the ones 
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determined at pH 10.5. This observation pointed out to the presence of cetirizine in the samples and 
was crucial to choose the optimal pH conditions for the quantification of carbamazepine in 
environmental samples with minor influence of cetirizine. 
 
 
Figure 5.5. ELISA calibration curves for carbamazepine (in blue) and cetirizine dihydrochloride (in red) at 
a) pH 4.5, b) pH 7.6 and c) 10.5, 3 replicates per calibrator; error bars correspond to standard deviation. 
 
 
5.3.2 Salinity and dissolved organic matter effects  
 
Matrix effects are a major issue on the analysis of environmental samples, due to their 
common high complexity. In the present study, the chemical characteristics of ground, surface and 
wastewaters vastly differ; the presence of sodium chloride and dissolved organic matter were 
selected as the most relevant interferences to take into consideration. 
 Surface water samples collected from the Aveiro Lagoon (Ria de Aveiro) have sodium 
chloride concentrations up to 30.0 g L-1. To level out the high concentration of salt, sample buffers 
(1 M glycine, pH 10.5 or 1 M TRIS, pH 7.6) with 3 M of sodium chloride and 2% EDTA (w/v) 
were tested and the effect of high sodium chloride concentrations in the sample was assessed 
(Figure 5.6). The sample buffer at pH 7.6 successfully eliminated possible matrix effects caused by 
sodium chloride. In the case of the sample buffer with pH 10.5, the observed ELISA signal slightly 
decreased with the increase of the sodium chloride concentration. This shift seems to be more 
significant for carbamazepine concentrations below 0.1 μg L-1. Overall, sample buffer at pH 7.6 is 
more effective in the decrease of salinity related matrix effects; however, both sample buffers 
proved to give satisfactory results for carbamazepine concentrations in a broad range around the 
test midpoint. 
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Figure 5.6. Evaluation of salinity effects on the ELISA calibration curves, at pH a) 7.6 and b) 10.5. 
Carbamazepine calibrators in the absence of sodium chloride and in the presence of 1.0, 10.0 and 30.0 g L-1 
of sodium chloride are represented in green, orange, blue and dark blue, respectively. 
 
 To evaluate the effect of dissolved organic matter on the performance of the assay, 
calibrators containing 0.1, 1.0 and 10.0 mg L-1 of commercial humic acids were assayed and 
compared with calibration curves obtained without humic acids. BSA (bovine serum albumin) is a 
potential agent to bind organic matter (Kalman and Turner, 2007) and thus it was tested if its 
addition led to any beneficial effect on the assay’s performance. The obtained results are shown in 
Figure 5.7. Only for the highest concentrations of humic acids there was a slight decrease of the 
observed optical density. This effect was only noticeable at carbamazepine concentrations below 
0.1 μg L-1. The presence of BSA did not contribute to a noteworthy decrease of the matrix effects. 
On the contrary, the addition of BSA increased the observed test midpoint and thus decreased the 
sensitivity of the test. Furthermore, it was difficult to pipet BSA solutions of the indicated 
concentration due to the formation of air bubbles. Taking these facts into account, the usage of 
BSA in the analysis of environmental samples was not considered.  
 Relative to organic matter effects, it is important to underline that these experiments only 
gave a first indication on the performance of the assay under the chosen conditions. The obtained 
results might not be representative for the effect of dissolved organic matter in real samples, which 
are expected to have a more complex composition than the commercial humic acids tested. Hence, 
wastewater samples with the highest concentration of organic matter were selected and spiked with 
0.5, 1.0 and 1.5 μg L-1 of carbamazepine. A graphical representation of the carbamazepine 
concentration in spiked samples, determined by ELISA, as a function of the spiking level is shown 
in Figure 5.8. The obtained linear regressions have correlation coefficients (r) of 0.990 and 1.000 
and slopes of 0.81 for wastewaters after biological treatment collected at North and South WWTPs, 
respectively. Correlation coefficients and slopes close to 1 should be indicative that no significant 
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organic matter interferences are taking place as these interferences are usually non-linear and 
concentration dependent. Very good correlation coefficients were obtained, indicating a linear 
behavior. The slope values do not reflect an optimal case; however, they are consistent with 
average recoveries between 86 ± 13% and 97 ± 11%, which were considered satisfactory. 
Interestingly, the carbamazepine concentration in the samples before spiking, given by the y-
intercept (0.61 ± 0.08 and 0.58 ± 0.01), is similar for the two different WWTPs. Note that, taking 
into account the complexity of the tested samples, these results should represent the worst case 
scenario of organic matter influences in the analyzed samples. 
 
 
Figure 5.7. Evaluation of organic matter effects a) in the absence and b) in the presence of BSA, on the 
ELISA calibration curves, at pH 10.5. Carbamazepine calibrators in the absence of humic acids and in the 
presence of 0.1, 1.0 and 10.0 mg L-1 of humic acids, are represented in green, orange, blue and dark blue, 
respectively. 
 
 
 
Figure 5.8. Carbamazepine concentrations determined by ELISA after spiking wastewater samples with 3 
different concentrations of carbamazepine. a) and b) display results obtained with samples after biological 
treatment collected at North and South WWTPs, respectively. 
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5.3.3 Selection of the optimal ELISA conditions 
 
The evaluation of different sample buffers in the assay´s performance allows choosing the 
optimal experimental conditions, considering the effects of dissolved organic matter, salinity and 
also cetirizine cross-reactivity. Table 5.2 presents a summary of the main aspects to take into 
account. Note that at pH 4.5, the antibody has more affinity for cetirizine than for carbamazepine 
and, for this reason, no matrix effects tests were performed under these conditions, as it was not  
considered to be the optimal pH value. In general, pH 7.6 yielded better results with lower turning 
points (thus, higher sensitivity), higher signal and also very good response to salinity and organic 
matter influences. However, at this pH, cross-reactivity with cetirizine is a major problem: the 
assay has roughly the same affinity towards both carbamazepine and cetirizine. In the light of the 
preliminary conclusions taken in section 5.3.1, where it was demonstrated that samples might be 
contaminated with cetirizine due to a systematic and significant difference on the results obtained 
at different pH, the sample buffer with pH 10.5 was selected as the optimal condition. At this pH, 
cross-reactivity with cetirizine is minimal and the results obtained for the matrix tests are still 
reasonable.  
 
Table 5.2. Comparison of some characteristics of the carbamazepine ELISA at pH 7.6 and 10.5. 
 pH 7.6 – TRIS buffer pH 10.5 – Glycine buffer 
Turning point Low High 
Colorimetric signal High Low 
Salinity effects No significant effects up to 30 g L-1 
of  NaCl 
Effects for [CBZ] < 0.1 µg L-1 might 
be significant 
Organic matter effects Satisfactory recoveries in the 
working range 
Satisfactory recoveries in the working 
range 
Cetirizine cross-reactivity High Low 
 
 
5.3.4 Performance of the ELISA methodology at pH 10.5 
 
 An ELISA dose-response calibration curve and respective precision profile, at pH 10.5, are 
presented in Figure 5.9. In order to adequately define the quantitation/working range of the assay, 
16 calibrators were assayed (6 replicates per calibrator). Considering a maximum allowable relative 
error of carbamazepine concentration of 30%, a quantitation range from 0.03 to 10 μg L-1 was 
determined. This quantitation range was defined not considering matrix effects. As stated before, 
salinity and organic matter might affect the test for carbamazepine concentrations below 0.1 μg L-1. 
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This could imply a narrower quantitation range in case of samples with complex matrices, leading 
to the conclusion that the precision of the method not only depends on the carbamazepine 
concentration but also on the complexity of the sample. 
 
 
 
Figure 5.9. Calibration curve of ELISA (red circles) (r2 = 0.999) and precision profile (open circles). The 
precision profile and determination of the relative error of concentration were calculated in accordance with 
Ekins (1981). A working range was defined between 0.03 and 10 μg L-1, considering a maximum allowable 
relative error of concentration of 30%. All data obtained at pH 10.5. 
 
 
5.3.5 Simultaneous determination of carbamazepine and cetirizine 
 
As concluded before, the collected samples might also contain cetirizine. Depending on the 
pH value, the determination of carbamazepine by ELISA can be affected by a positive bias and 
hence, the relevance of this systematic error will depend on the concentration of the cross-reactant. 
At pH 10.5, with a molar cross-reactivity of 15%, this bias is not expected to be significant. 
However, it is interesting to consider that the analysis of samples at two different pH values allows 
taking into account the contribution of cetirizine to the total concentration of carbamazepine 
recognized by the assay. Therefore, this data can be considered as data from two immunoassays of 
different selectivity for a two-parameter set which enables the quantification of both carbamazepine 
and cetirizine in the samples. The approach here described is similar to the one applied by 
Schneider et al. (1992) for the quantification of two triazine herbicides using immunoassays of 
different selectivity. Quantification of carbamazepine and cetirizine in the samples was done by 
solving the following equations (equations 5.7 and 5.8): 
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CTotal, pH4.5= CCBZ + CRpH4.5 × CCetirizine      (5.7) 
 CTotal, pH10.5= CCBZ + CRpH10.5 × CCetirizine     (5.8) 
 
where CCBZ and CCetirizine are the concentrations of carbamazepine and cetirizine in the samples, 
respectively; CRpH4.5 and CRpH10.5 are the cross-reactivities at pH 4.5 and 10.5, respectively and 
CTotal, pH4.5 and CTotal, pH10.5 are the total concentrations resulting from the assay, determined with the 
carbamazepine calibration curves, at pH 4.5 and pH 10.5, respectively. 
 In order to validate the proposed approach, contaminated surface water samples were 
spiked with 0.05 to 1.0 μg L-1 of carbamazepine, cetirizine or both and were analyzed at pH 4.5 and 
10.5, by ELISA. Subsequently, equations 3 and 4 were applied to the raw experimental data to 
calculate carbamazepine and cetirizine concentrations. Results are presented in Table 5.3.  
 
 
Table 5.3. ELISA response at pH 4.5 and 10.5 (± standard deviation, 3 replicates) and carbamazepine (CBZ) 
and cetirizine (CTRZ) extrapolated concentrations (using equations 3 and 4) for a surface water sample 
spiked with carbamazepine, cetirizine or both. Specific (mass-related) cross-reactivities of 298 and 14%, at 
pH 4.5 and 10.5, respectively, were used in the calculation. Mean recoveries, in percentage, are also shown. 
Spiked concentration/ 
(μg L-1) 
ELISA response/  
(μg L-1), n=3 
Extrapolated concentrations/ 
(μg L-1) Recoveries % 
CBZ CTRZ pH 4.5 pH 10.5 CBZ CTRZ CBZ CTRZ 
- - 0.41 ± 0.05 0.29 ± 0.04 0.29 0.041 - - 
0.059 - 0.44 ± 0.07 0.34 ± 0.02 0.34 0.032 98 - 
0.118 - 0.54 ± 0.02 0.41 ± 0.04 0.40 0.048 99 - 
0.297 - 0.72 ± 0.03 0.63 ± 0.05 0.63 0.032 107 - 
0.593 - 1.05 ± 0.03 0.91 ± 0.01 0.90 0.049 103 - 
1.180 - 1.7 ± 0.1 1.46 ± 0.04 1.4 0.071 99 - 
- 0.054 0.57 ± 0.06 0.30 ± 0.02 0.29 0.095 - 100 
- 0.108 0.7 ± 0.1 0.32 ± 0.03 0.30 0.14 - 95 
- 0.272 1.1 ± 0.2 0.35 ± 0.06 0.31 0.28 - 89 
- 0.543 2.0 ± 0.2  0.38 ± 0.03 0.30 0.56 - 96 
- 1.080 4.0 ± 0.4 0.43 ± 0.01 0.26 1.2 - 111 
0.059 0.054 0.64 ± 0.06  0.36 ± 0.03 0.35 0.10 101 104 
0.118 0.108 0.79 ± 0.02 0.43 ± 0.02 0.41 0.13 101 87 
0.297 0.272 1.45 ± 0.02 0.65 ± 0.01 0.61 0.28 104 90 
0.593 0.543 2.6 ± 0.2 0.97 ± 0.06 0.90 0.58 102 99 
1.180 1.080 5.0 ± 0.6 1.6 ± 0.2 1.4 1.2 98 106 
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The calculated concentrations are consistent with average recoveries between 98 and 107% 
for carbamazepine and 87 and 111% for cetirizine. Also, a linear regression analysis of the analyte 
concentration in the spiked samples as a function of the spiking level enabled to conclude that a 
satisfactory linear behavior is obtained in all cases, with correlation coefficients ranging from 0.997 
to 0.999 and slopes from 0.98 to 1.10. No significant differences were found in the linear response 
of the analyte concentration between samples spiked only with carbamazepine, only with cetirizine 
or both. These experiments allowed proving the reliability of the described approach to calculate 
the contribution of cetirizine in the ELISA response. 
 
                                                                                                                                                                                                                                                                                                                                                                  
5.3.6 Quantification of carbamazepine in ground, surface and 
wastewaters by ELISA 
 
The results of the analyses of environmental samples by ELISA, where carbamazepine was 
detected, are presented in Table 5.4 (raw data at pH 4.5 and 10.5 and extrapolated concentrations). 
The obtained results indicate that all the samples collected in WWTPs are contaminated with 
carbamazepine concentrations between 0.5 and 0.7 μg L-1 with relative standard deviations ranging 
from 11 to 19%. Carbamazepine concentrations did not decrease from stage to stage, indicating that 
the applied treatments (primary decantation, biological treatment and secondary decantation) are 
not efficient in the removal of this pharmaceutical. On the contrary, a possible increase of the 
carbamazepine concentration can be stated, especially in the South WWTP, which is fully 
compatible with previous studies indicating the possibility of deconjugation reactions in the 
sewage, causing an increase of the concentration of the deconjugated pharmaceutical (see chapter 
2). Cetirizine was also found in all the samples from WWTPs with concentrations between 0.31 ± 
0.04 and 0.60 ± 0.06 μg L-1 in the North WWTP and between 0.23 ± 0.04 and 0.38 ± 0.07 μg L-1 in 
the South WWTP. In opposition to carbamazepine, the concentration of cetirizine clearly decreases 
during the wastewater treatment process, specifically after undergoing biological treatment.  
The presence of cetirizine shows that it may be necessary to perform the ELISA test at two 
pH values to be able to present more accurate carbamazepine concentrations. However, note that 
ELISA results at pH 10.5, presented in Tables 5.3 and 5.4, do not significantly differ from the 
carbamazepine concentrations obtained after accounting for the presence of cetirizine and, thus, in 
this case, the analysis at a single pH (10.5) gives accurate results. This is valid due to low cross-
reactivity at pH 10.5 and as long as the concentration of cetirizine does not significantly exceed the 
concentration of carbamazepine. The information about the approximate ratio of these 
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pharmaceuticals in the samples becomes vital when large number of samples of unscreened areas 
need to be processed. It is important to highlight that performing the assay at two pH values 
doubles the work necessary but, on the other hand, also doubles the obtained data about the 
samples, as it enables the quantification of cetirizine. 
 
Table 5.4. Carbamazepine (CBZ) and cetirizine (CTRZ) concentrations (± standard deviation) determined by 
ELISA (3 replicates) and LC-MS/MS (2 replicates) (only for carbamazepine). Raw data obtained at pH 4.5 
and 10.5 are also shown. Samples were analyzed by both methodologies without any sample pretreatment. 
Omitted samples (7 ground and 10 surface waters) did not present detectable carbamazepine concentrations. 
Sampling site names are in accordance with designations presented in Figure 5.3. 
Sampling site* 
ELISA/ (μg L-1) LC-MS/MS/ (μg L-1) 
Response at  
pH 4.5 
Response at  
pH 10.5 
[CBZ]  
(corrected) 
[CTRZ] 
(corrected) 
[CBZ] 
SWW1 1.3 ± 0.1 0.5 ± 0.1 0.48 ± 0.07 0.38 ± 0.07 0.44 ± 0.01 
SWW2 1.13 ± 0.09 0.6 ± 0.1 0.58 ± 0.08 0.24 ± 0.02 0.49 ± 0.01 
SWW3 1.1 ± 0.2 0.6 ± 0.1 0.57 ± 0.06 0.23 ± 0.04 0.50 ± 0.01 
NWW1 2.0 ± 0.2 0.7 ± 0.1 0.65 ± 0.08 0.60 ± 0.06 0.50 ± 0.01 
NWW2 1.3 ± 0.1 0.6 ± 0.1 0.56 ± 0.08 0.31 ± 0.04 0.55 ± 0.02 
NWW3 1.3 ± 0.1 0.6 ± 0.1 0.60 ± 0.07 0.31 ± 0.03 0.54 ± 0.01 
S11 0.19 ± 0.05 0.11 ± 0.02 0.11 ± 0.02 0.04 ± 0.01 0.15 ± 0.01 
*Sample description: SWW1 - South WWTP after primary treatment; SWW2 - South WWTP after biological 
treatment; SWW3 - South WWTP, final effluent; NWW1 - North WWTP after primary treatment; NWW2 - 
North WWTP after biological treatment; NWW3 - North WWTP, final effluent; S11 - Surface water of Ria 
de Aveiro, collected in a coastal touristic area. 
 
 Considering surface water samples, only 1 of the 11 sampling points is contaminated with 
0.11 ± 0.02 μg L-1 of carbamazepine. The other surface waters as well as ground water samples did 
not have detectable levels of carbamazepine or cetirizine. Assuming that carbamazepine is, in fact, 
an adequate anthropogenic pollution marker, these results give a first indication that the coastal 
lagoon of Ria de Aveiro is not considerably polluted by domestic wastewaters. 
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5.3.7 Comparison between ELISA and LC-MS/MS 
 
In order to validate results obtained by ELISA, samples were analyzed by LC-MS/MS. 
Samples were directly injected after filtration and addition of internal standard, as it was previously 
demonstrated that these procedures effectively compensate matrix effects (Bahlmann et al., 2009). 
Linear regression and correlation coefficient of the LC-MS/MS are presented in Table 5.5. LC-
MS/MS results are presented in Table 5.4. Carbamazepine concentrations determined by ELISA 
are, in general, 2 to 28% higher than the LC-MS/MS results. This overestimation is presumably 
caused by the mix contribution of minor matrix effects and the presence of other cross-reactants 
such as epoxy-carbamazepine or 2-hydroxy-carbamazepine. Some relevant metabolites of 
carbamazepine were also simultaneously determined by LC-MS/MS and results are shown in Table 
5.6. Di-OH-carbamazepine is the metabolite with the highest concentration but it is also the 
metabolite with the lowest cross-reactivity (Table 5.1). The metabolites with the highest cross-
reactivity are epoxy-carbamazepine and 2-OH-carbamazepine and were positively identified in the 
samples with concentrations around 0.05 and 0.1 µg L-1, respectively. 
The determination of the cetirizine concentration in the samples appeared as a consequence 
of the ELISA methodology and the results were not validated by LC-MS/MS. Although not 
quantified, the presence of cetirizine in the samples was positively identified by the LC-MS/MS 
chromatograms. 
 
Table 5.5. Linear regression equation and correlation coefficients (r) of the LC-MS/MS methodology for 
carbamazepine (CBZ) and some metabolites.  
 Linear regression equation r 
CBZ y = (7.31 ± 0.01) x + 0.045 ± 0.005 1.000 
 Epoxy-CBZ y = (1.540 ± 0.006) x - 0.003 ± 0.002 0.9999 
2-OH-CBZ y = (3.14 ± 0.02) x - 0.007 ± 0.006 0.9999 
3-OH-CBZ y = (4.44 ± 0.03) x - 0.01 ± 0.01 0.9999 
10-OH-CBZ y = (2.18 ± 0.02) x - 0.007 ± 0.007 0.9998 
DiOH-CBZ y = (0.270 ± 0.003) x - 0.001 ± 0.001 0.9997 
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Table 5.6. Concentration (µg L-1 ± standard deviation) of the main carbamazepine metabolites determined by 
LC-MS/MS (2 replicates). Sampling site names are in accordance with designations presented in Figure 5.3. 
Sampling site Epoxy-CBZ 2-OH-CBZ 3-OH-CBZ 10-OH-CBZ DiOH-CBZ 
SWW1 0.054 ± 0.005 0.081 ± 0.004 0.089 ± 0.001 0.191 ± 0.002 1.6 ± 0.1 
SWW2 0.05 ± 0.01 0.10 ± 0.01 0.089 ± 0.007 0.211 ± 0.003 1.78 ± 0.05 
SWW3 0.056 ± 0.001 0.10 ± 0.01 0.08 ± 0.01 0.226 ± 0.004 1.74 ± 0.05 
NWW1 - 0.10 ± 0.01 0.09 ± 0.02 0.34 ± 0.02 2.1 ± 0.2 
NWW2 0.042 ± 0.007 0.106 ± 0.009 0.106 ± 0.003 0.301 ± 0.007 2.2 ± 0.2 
NWW3 0.044 ± 0.002 0.096 ± 0.005 0.11 ± 0.01 0.31 ± 0.02 2.27 ± 0.01 
S11 - - - - - 
 
  In general, results obtained by ELISA were considered highly satisfactory. As stated 
before, running the ELISA test at two different pH values doubles the effort and decreases the time 
efficiency of this methodology. However, even in this worst-case scenario, the proposed 
methodology presents some interesting advantages when compared to LC-MS/MS. This 
methodology is much cheaper concerning costs involved in equipment and maintenance. Moreover, 
it is still feasible to analyze dozens of samples in a few hours, allowing to perform large 
environmental screenings. ELISA and LC-MS/MS should be considered as two complementary 
techniques, with different applicability and purposes. Combining both methods, when large 
amounts of samples need to be processed, enables, in a first step, to carry out large screenings to 
identify contaminated areas by ELISA followed by reanalysis of specific samples or questionable 
results by LC-MS/MS. It is not reasonable to consider LC-MS/MS as an adequate approach to large 
preliminary screenings as well as ELISA might not be the most adequate technique to use in 
situations that demand extremely accurate analysis. 
 
 
 
 
 
 
 
 
 
 
Quantification of carbamazepine in the environment by ELISA | Chapter 5 
 
163 
 
5.4 CONCLUSIONS 
 
In this study, a previously developed immunochemical method was applied to the 
quantification of carbamazepine in aqueous environmental samples.  
The assay has proven to be adequate for the analysis of complex matrix samples, namely 
with high concentrations of dissolved organic matter and sodium chloride. The implementation of 
this methodology revealed that samples as complex as wastewaters (even at the initial stage of the 
treatment process) can be analyzed without any further sample cleanup, except from a filtration 
step. The optimal conditions of the assay were chosen taking into consideration the pH dependent 
cross-reactivity to the pharmaceutical cetirizine, which was found to be present in surface and 
wastewaters contaminated with carbamazepine, in the Portuguese region studied. To overcome this 
problem, it is possible to perform the assay at pH 10.5 (conditions at which the cross-reactivity is 
minimal) or to perform the assay at two pH values allowing to correct the carbamazepine 
concentrations and to determine cetirizine in the samples, too. 
Validation with LC-MS/MS showed that ELISA results were 2 to 28% overestimated. The 
obtained results highlight that the developed methodology is adequate to perform large 
environmental screenings in samples with distinct matrices, being a valid alternative and/or 
complementary methodology to the reference chromatographic techniques, in the context of high-
throughput analysis. 
  Relative to the carbamazepine concentrations found, the results are in accordance with 
available literature data from other countries: carbamazepine is not effectively removed during 
wastewater treatments. In the particular case of the studied WWTPs, the final effluent showed 
carbamazepine concentrations around 0.6 μg L-1. Also, it is possible to conclude that no significant 
differences were found in the concentration of carbamazepine of samples collected at different 
phases of the treatment, reinforcing the established inadequacy and quasi-total inefficiency of these 
removal stages with respect to this pharmaceutical. From 6 ground water and 11 surface water 
samples, only 1 surface water was contaminated with carbamazepine which demonstrates that the 
lagoon of Ria de Aveiro is not facing serious issues of contamination with domestic wastewaters. 
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CHAPTER 6 
Adsorption of carbamazepine onto agricultural soils 
 
 
 
In this chapter, the sorption behavior of carbamazepine onto agricultural soils was studied. 
For this purpose, batch equilibrium experiments were performed using soils subjected to distinct 
long-term fertilizations. The adsorption experiments were followed by UV spectral deconvolution 
and the results compared with those from micellar electrokinetic chromatography. It was possible 
to conclude that results obtained by both methods did not present significant statistical differences 
at 95% confidence level, proving that, in this context, UV spectral deconvolution is a simple and 
fast procedure adequate to follow sorption experiments. The adsorption of carbamazepine onto the 
selected soils was satisfactorily described by the Freundlich equation; the Freundlich adsorption 
coefficients (KF) (between 2.1 ± 0.2 and 5.0 ± 0.3 mg1-N LN Kg-1) indicate that the adsorption 
behavior of carbamazepine is dependent on the soil fertilization. Also, this anti-epileptic 
pharmaceutical is not extensively adsorbed and thus, a significant percentage of carbamazepine 
appears to remain in the aqueous phase. Moreover, it is expectable that contaminated soils 
constitute a potential source of contamination for surface and ground waters through run-off and 
infiltration.  
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6.1 CONTEXTUALIZATION 
 
 The study of the sorption behavior of pharmaceuticals is of great relevance to understand 
the fate of these compounds in the water/soil (or sediment) interface and constitute an 
indispensable element to evaluate their real environmental impact. 
In this chapter, the adsorption of carbamazepine onto agricultural soils subjected to long-
term fertilization experiments was studied. This research aims to evaluate the effects of distinct soil 
amendments (and, thus, different soil organic matter contents and characteristics) on the adsorption 
of carbamazepine and to assess if carbamazepine contaminated soils constitute a potential source of 
contamination of adjacent waters. Additionally, the results presented in this chapter also aim at 
assessing the adequacy of a simple and fast UV spectral deconvolution (UVSD) method to follow 
sorption experiments. The validation of the proposed methodology was done by micellar 
electrokinetic chromatography (MEKC), used as reference technique. A brief introduction to the 
main concepts involved in this study is presented below. 
 
6.1.1 The environmental relevance of sorption studies 
 
The literature review previously presented highlighted that WWTPs are the main vehicle 
for the introduction of pharmaceuticals in the environment through the discharge of contaminated 
effluents. However, and apart from discharge in surface waters, WWTPs effluents are frequently 
used for irrigation of agricultural fields, especially in arid or semiarid areas where they are 
considered an important water resource (Pedersen et al., 2005; Williams et al., 2006; Glassmeyer et 
al., 2008; Gielen et al., 2009). Additionally, the sludge produced in WWTPs is also commonly 
applied in agricultural fields as a soil amendment, taking advantage of its organic matter rich 
matrix to improve soil properties (Carmosini and Lee, 2008; Wu et al., 2010). This reuse of the 
effluents and sludge reduces the demand for water and fertilizer resources which is particularly 
relevant in the case of irrigation waters that account for roughly 65% of the total water needs 
worldwide (Levine and Asano, 2004). Despite the referred benefits, these practices constitute the 
most important pathways for the introduction of pharmaceuticals into soils which might then 
contribute to the contamination of surface and ground waters through run-off, leaching and 
overland flow (Pedersen et al., 2005; Wu et al., 2010).  
The study of the sorption behavior of pharmaceuticals that are frequently found in WWTPs 
effluents and sludge is essential for the understanding of their mobility between different 
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environmental compartments and, consequently, the main degradation processes that will affect 
their persistence in such compartments. In the specific case of carbamazepine, a potential 
anthropogenic pollution indicator, sorption studies are even more relevant. Pharmaceuticals with 
high adsorption affinity cannot be considered adequate anthropogenic pollution indicators due to 
their high preference to adsorb onto the solid matrix. Therefore, low to medium adsorption 
affinities are a pre-requisite for a pharmaceutical to be considered a marker of anthropogenic 
pollution in aqueous environments. 
 
6.1.2 Sorption experiments and isotherms 
 
Sorption studies are usually performed using batch or column displacement methods 
(Limousin et al., 2007; Carmosini and Lee, 2008). Column displacement methods involve the 
evaluation, over time, of the movement of a pollutant through a soil column and the outflow 
concentration of the pollutant versus time is analyzed (Carmosini and Lee, 2008). These methods 
were not used in the sorption experiments hereby described and are, thus, out of the scope of this 
contextualization. On the other hand, batch experiments, applied in this study, consist on shaking 
the soil/sediment with a solution containing the pollutant of interest until the adsorption/desorption 
equilibrium is reached. The equilibrium concentration of the pollutant in the aqueous/solid phases 
is then measured (Limousin et al., 2007). Using this approach, multiple concentrations of the 
pollutant are tested using a defined amount of solid phase. The soil/sediment mass to solution 
volume ratio should be chosen so that 40-60% of sorption is attained at the end of the experiment. 
The sorption data are then analyzed by plotting the concentration of pollutant in the solid phase 
against the concentration which remained in solution, and a sorption isotherm, which characterizes 
the sorption affinity of the analyte, is obtained (Carmosini and Lee, 2008). 
In the literature, sorption isotherms are most commonly described by one of the following 
models (Carmosini and Lee, 2008): 
a) Linear model: Qe = Kd × Ce    (6.1) 
 
where Kd is the linear distribution coefficient (L Kg-1), Qe and Ce are the analyte concentration in 
the solid phase (mg Kg-1 or mol Kg-1) and in the aqueous phase (mg L-1 or mol L-1), respectively.   
b) Freundlich model: Qe = KF × CeN     (6.2) 
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where KF is the Freundlich sorption coefficient (mg1-N LN Kg-1 or mol1-N LN Kg-1) and N defines the 
isotherm non-linearity (dimensionless). Note that when N equals 1, this equation is equivalent to 
the linear model of equation 6.1. 
c) Langmuir model: Qe = Qe,max × KL × Ce1 + KL × Ce     (6.3) 
 
where KL is the Langmuir affinity coefficient (L mg-1 or L mol-1) and Qe,max defines the maximum 
adsorption capacity (mg Kg-1 or mol Kg-1). 
The linear model describes a sorption behavior in which the ratio between the 
concentration of the analyte in the aqueous and solid phases is constant at any concentration level. 
Conversely, the non-linear models describe isotherms characterized by a decrease of the ratio 
between solid and aqueous phase concentrations with the increase of the analyte concentration. The 
presented non-linear models fit two distinct situations: (a) the curve reaches a plateau, indicating 
that the soil/sediment achieved saturation, and a maximum adsorption capacity is defined – 
Langmuir equation and (b) a plateau is never achieved and, accordingly, the solid phase does not 
clearly exhibits a limited sorption capacity (Aboul-Kassim and Simoneit, 2001; Limousin et al., 
2007). On the whole, for all these models, the relation between Qe and Ce established by the 
isotherm implies that the adsorption/desorption processes have reached an equilibrium and that all 
the physico-chemical parameters of the system are constant (Limousin et al., 2007). 
 The comparison between sorption coefficients obtained by different studies or with 
different soils must be carefully interpreted. For instance, when comparing sorption coefficients 
determined for different soils and the isotherms have different linearity, a concentration specific 
distribution coefficient (Kd*) - at a chosen concentration within the experimental range tested - 
should be determined from the non-linear coefficients. Kd* is then independent of the linearity of 
the isotherm; this parameter can be determined using the following equation (Carmosini and Lee, 
2008): Kd∗ = KF × CeN−1    (6.4) 
 
Moreover, when comparing results from different soils/sediments, their organic matter content 
should be taken into account, as it influences the sorption process, especially in the case of highly 
hydrophobic analytes. Sorption coefficients independent of the organic carbon content can be 
obtained by determining the ratio between the sorption coefficient and the percentage of the total 
organic carbon of the solid phase (Aboul-Kassim and Simoneit, 2001).  
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6.1.3 UV spectral deconvolution 
 
The use of techniques such as HPLC and capillary electrophoresis to follow sorption 
studies implies, in most cases, performing complex sample preparation protocols and/or time 
consuming analysis. The high number of samples that result from batch experiments demands the 
application of less expensive and more time efficient procedures. In this context, an UVSD method 
was proposed as a simple and fast alternative to follow sorption experiments. 
UVSD was applied for the first time to environmental related analysis in 1993 by Thomas 
et al. (1993) and since then several other studies have been published (Escalas et al., 2003; 
Coulomb et al., 2006; Hassouna et al., 2007; Kibbey et al., 2009; Lima et al., 2010). The principle 
of UVSD is based on the assumption that the total absorbance spectrum of a mixture can be 
decomposed in a few reference spectra; on other words, the spectrum of a mixture can be 
considered as a linear combination of the spectra of its individual components (Thomas et al., 
1993). Hence, this approach allows the quantification of the components of a mixture without the 
need to perform their physical separation. However, this is only feasible if all the components of 
the mixture are known and if it is possible to obtain a UV spectrum of each of them individually.  
Considering the UV spectra of the individual components of a mixture (referred to as 
references), the quantification of a given analyte in the solution is then possible by determining its 
coefficient in the linear combination, by means of the following equation: 
SOD = � ai × REFi(pi=1 λ) ± r   (6.5) 
 
where SOD is the sample optical density, p is the number of the reference spectra, ai is the 
coefficient of the ith reference spectrum in the linear combination, REFi (λ) is the absorbance of the 
ith reference spectrum at the wavelength λ and r is the error at each wavelength (Hassouna et al., 
2007; Nam et al., 2008; Lima et al., 2010). 
 The implementation of this principle in sorption experiments allows a huge increase of the 
time efficiency of the whole procedure. In this study, the validity of the UVSD results will be 
assessed by MEKC analysis.  
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6.2 MATERIALS AND METHODS 
 
6.2.1 Chemicals and Instrumentation 
 
All chemicals used were of analytical grade: carbamazepine (99%, Sigma), sodium 
dodecylsulphate (99%, for electrophoresis, Sigma-Aldrich), hexadimethrine bromide (polybrene, 
Sigma-Aldrich), sodium chloride, ethylvanillin (99%, Aldrich), sodium tetraborate (Riedel-de 
Haën), acetonitrile (HPLC gradient grade, VWR, Prolabo) and methanol (HPLC grade). All the 
solutions (buffers and standard solutions) were prepared in ultra-pure water, obtained using a Milli-
Q Millipore system (Milli-Q plus 185).  
 The capillary electrophoresis analyses were performed using a commercial instrument 
(Beckman P/ACE MDQ (Fullerton, CA, USA)), equipped with a UV-Vis photodiode array 
detection system. UV spectra were obtained using a UV-Vis Shimadzu spectrophotometer. 
Adsorption experiment samples were shaken using an overhead shaker (Heidolph, Reax 2) at 50 
rpm. Samples were centrifuged using a Selecta centrifuge (Mixtasel, Model 540) at 4 000 rpm. 
 
6.2.2 Soil Samples 
 
The soil samples (0 – 30 cm) were collected from agricultural fields subjected to a long-
term experiment (since 1962) at the experimental farm of INRES – Institute of Plant Nutrition, 
University of Bonn, Germany. The soils studied in this investigation were subjected to different 
fertilizations: MIN (mineral fertilization), SLU (sewage sludge from a WWTP) and COM (compost 
from organic household waste) and were characterized in a previous study (Lima et al., 2009). 
Total organic matter (TOM) contents were determined by loss on ignition of portions of the soil at 
550 ºC for 4 h, and total organic carbon (TOC) contents were determined by means of dry 
combustion - results shown in Table 6.1 (Lima et al., 2009). Prior to sorption studies, the soils were 
air dried and passed through a sieve with mesh size of 2 mm. 
 
Table 6.1. Total organic matter (TOM) and total organic carbon (TOC), in percentage, of the studied soils, as 
presented in Lima et al. (2009). 
 TOM %, (n=3) TOC % 
MIN 5.3 ± 0.3 1.24 
SLU 6.2 ± 0.3 1.98 
COM 9.4 ± 1.0 2.76 
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6.2.3 MEKC analysis 
 
The MEKC methodology, used as reference to validate UVSD results, was adapted from 
the work presented in chapter 3.  
 
6.2.3.1 Capillary column conditioning and coating  
 
Briefly, a fused-silica capillary with a total length of 50 cm (40 cm to detector) and 75 μm 
of internal diameter was used. Approximately 1 mm of the capillary external coating was removed 
by burning the extremities prior to conditioning; the capillary extremities were then polished to 
decrease the baseline noise. New capillaries were conditioned with 1 M NaOH for 30 min followed 
by ultra-pure water for 15 min. Subsequently, the capillary was coated with hexadimethrine 
bromide (polybrene) 0.5% (w/v) in 0.5 M NaCl, by flushing it for 20 min. Finally, the capillary was 
washed with ultra-pure water for 2 min followed by running buffer for 20 min. The running buffer 
consisted on 25 mM borax and 50 mM SDS, pH 9.2, freshly prepared every 2 days and stored at    
4 ºC. 
 
6.2.3.2 Separation conditions 
 
Samples and standard solutions were injected for 4 s at 0.5 psi. Electrophoretic separations 
were performed in direct polarity with a positive potential supply of 20 kV for 13 min. The 
temperature of the capillary was maintained at 25 ºC. Detection of carbamazepine was monitored at 
210 nm. Running buffer vials were changed every 6 runs. 
 
6.2.3.3 Analysis of standard solutions and samples 
 
A stock solution of ethylvanillin was used as internal standard (IS). This solution was 
prepared by dissolving ethylvanillin in acetonitrile (approximately 10% of the final volume) and 
further diluting it with ultra-pure water to a final concentration of 167 mg L-1. IS was added to 
standard solutions and samples to a final concentration of 3.34 mg L-1. The MEKC calibration 
curve was obtained by analyzing seven standard solutions of carbamazepine in quadruplicate, with 
concentrations ranging from 0.50 to 10.00 mg L-1.  
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6.2.4 UVSD analysis 
 
UVSD was performed using Microsoft Excel®. The output data consisted on the coefficient 
of each component in the linear combination (carbamazepine, organic matter and background), 
statistical parameters involving the determination of the coefficients and deconvolution residuals. 
Firstly, the UV spectra of the reference solutions (containing each sample component 
separately) were obtained. Reference solutions consisted on (1) CaCl2 0.005 M, (2) a 
carbamazepine standard solution 2.00 mg L-1 in CaCl2 and (3) raw extract of the soil organic 
matter. The organic matter raw extract was obtained by shaking tubes containing the soil under 
study and a CaCl2 solution 0.01 M (ratio 1:2 (w/v)) during 4 h at 24 ± 1 ºC. The tubes were 
centrifuged and the supernatant filtered and diluted by a factor of 2 to avoid matrix effects on the 
UVSD analysis due to high concentration of organic matter. 
UVSD calibration curves were obtained by analyzing 7 standard solutions with 
concentrations ranging from 0.10 to 5.00 mg L-1. The standard solutions were constituted by the 
analyte and raw organic matter extract in 0.01 M CaCl2 diluted by a factor of two. Samples were 
centrifuged, filtered and diluted two times prior to analysis. 
UV spectra of reference solutions, standard solutions and samples were performed using 
microcells from Brand, with 1 cm of light path. Spectra were registered between 230 and 320 nm 
for MIN and SLU soils and from 235 to 320 nm for COM soil. A slightly narrower wavelength 
range was selected for COM soil in order to avoid matrix effects due to the very high concentration 
of organic matter. All spectra were obtained in triplicate.  
 The UVSD method described above was adapted from Lima et al. (2010).  
 
6.2.5 Adsorption experiments 
 
The adsorption studies were performed according to the recommendations described in the 
OECD guideline nº 106 (OECD, 2000). 
 A stock solution of carbamazepine (10.0 g L-1) was prepared in methanol and a solution 
with an intermediate concentration (0.10 g L-1) was prepared by diluting the stock solution in ultra-
pure water. The carbamazepine solutions used in the adsorption experiments were prepared by 
diluting the 0.10 g L-1 carbamazepine solution in CaCl2 0.01 M. 
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6.2.5.1 Preliminary studies and suitability of MEKC and UVSD methods 
 
Prior to the determination of carbamazepine adsorption isotherm, some preliminary 
experiments were undertaken in order to determine the time needed to attain the adsorption 
equilibrium. For this purpose, polypropylene tubes with a soil solution ratio of 1:2 (w/v) were 
shaken for different periods of time (from 15 min to 48 h) and analyzed by MEKC.  
Some experiments to test the suitability of the adopted methodologies were also performed. 
To test the stability of carbamazepine and the possibility of adsorption to the polypropylene tubes, 
carbamazepine solutions in 0.01 M CaCl2 were shaken during 4 h at the same conditions of the 
adsorption experiments. The samples were centrifuged, filtered and analyzed as described above. 
Also, tubes with a soil solution ratio of 1:2 (w/v) were shaken for 4 h with a 0.01 M CaCl2 solution 
(without the test substance). Afterwards, and in order to investigate possible matrix effects, the 
samples were centrifuged, filtered and spiked with carbamazepine to a final concentration of 5 mg 
L-1 and subsequently analyzed. For this series of tests, recovery rates were obtained for both MEKC 
and UVSD analysis. All the described experiments were made in triplicate and samples were 
analyzed within the next two days. 
 
6.2.5.2 Batch experiments 
 
Adsorption studies of carbamazepine onto the three selected soils were made using batch 
equilibrium experiments. Five carbamazepine solutions with concentrations ranging from 2.00 to 
10.0 mg L-1 were prepared in 0.01 M CaCl2. The solutions with concentrations ranging from 2.00 
to 8.00 mg L-1 were spiked with methanol so as to level out the methanol percentages in all the 
samples, as it was previously established that it influences the adsorption of the analyte onto soils. 
Accordingly, the final concentration of methanol in all samples was set to 0.1%. For each 
concentration, the carbamazepine solution was added to polypropylene tubes containing a soil 
sample so as to attain a final soil to solution ratio of 1:2 (w/v). Tubes containing carbamazepine 
solutions in the absence of the soil were included for control purposes. The tubes were shaken 
(head over head) at 50 rpm for 4 hours at 24 ± 1º C, centrifuged at 4 000 rpm for 15 min and 
filtered through a 0.22 μm membrane filter. Subsequently, samples were analyzed, in triplicate, by 
MEKC and UVSD. 
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6.3 RESULTS AND DISCUSSION 
 
6.3.1 MEKC and UVSD calibration curves 
 
For MEKC, a linear calibration curve was obtained using 7 standard solutions with 
concentrations ranging from 0.50 to 10.0 mg L-1, by means of a least-squares linear regression 
based on the mean ratio between the peak area of carbamazepine and the peak area of the IS as a 
function of the standard solution concentration. Each standard solution was analyzed in 
quadruplicate; relative standard deviations of areas from repeated injections were below 2%. 
 The UVSD calibration curve was obtained by analyzing 7 standard solutions with 
concentrations ranging from 0.10 to 5.00 mg L-1. The standard solutions were prepared in the same 
matrix of the samples obtained by batch experiments. The results were fitted to a least-squares 
linear regression by plotting the coefficient of carbamazepine in the linear combination of the 
spectra of the individual components as a function of the carbamazepine concentration. The 
calibration procedure was performed for each soil, as the composition of the standard solution 
depends on the soil. Each spectrum was obtained in triplicate and relative standard deviations of the 
carbamazepine coefficient in the linear combination were below 2.5%. 
 The statistical parameters of the calibration curves obtained by MEKC and UVSD are 
shown in Table 6.2. Both methodologies have very good correlation coefficients, confirming the 
good linear response of the methods in the studied range of concentrations. Limit of detection 
(LOD) and limit of quantification (LOQ) were also determined by taking 3sx/y /b and 10sx/y /b, 
respectively, where b is the slope and sx/y is the residual standard deviation of the determined linear 
regression (J.N. Miller and Miller, 2005). Similar results were obtained for both methods, with the 
exception of the LOQ value for the MIN soil, determined by UVSD, which is slightly higher than 
the value obtained by MEKC or the LOQ values obtained for other soils. Nevertheless, the adopted 
methods presented satisfactory statistical figures.  
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Table 6.2. Linear regression equations, correlation coefficients (r), limits of detection (LOD) and limits of 
quantification (LOQ) of the MEKC and UVSD methods, considering the indicated concentration range. 
Linear Regression r LOD/  (mg L-1) 
LOQ/  
(mg L-1) 
Conc. range/  
(mg L-1) 
MEKC 
y = (0.813 ± 0.002) x – (0.026 ± 0.008) 1.0000 0.050 0.104 0.50 – 10.0 
UVSD - SLU 
y = (0.488 ± 0.004) x + (0.00 ± 0.01) 0.9998 0.05 0.17 0.10 – 5.00 
UVSD - COM 
y = (0.465 ± 0.003) x + (0.019 ± 0.009) 0.9998 0.064 0.189 0.10 – 5.00 
UVSD - MIN 
y = (0.483 ± 0.007) x + (0.01 ± 0.02) 0.9994 0.09 0.31 0.10 – 5.00 
 
 
6.3.2 Preliminary studies and suitability of MEKC and UVSD to 
follow the adsorption experiments 
 
Preliminary experiments had shown that a soil solution ratio of 1:2 (w/v) was adequate to 
achieve between 40 and 60% of adsorption of the initial liquid-phase concentration; hence, this 
ratio was adopted to perform the subsequent experiments. 
 The experiments concerning the adsorption kinetics of carbamazepine enabled to conclude 
that the adsorption equilibrium was quickly reached, attaining approximately 55% of adsorbed 
analyte. No significant differences were found between the amount of carbamazepine adsorbed 
after 15 min or after 48 h of shaking. Based on these results, a reasonable 4 h period was 
established for performing batch experiments. 
 The suitability of MEKC and UVSD to analyze batch experiment samples was also tested. 
This procedure was intended to evaluate the existence of matrix effects capable of significantly 
influencing the performance of the methods. The raw organic matter extract (in 0.01 M CaCl2) of 
the SLU soil was spiked with carbamazepine (at concentration levels of 5.0 mg L-1 and 2.5 mg L-1 
for MEKC and UVSD, respectively). The solutions were subsequently analyzed and mean 
recoveries (n=3) of 95 ± 3% and 90.2 ± 0.7% were obtained for MEKC and UVSD, respectively. 
Additionally, and in order to test the stability of carbamazepine during batch experiments or even 
the adsorption of carbamazepine onto the polypropylene tubes, control samples (in the absence of 
the soils) were analyzed. Table 6.3 presents the average recoveries obtained by both methodologies 
when analyzing control samples at different concentration levels. Once again, satisfactory 
recoveries between 90 ± 1% and 100 ± 2% (for MEKC) and 84.0 ± 0.5% and 105 ± 1% (for 
Adsorption of carbamazepine onto agricultural soils | Chapter 6 
 
179 
 
UVSD) were obtained, confirming the suitability of the selected methodologies to follow 
adsorption experiments of carbamazepine onto soils. 
 
Table 6.3. Average recoveries (%) (± standard deviation) of carbamazepine in control samples obtained by 
MEKC and UVSD at two concentration levels (2 and 8 mg L-1; 1 and 4 mg L-1, respectively). Data are an 
average of triplicate batch experiments. 
 
MEKC UVSD 
2 mg L-1 8 mg L-1 1 mg L-1 4 mg L-1 
SLU 96 ± 3 100 ± 2 93.0 ± 0.2 96.0 ± 0.2 
COM 94.8 ± 0.7 99 ± 1 99 ± 1 105 ± 1 
MIN 93 ± 2 90 ± 1 86.7 ± 0.6 84.0 ± 0.5 
 
 
6.3.3 Adsorption experiments 
 
6.3.3.1 UVSD analysis 
 
The samples were diluted by a factor of two prior to UVSD analysis to avoid potential 
problems caused by the high concentrations of dissolved organic matter. In Figure 6.1a, examples 
of spectra of reference solutions (0.005 M CaCl2, organic matter raw extract and carbamazepine) 
and a spectrum of a sample obtained by batch experiments with the soil SLU are shown. By 
observing the residuals plots of the carbamazepine coefficient in the linear combination it was 
possible to conclude that the obtained residuals were independent of the detection wavelength in all 
the studied soils (example in Figure 6.1b). This leads to the conclusion that the quantification of 
carbamazepine by UVSD was not affected by systematic errors and the wavelength range used to 
the UVSD analysis was adequately selected.  
 
6.3.3.2 Comparison between MEKC and UVSD 
 
Carbamazepine adsorption isotherms were obtained by plotting the amount of 
carbamazepine adsorbed per unit weight of soil (Qe) as a function of the carbamazepine 
concentration that remained in solution (Ce) and by fitting the Freundlich equation (equation 6.2) to 
the results. The results obtained by MEKC and UVSD for the 3 selected soils are presented in 
Figure 6.2. 
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Figure 6.1. a) UV spectra of reference solutions for adsorption experiments with soil fertilized with sewage 
sludge (background, organic matter raw extract and carbamazepine) and total UV spectrum of a sample, in 
the wavelength range used to perform the deconvolution. b) Residuals of the carbamazepine coefficient as a 
function of the wavelength. 
 
 
 
Figure 6.2. Comparison of adsorption isotherms obtained for carbamazepine with the soils a) MIN (mineral 
fertilization), b) SLU (sewage sludge fertilization) and c) COM (compost fertilization). Results obtained by 
MEKC and UVSD are shown in green and blue, respectively and are an average of triplicate batch 
experiments (± standard deviation). 
 
 In the Table 6.4, the Freundlich adsorption coefficient KF, the degree of non-linearity N and 
the correlation coefficient r of the fitting to the Freundlich equation are shown. The Freundlich 
equation is an adequate model to describe the carbamazepine adsorption onto these soils, as the 
correlation coefficients range from 0.994 to 0.996 and from 0.999 to 1.000 for MEKC and UVSD, 
respectively. A two-tailed t-student test was performed to investigate significant differences 
between the results determined by both methods. The calculated t values are lower than the critical 
t value at 95% confidence level (with 4 degrees of freedom) for the two evaluated parameters and 
for all the soils. This test confirms that there are no statistical differences between the results 
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obtained by both methodologies, validating the UVSD method to follow the adsorption of 
carbamazepine onto soils. 
 
Table 6.4. Freundlich adsorption coefficients (KF) and degree of non-linearity (N) for the adsorption of 
carbamazepine onto agricultural soils subject to long-term fertilizations: sewage sludge (SLU), compost 
(COM) and mineral (MIN). Results are an average of triplicate adsorption batch experiments (± standard 
deviation). The two-tailed t-student test is also presented. 
  MEKC UVSD t-student* 
SL
U
 KF /(mg1-N LN Kg-1) 3.0 ± 0.2 3.35 ± 0.04 2.68 
N 0.84 ± 0.06 0.82 ± 0.01 0.48 
r 0.996 1.000 - 
C
O
M
 KF /(mg1-N LN Kg-1) 5.0 ± 0.3  4.8 ± 0.2 1.32 
N 0.82 ± 0.07 0.90 ± 0.04 1.77 
r 0.994 0.999 - 
M
IN
 KF /(mg1-N LN Kg-1) 2.1 ± 0.2 1.79 ± 0.07 2.56 
N 0.88 ± 0.08 0.97 ± 0.03 1.58 
r 0.995 0.999 - 
* For 4 degrees of freedom at 95% confidence level, the critical t value is 2.78 (two-tailed test). 
 
 
6.3.4 Environmental relevance of the results 
 
Carbamazepine adsorption presents a non-linear behavior (N ranging from 0.82 ± 0.07 to 
0.88 ± 0.08 and from 0.82 ± 0.01 to 0.97 ± 0.03, as determined by MEKC and UVSD, respectively) 
which indicates a decrease on the tendency to adsorb onto soils with the increase of the initial 
concentration of carbamazepine in solution. Also, the results emphasize that the adsorption 
behavior of carbamazepine is clearly dependent on the soil organic matter content. Higher 
adsorption coefficients (see Table 6.4) were obtained for the soil with the highest content of 
organic matter (COM, total organic matter 9.4 ± 1.0%) and lower coefficients were obtained for the 
soil with the lowest content of organic matter (MIN, total organic matter 5.3 ± 0.3%). KF values 
normalized to the soils’ TOC (KFOC) were also determined, using KF coefficients obtained by 
MEKC (Table 6.5). The normalized KF coefficient is independent of the total content of organic 
carbon and only depends on the organic matter specific characteristics (such as origin and genesis, 
which are also known to influence the sorption capacity of a soil). After normalization, very similar 
KFOC were obtained, ranging from 151.5 to 181.2. The highest normalized adsorption coefficient 
was still observed for the COM soil, similarly to the non-normalized results; however, the MIN soil 
(the soil with lowest organic matter content) has a higher KFOC than the SLU soil (Table 6.5), 
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indicating that the specific characteristics of the MIN soil organic matter are more favorable to the 
adsorption of carbamazepine than those of the SLU soil. Moreover, a concentration specific 
distribution coefficient (Kd*), independent of the isotherm linearity, was determined and the results 
were also normalized to the soils’ TOC (Koc*). These values are consistent with the conclusions 
taken for KF and KFOC. However, Kd* and Koc* also allow a proper comparison with data from other 
studies where the linearity of the adsorption isotherm is different or the Freundlich fitting is not 
applied. Results are gathered in Table 6.5.  
 
Table 6.5. Freundlich adsorption coefficient (KF in mg1-N LN Kg-1), concentration specific distribution 
coefficient (Kd* in L Kg-1, determined using an initial concentration of 6 mg L-1) and respective values 
normalized to the total organic carbon content (KFOC and KOC*). The presented parameters were calculated 
with data determined by MEKC. 
 KF KFOC Kd* KOC* 
SLU  3.0 ± 0.2 151.5 2.6 ± 0.2 130.7 
COM  5.0 ± 0.3 181.2 4.4 ± 0.4 161.1 
MIN  2.1 ± 0.2 169.4 1.9 ± 0.2 150.3 
 
 
In the literature, there are three main studies about the sorption characteristics of 
carbamazepine onto soils, considering soils with different properties and organic matter contents 
(Williams et al., 2006; Chefetz et al., 2008; Yu et al., 2009). Yu et al. (2009) reported KF 
coefficients between 0.10 ± 0.01 and 14.3 ± 0.01 mg1-N LN Kg-1, depending on the soil under study 
and Chefetz et al. (2008) determined KOC values from 116.3 to 176.0. On the whole, results from 
these two studies are in good agreement with this work, describing carbamazepine as a medium-
low adsorption affinity pharmaceutical with a non-linear behavior. On the other hand, Williams et 
al. (2006) reported higher KOC values (from 885 to 1250) and identified carbamazepine as a 
pharmaceutical that highly adsorbs onto soils and with low soil mobility. These differences should 
be indicative that the sorption behavior of carbamazepine exhibits a significant dependence of 
several factors such as soil composition, fertilization or irrigation conditions, which also make an 
accurate comparison of inter-study results harder. 
Overall, the relatively low adsorption coefficients determined in this study, even 
considering the soil fertilized with compost, demonstrate that this pharmaceutical, apart from 
quickly adsorbing onto soils (very fast adsorption kinetics), is not extensively adsorbed. Hence, it is 
reasonable to expect that a significant percentage of carbamazepine present at the water/soil 
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interface remains in solution. It is also expectable that soils that frequently receive wastewater 
effluents and sludge constitute a source of carbamazepine to adjacent rivers and ground waters.   
 
6.4 CONCLUSIONS 
 
The adsorption behavior of carbamazepine onto agricultural soils was found to be 
dependent on soil fertilization (directly related to its organic matter content): higher organic matter 
content resulted in higher sorption capacity. The results highlight that carbamazepine is not 
extensively adsorbed onto soils particularly in the case of those subjected to mineral fertilization. 
Consequently, contaminated soils (due to the common use of effluents for crop irrigation and 
application of sludge) may be a potential source of carbamazepine into adjacent surface and ground 
waters by leaching. The results here presented underline the environmental risks involved in these 
applications of treated effluents and sludge, taking into account that the presence of carbamazepine 
in these matrices is generalized worldwide.   
The medium-low distribution coefficients also indicate that, when in the water/soil 
interface, a significant amount of carbamazepine should remain in the aqueous phase which further 
validates the adequacy of this anti-epileptic to be used as a marker of anthropogenic pollution. 
 In what concerns the adopted UVSD method, this study shows that it constitutes a valid 
and accurate approach to follow sorption experiments onto soils. The use of this methodology, in 
comparison with the reference method used (MEKC), has the main advantage of being a simple 
and fast procedure, enabling the analysis of a large number of samples in a few hours and with low 
equipment requirements.  
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7.1 CONCLUSIONS 
 
The occurrence of psychiatric pharmaceuticals in the environment has recently raised a 
widespread concern about the serious effects that their presence might have in the ecosystems. As a 
part of the global effort that, in the last few years, is being made to improve the understanding of 
this multidisciplinary issue, the work presented in this thesis is intended to positively contribute to 
the clarification of some important processes that affect the environmental occurrence and fate of 
psychiatric pharmaceuticals.  
Overall, and in what concerns the anti-epileptic pharmaceutical carbamazepine, the 
evidence presented in this thesis allows to support the hypothesis which considers carbamazepine 
as an adequate marker of anthropogenic pollution. Carbamazepine has shown to be particularly 
resistant to direct photodegradation under environmentally relevant conditions and, in water/soil 
interfaces it remains in the aqueous phase in significant amounts. The described results, in 
conjunction with the global high levels of consumption and its resistance to WWTP degradation 
processes (well document in the literature and confirmed  in  Chapter 5), make this pharmaceutical 
a good target compound to the identification of relevant focus of pollution, caused by domestic and 
urban wastewaters. In line with this assessment, this work was also concerned with the 
development of a fast and reliable method to the determination of such an important pollutant in 
many types of real aqueous matrices. As a result, an enzyme-linked immunosorbent assay was 
developed and optimized, being an important tool to perform future large-scale screenings. 
This thesis also presents results concerning the direct and indirect photodegradation of 
benzodiazepines under environmentally relevant conditions. This was the first work to give insights 
into the relevance of photo processes in the persistence of this group of pharmaceuticals. The 
reported data revealed that pharmaceuticals such as diazepam, oxazepam and alprazolam are not 
significantly eliminated from aquatic environments by photodegradation, at a reasonable time 
scale. On the contrary, the benzodiazepine lorazepam was quickly eliminated under the same 
conditions. Environmental half-lives of diazepam, oxazepam and alprazolam seem to be higher 
than the ones observed for carbamazepine (which is already described in literature as an extremely 
resistant compound). This fact is a clear indication that studying benzodiazepines under 
environmental conditions should be a priority issue in future research. Furthermore, this study also 
elucidated that distinct fractions of dissolved organic matter influence the photodegradation 
processes of these compounds differently. 
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One of the main focuses of this research work was the identification of the direct 
photodegradation products of the five selected compounds. The majority of the identified 
photoproducts is documented here for the first time. This identification is crucial for future 
investigations as it will allow evaluating whether these photoproducts occur in the environment in 
significant quantities (in relation to the parent compound) and to assess potential toxicological 
problems that may be derived from their presence.  
 
7.2 FUTURE WORK 
 
As was emphasized along this document, the existing knowledge about the phenomena that 
dictate the fate and persistence of psychiatric pharmaceuticals is still limited. Thus, as a result of 
the novelty and complexity of the addressed topics (and also inherently to the scientific research 
process) the work here presented not only provides answers but also raises a number of pertinent 
questions. 
Concerning photodegradation processes, the reasons behind the observed influence of 
environmentally relevant parameters such as dissolved oxygen and dissolved organic matter is still 
lacking a consistent and mechanistic elucidation. In this context, further work should be performed 
in order to clarify the chemical species involved, for instance, in the enhancement of 
carbamazepine´s photodegradation in the absence of oxygen and also in the enhancement of 
benzodiazepines’ photodegradation in the presence of some fractions of humic substances and in a 
larger range of concentrations. Moreover, and in order to provide progressively more 
environmentally relevant data, it should be interesting to perform photodegradation experiments 
using real aqueous matrices from different proveniences and with different well-defined 
characteristics. These studies would allow not only to have an even more realistic idea about the 
resistance of these pharmaceuticals to photodegradation in real environments, but also to identify 
the individual components responsible for enhancing/inhibitory effects. 
In order to complement the performed photodegradation studies of benzodiazepines, and 
similarly to carbamazepine, the behavior of these psychiatric pharmaceuticals in water/soil 
interfaces should be investigated. The preference of these compounds to remain in the aqueous or 
in the solid phase will largely influence the relevance of the described photodegradation processes 
and will positively contribute to the definition of the most relevant issues to be addressed in future 
work.  
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